|
G |
A2m |
alpha-2-macroglobulin |
increases expression decreases expression |
EXP ISO |
ochratoxin A results in increased expression of A2M mRNA ochratoxin A results in decreased expression of A2M mRNA |
CTD |
PMID:12700408 PMID:30008028 |
|
NCBI chr 4:154,897,770...154,947,787
Ensembl chr 4:154,897,877...154,947,786
|
|
G |
Aadac |
arylacetamide deacetylase |
affects expression |
EXP |
ochratoxin A affects the expression of AADAC mRNA |
CTD |
PMID:17483316 |
|
NCBI chr 2:144,163,436...144,186,086
Ensembl chr 2:144,135,319...144,174,734
|
|
G |
Aars1 |
alanyl-tRNA synthetase 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of AARS1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr19:38,999,130...39,021,152
Ensembl chr19:38,999,163...39,021,147
|
|
G |
Abat |
4-aminobutyrate aminotransferase |
decreases expression |
EXP |
ochratoxin A results in decreased expression of ABAT mRNA |
CTD |
PMID:18417182 |
|
NCBI chr10:6,996,688...7,092,835
Ensembl chr10:6,999,819...7,092,835
|
|
G |
Abca8 |
ATP binding cassette subfamily A member 8 |
affects transport multiple interactions |
ISO |
ABCA8 protein affects the transport of ochratoxin A ochratoxin A inhibits the reaction [ABCA8 protein results in increased uptake of estradiol-17 beta-glucuronide] |
CTD |
PMID:12379217 |
|
NCBI chr10:94,917,520...94,991,199
Ensembl chr10:94,917,520...94,990,988
|
|
G |
Abcb11 |
ATP binding cassette subfamily B member 11 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of ABCB11 mRNA |
CTD |
PMID:12700408 |
|
NCBI chr 3:54,016,854...54,112,797
Ensembl chr 3:54,017,127...54,112,730
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
decreases expression |
EXP |
ochratoxin A results in decreased expression of ABCB1A mRNA |
CTD |
PMID:18417182 |
|
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
|
|
G |
Abcb1b |
ATP-binding cassette, sub-family B member 1B |
increases expression |
EXP |
ochratoxin A results in increased expression of ABCB1B mRNA |
CTD |
PMID:16251485 |
|
NCBI chr 4:25,242,761...25,325,194
Ensembl chr 4:25,242,798...25,325,199
|
|
G |
Abcb6 |
ATP binding cassette subfamily B member 6 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of ABCB6 mRNA |
CTD |
PMID:19287073 |
|
NCBI chr 9:76,668,554...76,677,263
Ensembl chr 9:76,668,554...76,676,924
|
|
G |
Abcc2 |
ATP binding cassette subfamily C member 2 |
multiple interactions affects export affects transport decreases expression increases expression |
ISO EXP |
biochanin A inhibits the reaction [ABCC2 protein affects the export of ochratoxin A]; chrysin inhibits the reaction [ABCC2 protein affects the export of ochratoxin A]; Genistein inhibits the reaction [ABCC2 protein affects the export of ochratoxin A]; Polyphenols inhibits the reaction [ABCC2 protein affects the export of ochratoxin A]; Polyphenols metabolite inhibits the reaction [ABCC2 protein affects the export of ochratoxin A]; Quercetin inhibits the reaction [ABCC2 protein affects the export of ochratoxin A]; resveratrol inhibits the reaction [ABCC2 protein affects the export of ochratoxin A] ABCC2 protein affects the transport of ochratoxin A ochratoxin A results in decreased expression of ABCC2 mRNA ochratoxin A results in increased expression of ABCC2 mRNA |
CTD |
PMID:15955639 PMID:16251485 PMID:19505989 PMID:23358140 PMID:26505656 PMID:28532671 PMID:29126803 More...
|
|
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
|
|
G |
Abcg1 |
ATP binding cassette subfamily G member 1 |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of ABCG1 mRNA; ochratoxin A results in decreased expression of ABCG1 mRNA |
CTD |
PMID:24356939 |
|
NCBI chr20:9,126,687...9,182,948
Ensembl chr20:9,126,687...9,182,948
|
|
G |
Abcg2 |
ATP binding cassette subfamily G member 2 |
affects response to substance decreases transport affects transport decreases response to substance decreases expression increases expression increases transport |
ISO EXP |
ABCG2 protein affects the susceptibility to ochratoxin A ABCG2 protein results in decreased transport of ochratoxin A ABCG2 protein affects the transport of ochratoxin A ABCG2 protein results in decreased susceptibility to ochratoxin A ochratoxin A results in decreased expression of ABCG2 mRNA ochratoxin A results in increased expression of ABCG2 mRNA ABCG2 protein results in increased transport of ochratoxin A |
CTD |
PMID:28532671 PMID:29126803 PMID:32470353 |
|
NCBI chr 4:87,676,241...87,802,757
Ensembl chr 4:87,745,319...87,802,409
|
|
G |
Abcg4 |
ATP binding cassette subfamily G member 4 |
decreases methylation increases expression |
EXP |
ochratoxin A results in decreased methylation of ABCG4 gene ochratoxin A results in increased expression of ABCG4 mRNA |
CTD |
PMID:37162024 |
|
NCBI chr 8:44,611,187...44,629,818
Ensembl chr 8:44,611,187...44,626,881
|
|
G |
Abhd14a |
abhydrolase domain containing 14A |
increases expression |
EXP |
ochratoxin A results in increased expression of ABHD14A mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 8:107,079,139...107,089,004
Ensembl chr 8:107,079,144...107,086,985
|
|
G |
Abhd3 |
abhydrolase domain containing 3, phospholipase |
decreases expression increases methylation |
EXP |
ochratoxin A results in decreased expression of ABHD3 mRNA ochratoxin A results in increased methylation of ABHD3 gene |
CTD |
PMID:37162024 |
|
NCBI chr18:1,723,203...1,778,488
Ensembl chr18:1,720,718...1,803,428
|
|
G |
Abi3 |
ABI family, member 3 |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of ABI3 mRNA; ochratoxin A results in decreased expression of ABI3 mRNA |
CTD |
PMID:26314263 |
|
NCBI chr10:80,769,819...80,780,816
Ensembl chr10:80,769,822...80,780,816
|
|
G |
Abraxas1 |
abraxas 1, BRCA1 A complex subunit |
decreases expression |
EXP |
ochratoxin A results in decreased expression of ABRAXAS1 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr14:8,796,281...8,810,625
Ensembl chr14:8,796,266...8,810,622
|
|
G |
Acaa1a |
acetyl-CoA acyltransferase 1A |
decreases expression |
ISO EXP |
ochratoxin A results in decreased expression of ACAA1 mRNA ochratoxin A results in decreased expression of ACAA1A mRNA |
CTD |
PMID:12700408 PMID:19287073 |
|
NCBI chr 8:119,079,401...119,088,626
Ensembl chr 8:119,079,775...119,088,624
|
|
G |
Acp4 |
acid phosphatase 4 |
decreases methylation increases expression |
EXP |
ochratoxin A results in decreased methylation of ACP4 gene ochratoxin A results in increased expression of ACP4 mRNA |
CTD |
PMID:37162024 |
|
NCBI chr 1:94,736,376...94,751,871
Ensembl chr 1:94,735,514...94,744,623
|
|
G |
Acsl1 |
acyl-CoA synthetase long-chain family member 1 |
increases expression |
EXP |
ochratoxin A results in increased expression of ACSL1 mRNA |
CTD |
PMID:16251485 |
|
NCBI chr16:45,755,246...45,821,541
Ensembl chr16:45,755,254...45,821,541
|
|
G |
Acss1 |
acyl-CoA synthetase short-chain family member 1 |
increases methylation decreases expression |
EXP |
ochratoxin A results in increased methylation of ACSS1 gene ochratoxin A results in decreased expression of ACSS1 mRNA |
CTD |
PMID:37162024 |
|
NCBI chr 3:139,450,383...139,500,325
Ensembl chr 3:139,450,383...139,500,325
|
|
G |
Acss2 |
acyl-CoA synthetase short-chain family member 2 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of ACSS2 mRNA |
CTD |
PMID:19717638 |
|
NCBI chr 3:144,003,808...144,047,452
Ensembl chr 3:144,004,336...144,059,675
|
|
G |
Acta2 |
actin alpha 2, smooth muscle |
increases expression multiple interactions |
EXP ISO |
ochratoxin A results in increased expression of ACTA2 protein Ethanol affects the reaction [ochratoxin A results in increased expression of ACTA2 protein] 4-(4-(3-(pyridin-2-yl)-1H-pyrazol-4-yl)pyridin-2-yl)-N-(tetrahydro-2H-pyran-4-yl)benzamide inhibits the reaction [ochratoxin A results in increased expression of ACTA2 protein]; [ochratoxin A co-treated with Citrinin] results in increased expression of ACTA2 mRNA; [ochratoxin A co-treated with Citrinin] results in increased expression of ACTA2 protein; SMAD2 affects the reaction [ochratoxin A results in increased expression of ACTA2 mRNA]; SMAD2 affects the reaction [ochratoxin A results in increased expression of ACTA2 protein]; SMAD3 affects the reaction [ochratoxin A results in increased expression of ACTA2 mRNA]; SMAD3 affects the reaction [ochratoxin A results in increased expression of ACTA2 protein] ochratoxin A results in increased expression of ACTA2 mRNA; ochratoxin A results in increased expression of ACTA2 protein |
CTD |
PMID:16622519 PMID:29673704 PMID:32617660 PMID:33543323 PMID:35543154 |
|
NCBI chr 1:231,746,527...231,759,307
Ensembl chr 1:231,746,548...231,759,554
|
|
G |
Actb |
actin, beta |
increases expression |
ISO |
ochratoxin A results in increased expression of ACTB protein |
CTD |
PMID:31276768 |
|
NCBI chr12:11,663,112...11,666,697
Ensembl chr12:11,663,109...11,672,877
|
|
G |
Actn1 |
actinin, alpha 1 |
increases expression |
ISO |
ochratoxin A metabolite results in increased expression of ACTN1 mRNA; ochratoxin A results in increased expression of ACTN1 mRNA |
CTD |
PMID:26314263 |
|
NCBI chr 6:98,998,553...99,093,334
Ensembl chr 6:98,998,556...99,093,251
|
|
G |
Acvr2a |
activin A receptor type 2A |
increases expression |
EXP |
ochratoxin A results in increased expression of ACVR2A mRNA |
CTD |
PMID:12700408 |
|
NCBI chr 3:33,204,961...33,292,673
Ensembl chr 3:33,205,523...33,289,968
|
|
G |
Acy1 |
aminoacylase 1 |
increases expression |
EXP |
ochratoxin A results in increased expression of ACY1 protein |
CTD |
PMID:31369848 |
|
NCBI chr 8:107,072,354...107,077,756
Ensembl chr 8:107,072,358...107,077,682
|
|
G |
Adh1c |
alcohol dehydrogenase 1C (class I), gamma polypeptide |
decreases expression |
EXP |
ochratoxin A results in decreased expression of ADH1 mRNA |
CTD |
PMID:12700408 |
|
NCBI chr 2:226,797,303...226,808,892
Ensembl chr 2:226,797,303...226,808,892
|
|
G |
Adh6 |
alcohol dehydrogenase 6 (class V) |
decreases expression |
EXP |
ochratoxin A results in decreased expression of ADH6 mRNA |
CTD |
PMID:30449730 |
|
NCBI chr 2:226,903,208...226,934,564
Ensembl chr 2:226,903,250...226,934,534
|
|
G |
Adm |
adrenomedullin |
increases expression |
EXP |
ochratoxin A results in increased expression of ADM mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 1:164,745,484...164,747,655
Ensembl chr 1:164,745,466...164,747,654
|
|
G |
Adora2a |
adenosine A2a receptor |
increases acetylation |
ISO |
ochratoxin A results in increased acetylation of ADORA2A promoter |
CTD |
PMID:29098329 |
|
NCBI chr20:13,315,848...13,333,386
Ensembl chr20:13,315,853...13,333,386
|
|
G |
Afp |
alpha-fetoprotein |
increases expression |
ISO |
ochratoxin A results in increased expression of AFP mRNA |
CTD |
PMID:30008028 |
|
NCBI chr14:17,573,412...17,591,476
Ensembl chr14:17,573,412...17,591,480
|
|
G |
Aggf1 |
angiogenic factor with G patch and FHA domains 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of AGGF1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 2:26,619,336...26,646,050
Ensembl chr 2:26,619,339...26,645,952
|
|
G |
Agt |
angiotensinogen |
decreases expression |
EXP |
ochratoxin A results in decreased expression of AGT mRNA |
CTD |
PMID:16251485 |
|
NCBI chr19:52,529,139...52,549,618
Ensembl chr19:52,529,185...52,540,977
|
|
G |
Ahr |
aryl hydrocarbon receptor |
increases expression affects localization multiple interactions |
ISO |
ochratoxin A results in increased expression of AHR mRNA ochratoxin A affects the localization of AHR protein AHR protein affects the reaction [ochratoxin A results in increased expression of GCLC mRNA]; AHR protein affects the reaction [ochratoxin A results in increased expression of HAVCR1 mRNA]; AHR protein affects the reaction [ochratoxin A results in increased expression of HMOX1 mRNA]; AHR protein affects the reaction [ochratoxin A results in increased expression of NFE2L2 mRNA] |
CTD |
PMID:21834667 PMID:30291945 |
|
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
|
|
G |
Aifm1 |
apoptosis inducing factor, mitochondria associated 1 |
multiple interactions decreases expression |
ISO |
BNIP3L protein inhibits the reaction [ochratoxin A results in decreased expression of AIFM1 mRNA] |
CTD |
PMID:24755393 |
|
NCBI chr X:127,650,223...127,689,356
Ensembl chr X:127,650,226...127,689,256
|
|
G |
Aimp1 |
aminoacyl tRNA synthetase complex-interacting multifunctional protein 1 |
increases expression |
ISO |
ochratoxin A metabolite results in increased expression of AIMP1 mRNA; ochratoxin A results in increased expression of AIMP1 mRNA |
CTD |
PMID:26314263 |
|
NCBI chr 2:221,151,907...221,175,458
Ensembl chr 2:221,151,904...221,175,728
|
|
G |
Ak1 |
adenylate kinase 1 |
increases expression |
EXP |
ochratoxin A results in increased expression of AK1 mRNA |
CTD |
PMID:18417182 |
|
NCBI chr 3:15,912,431...15,923,045
Ensembl chr 3:15,912,485...15,923,041
|
|
G |
Ak2 |
adenylate kinase 2 |
increases expression |
ISO |
ochratoxin A results in increased expression of AK2 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 5:141,308,650...141,364,633
Ensembl chr 5:141,346,063...141,364,632
|
|
G |
Akap12 |
A-kinase anchoring protein 12 |
increases expression |
EXP |
ochratoxin A results in increased expression of AKAP12 mRNA |
CTD |
PMID:19717638 |
|
NCBI chr 1:40,730,123...40,819,863
Ensembl chr 1:40,730,123...40,819,886
|
|
G |
Akap17a |
A-kinase anchoring protein 17A |
decreases expression |
EXP |
ochratoxin A results in decreased expression of AKAP17B mRNA |
CTD |
PMID:30449730 |
|
NCBI chr12:16,310,427...16,315,166
Ensembl chr12:16,310,437...16,314,479
|
|
G |
Akr1a1 |
aldo-keto reductase family 1 member A1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of AKR1A1 mRNA |
CTD |
PMID:32905824 |
|
NCBI chr 5:130,092,945...130,130,277
Ensembl chr 5:130,092,732...130,113,674
|
|
G |
Akr1b1 |
aldo-keto reductase family 1 member B1 |
increases expression |
ISO |
ochratoxin A results in increased expression of AKR1B1 mRNA |
CTD |
PMID:32905824 |
|
NCBI chr 4:62,932,033...62,946,126
Ensembl chr 4:62,932,031...62,946,157
|
|
G |
Akr1b10 |
aldo-keto reductase family 1 member B10 |
decreases expression |
EXP ISO |
ochratoxin A results in decreased expression of AKR1B10 mRNA |
CTD |
PMID:18417182 PMID:32905824 |
|
NCBI chr 4:63,038,459...63,060,336
Ensembl chr 4:63,040,169...63,053,852
|
|
G |
Akr1b7 |
aldo-keto reductase family 1, member B7 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of AKR1B7 mRNA |
CTD |
PMID:30449730 |
|
NCBI chr 4:63,053,560...63,100,934
Ensembl chr 4:63,076,800...63,089,502
|
|
G |
Akr1c1 |
aldo-keto reductase family 1, member C1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of AKR1C1 mRNA |
CTD |
PMID:19287073 PMID:32905824 |
|
NCBI chr17:65,810,474...65,837,385
Ensembl chr17:65,810,475...65,837,326
|
|
G |
Akr1c2 |
aldo-keto reductase family 1, member C2 |
decreases expression |
ISO EXP |
ochratoxin A results in decreased expression of AKR1C2 mRNA |
CTD |
PMID:19287073 PMID:30449730 PMID:32905824 |
|
NCBI chr17:65,759,778...65,808,013
Ensembl chr17:65,759,788...65,775,764
|
|
G |
Akr1c3 |
aldo-keto reductase family 1, member C3 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of AKR1C3 mRNA |
CTD |
PMID:19287073 PMID:32905824 |
|
NCBI chr17:66,110,970...66,127,867
Ensembl chr17:66,110,963...66,127,873
|
|
G |
Akr7a3 |
aldo-keto reductase family 7 member A3 |
multiple interactions decreases expression |
EXP |
[cafestol co-treated with kahweol] inhibits the reaction [ochratoxin A results in decreased expression of AKR7A3 protein] ochratoxin A results in decreased expression of AKR7A3 mRNA; ochratoxin A results in decreased expression of AKR7A3 protein |
CTD |
PMID:16251485 PMID:17110534 |
|
NCBI chr 5:151,590,968...151,601,394
Ensembl chr 5:151,584,479...151,601,394
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
increases expression increases phosphorylation multiple interactions |
EXP ISO |
ochratoxin A results in increased expression of AKT1 mRNA ochratoxin A results in increased phosphorylation of AKT1 protein 5-((2,6-dichlorobenzyl)sulfonyl)-3-((3,5-dimethyl-4-((2-(pyrrolidin-1-ylmethyl)pyrrolidin-1-yl)carbonyl)-1H-pyrrol-2-yl)methylene)-1,3-dihydro-2H-indol-2-one inhibits the reaction [ochratoxin A results in increased phosphorylation of AKT1 protein]; INS protein inhibits the reaction [ochratoxin A results in decreased phosphorylation of AKT1 protein]; Wortmannin inhibits the reaction [ochratoxin A results in increased phosphorylation of AKT1 protein] |
CTD |
PMID:16251485 PMID:23172667 PMID:25002221 PMID:30287338 PMID:31154016 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Alad |
aminolevulinate dehydratase |
decreases expression |
EXP |
ochratoxin A results in decreased expression of ALAD mRNA |
CTD |
PMID:18417182 |
|
NCBI chr 5:75,961,993...75,972,334
Ensembl chr 5:75,961,993...75,972,474
|
|
G |
Alb |
albumin |
affects binding decreases transport |
EXP ISO |
ochratoxin A binds to ALB protein ALB protein results in decreased transport of ochratoxin A |
CTD |
PMID:10454219 PMID:22037670 |
|
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
|
|
G |
Aldh1a1 |
aldehyde dehydrogenase 1 family, member A1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of ALDH1A1 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 1:218,000,470...218,152,962
Ensembl chr 1:218,042,127...218,152,961
|
|
G |
Aldh1a2 |
aldehyde dehydrogenase 1 family, member A2 |
increases expression |
EXP |
ochratoxin A results in increased expression of ALDH1A2 mRNA |
CTD |
PMID:18417182 |
|
NCBI chr 8:71,877,850...71,957,107
Ensembl chr 8:71,877,850...71,957,107
|
|
G |
Aldh3a2 |
aldehyde dehydrogenase 3 family, member A2 |
increases expression decreases expression |
EXP ISO |
ochratoxin A results in increased expression of ALDH3A2 mRNA ochratoxin A results in decreased expression of ALDH3A2 mRNA |
CTD |
PMID:16251485 PMID:32905824 |
|
NCBI chr10:45,928,313...45,949,366
Ensembl chr10:45,908,524...45,949,281
|
|
G |
Aldh4a1 |
aldehyde dehydrogenase 4 family, member A1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of ALDH4A1 protein |
CTD |
PMID:31369848 |
|
NCBI chr 5:151,880,002...151,905,491
Ensembl chr 5:151,830,701...151,925,345
|
|
G |
Aldh7a1 |
aldehyde dehydrogenase 7 family, member A1 |
decreases acetylation |
ISO |
ochratoxin A results in decreased acetylation of ALDH7A1 promoter |
CTD |
PMID:29098329 |
|
NCBI chr18:50,003,242...50,042,193
Ensembl chr18:50,009,934...50,042,193
|
|
G |
Aldh8a1 |
aldehyde dehydrogenase 8 family, member A1 |
increases expression |
ISO |
ochratoxin A metabolite results in increased expression of ALDH8A1 mRNA; ochratoxin A results in increased expression of ALDH8A1 mRNA |
CTD |
PMID:23824090 PMID:24356939 |
|
NCBI chr 1:16,183,940...16,203,385
Ensembl chr 1:16,183,940...16,203,385
|
|
G |
Alg13 |
ALG13, UDP-N-acetylglucosaminyltransferase subunit |
decreases expression |
ISO |
ochratoxin A results in decreased expression of ALG13 mRNA |
CTD |
PMID:19287073 |
|
NCBI chr X:107,906,320...107,968,232
Ensembl chr X:107,885,093...107,942,695
|
|
G |
Alox15b |
arachidonate 15-lipoxygenase, type B |
increases expression |
EXP |
ochratoxin A results in increased expression of ALOX15B mRNA |
CTD |
PMID:30449730 |
|
NCBI chr10:53,892,496...53,901,812
Ensembl chr10:53,892,466...53,901,812
|
|
G |
Alox5 |
arachidonate 5-lipoxygenase |
affects expression decreases expression |
ISO |
ochratoxin A affects the expression of ALOX5 mRNA ochratoxin A results in decreased expression of ALOX5 mRNA |
CTD |
PMID:26505656 |
|
NCBI chr 4:149,531,329...149,578,696
Ensembl chr 4:149,531,515...149,578,743
|
|
G |
Alpl |
alkaline phosphatase, biomineralization associated |
increases expression |
ISO |
ochratoxin A results in increased expression of ALPL protein |
CTD |
PMID:35543154 |
|
NCBI chr 5:149,951,397...150,006,424
Ensembl chr 5:149,951,409...150,006,446
|
|
G |
Amigo2 |
adhesion molecule with Ig like domain 2 |
decreases acetylation multiple interactions decreases expression affects expression |
ISO |
ochratoxin A results in decreased acetylation of AMIGO2 promoter [ochratoxin A results in decreased acetylation of AMIGO2 promoter] which results in decreased expression of AMIGO2 mRNA ochratoxin A results in decreased expression of AMIGO2 mRNA ochratoxin A affects the expression of AMIGO2 mRNA |
CTD |
PMID:29098329 PMID:30008028 |
|
NCBI chr 7:128,391,493...128,394,589
Ensembl chr 7:128,390,412...128,394,695
|
|
G |
Amotl2 |
angiomotin like 2 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of AMOTL2 mRNA |
CTD |
PMID:30763683 |
|
NCBI chr 8:103,303,368...103,319,161
Ensembl chr 8:103,302,992...103,318,910
|
|
G |
Ang |
angiogenin |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of ANG mRNA; ochratoxin A results in decreased expression of ANG mRNA |
CTD |
PMID:26314263 |
|
NCBI chr15:24,312,711...24,323,361
|
|
G |
Angpt1 |
angiopoietin 1 |
increases expression |
EXP |
ochratoxin A results in increased expression of ANGPT1 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 7:73,528,345...73,783,953
Ensembl chr 7:73,531,486...73,784,067
|
|
G |
Ankrd2 |
ankyrin repeat domain 2 |
increases expression decreases methylation |
EXP |
ochratoxin A results in increased expression of ANKRD2 mRNA ochratoxin A results in decreased methylation of ANKRD2 gene |
CTD |
PMID:37162024 |
|
NCBI chr 1:240,847,111...240,856,563
Ensembl chr 1:240,847,072...240,856,566
|
|
G |
Anln |
anillin, actin binding protein |
increases expression |
ISO |
ochratoxin A results in increased expression of ANLN mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 8:20,858,227...20,921,602
Ensembl chr 8:20,858,228...20,921,538
|
|
G |
Ano6 |
anoctamin 6 |
increases methylation |
EXP |
ochratoxin A results in increased methylation of ANO6 gene |
CTD |
PMID:26431795 |
|
NCBI chr 7:126,933,919...127,113,588
Ensembl chr 7:126,933,936...127,113,589
|
|
G |
Anxa1 |
annexin A1 |
increases expression |
EXP |
ochratoxin A results in increased expression of ANXA1 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 1:217,861,175...217,877,205
Ensembl chr 1:217,861,175...217,877,343
|
|
G |
Anxa13 |
annexin A13 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of ANXA13 mRNA |
CTD |
PMID:30449730 |
|
NCBI chr 7:89,884,356...89,936,907
Ensembl chr 7:89,884,356...89,936,907
|
|
G |
Anxa2 |
annexin A2 |
increases expression |
EXP |
ochratoxin A results in increased expression of ANXA2 mRNA |
CTD |
PMID:12700408 PMID:18417182 |
|
NCBI chr 8:70,105,268...70,141,663
Ensembl chr 8:70,105,253...70,141,658
|
|
G |
Anxa3 |
annexin A3 |
increases expression decreases methylation |
EXP ISO |
ochratoxin A results in increased expression of ANXA3 mRNA ochratoxin A results in increased expression of ANXA3 mRNA; ochratoxin A results in increased expression of ANXA3 protein ochratoxin A results in decreased methylation of ANXA3 gene |
CTD |
PMID:18417182 PMID:31276768 PMID:37162024 |
|
NCBI chr14:12,727,708...12,781,717
Ensembl chr14:12,719,795...12,781,617
|
|
G |
Anxa4 |
annexin A4 |
increases expression |
EXP |
ochratoxin A results in increased expression of ANXA4 protein |
CTD |
PMID:31369848 |
|
NCBI chr 4:119,184,378...119,241,183
Ensembl chr 4:119,184,374...119,241,161
|
|
G |
Aoc3 |
amine oxidase, copper containing 3 |
increases expression |
EXP ISO |
ochratoxin A results in increased expression of AOC3 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr10:86,272,757...86,280,702
|
|
G |
Apaf1 |
apoptotic peptidase activating factor 1 |
increases expression decreases expression multiple interactions |
EXP ISO |
ochratoxin A results in increased expression of APAF1 mRNA ochratoxin A results in decreased expression of APAF1 mRNA [fumonisin B1 co-treated with ochratoxin A] results in increased expression of APAF1 protein; fumonisin B1 promotes the reaction [ochratoxin A results in increased expression of APAF1 mRNA] |
CTD |
PMID:17316727 PMID:19562491 PMID:36397609 |
|
NCBI chr 7:25,494,143...25,579,540
Ensembl chr 7:25,494,609...25,579,540
|
|
G |
Apex1 |
apurinic/apyrimidinic endodeoxyribonuclease 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of APEX1 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr15:24,144,595...24,146,785
Ensembl chr15:24,144,362...24,146,785
|
|
G |
Aplf |
aprataxin and PNKP like factor |
increases expression |
EXP |
ochratoxin A results in increased expression of APLF mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 4:120,070,471...120,122,656
Ensembl chr 4:120,070,471...120,122,633
|
|
G |
Apoa4 |
apolipoprotein A4 |
increases expression |
EXP |
ochratoxin A results in increased expression of APOA4 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 8:46,539,083...46,541,464
Ensembl chr 8:46,539,082...46,541,469
|
|
G |
Apob |
apolipoprotein B |
decreases expression |
EXP |
ochratoxin A results in decreased expression of APOB mRNA |
CTD |
PMID:16251485 PMID:19717638 |
|
NCBI chr 6:30,844,386...30,883,983
Ensembl chr 6:30,844,368...30,892,497
|
|
G |
Apoc1 |
apolipoprotein C1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of APOC1 mRNA |
CTD |
PMID:12700408 |
|
NCBI chr 1:79,347,057...79,350,340
Ensembl chr 1:79,346,136...79,350,375
|
|
G |
Apoe |
apolipoprotein E |
increases expression |
EXP |
ochratoxin A results in increased expression of APOE mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 1:79,353,924...79,357,852
Ensembl chr 1:79,353,916...79,357,932
|
|
G |
App |
amyloid beta precursor protein |
increases expression |
ISO |
ochratoxin A results in increased expression of APP mRNA |
CTD |
PMID:30008028 |
|
NCBI chr11:24,019,774...24,236,584
Ensembl chr11:24,019,778...24,236,561
|
|
G |
Appbp2 |
amyloid beta precursor protein binding protein 2 |
increases expression |
EXP |
ochratoxin A results in increased expression of APPBP2 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr10:70,057,774...70,099,877
Ensembl chr10:70,057,774...70,099,835
|
|
G |
Aptx |
aprataxin |
decreases expression |
EXP |
ochratoxin A results in decreased expression of APTX mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 5:55,798,896...55,822,963
Ensembl chr 5:55,800,248...55,822,855
|
|
G |
Aqp1 |
aquaporin 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of AQP1 mRNA |
CTD |
PMID:16251485 PMID:18417182 |
|
NCBI chr 4:84,482,512...84,494,690
Ensembl chr 4:84,482,512...84,494,690
|
|
G |
Aqp8 |
aquaporin 8 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of AQP8 mRNA |
CTD |
PMID:16251485 |
|
NCBI chr 1:177,993,313...177,999,158
Ensembl chr 1:177,993,305...177,999,158
|
|
G |
Ar |
androgen receptor |
decreases activity |
ISO |
ochratoxin A results in decreased activity of AR protein |
CTD |
PMID:27481073 |
|
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
|
|
G |
Arap2 |
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2 |
increases methylation |
EXP |
ochratoxin A results in increased methylation of ARAP2 gene |
CTD |
PMID:26431795 |
|
NCBI chr14:46,717,657...46,917,326
Ensembl chr14:46,718,760...46,917,154
|
|
G |
Arfgap2 |
ADP-ribosylation factor GTPase activating protein 2 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of ARFGAP2 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 3:77,236,305...77,248,445
Ensembl chr 3:77,236,322...77,248,455
|
|
G |
Arfgef1 |
ADP ribosylation factor guanine nucleotide exchange factor 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of ARFGEF1 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 5:8,982,061...9,076,326
Ensembl chr 5:8,981,540...9,076,326
|
|
G |
Arg1 |
arginase 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of ARG1 mRNA |
CTD |
PMID:30008028 |
|
NCBI chr 1:20,475,878...20,488,422
Ensembl chr 1:20,475,968...20,488,422
|
|
G |
Arhgap35 |
Rho GTPase activating protein 35 |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of ARHGAP35 mRNA; ochratoxin A results in decreased expression of ARHGAP35 mRNA |
CTD |
PMID:26314263 |
|
NCBI chr 1:77,202,436...77,319,298
Ensembl chr 1:77,202,436...77,319,298
|
|
G |
Arl4c |
ADP ribosylation factor like GTPase 4C |
decreases expression |
ISO |
ochratoxin A results in decreased expression of ARL4C mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 9:89,300,335...89,303,770
Ensembl chr 9:89,298,005...89,304,513
|
|
G |
Arl5a |
ADP-ribosylation factor like GTPase 5A |
decreases expression |
ISO |
ochratoxin A results in decreased expression of ARL5A mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 3:36,878,461...36,903,362
Ensembl chr 3:36,880,712...36,903,211
|
|
G |
Arrdc3 |
arrestin domain containing 3 |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of ARRDC3 mRNA; ochratoxin A results in decreased expression of ARRDC3 mRNA |
CTD |
PMID:24356939 |
|
NCBI chr 2:11,137,464...11,149,978
Ensembl chr 2:11,137,460...11,149,978
|
|
G |
Asb13 |
ankyrin repeat and SOCS box-containing 13 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of ASB13 mRNA |
CTD |
PMID:18417182 |
|
NCBI chr17:66,564,653...66,583,365
Ensembl chr17:66,562,434...66,583,337
|
|
G |
Ascl1 |
achaete-scute family bHLH transcription factor 1 |
decreases expression multiple interactions |
EXP |
ochratoxin A results in decreased expression of ASCL1 mRNA SHH protein modified form inhibits the reaction [ochratoxin A results in decreased expression of ASCL1 mRNA] |
CTD |
PMID:21703336 |
|
NCBI chr 7:21,903,136...21,906,003
Ensembl chr 7:21,903,126...21,905,993
|
|
G |
Asic1 |
acid sensing ion channel subunit 1 |
increases acetylation increases expression multiple interactions |
ISO |
ochratoxin A results in increased acetylation of ASIC1 promoter ochratoxin A results in increased expression of ASIC1 mRNA [ochratoxin A results in increased acetylation of ASIC1 promoter] which results in increased expression of ASIC1 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 7:130,798,317...130,828,535
Ensembl chr 7:130,799,917...130,828,541
|
|
G |
Asl |
argininosuccinate lyase |
decreases expression |
EXP |
ochratoxin A results in decreased expression of ASL mRNA |
CTD |
PMID:12700408 |
|
NCBI chr12:26,659,664...26,677,136
Ensembl chr12:26,659,565...26,679,662
|
|
G |
Asns |
asparagine synthetase (glutamine-hydrolyzing) |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of ASNS mRNA; ochratoxin A results in decreased expression of ASNS mRNA |
CTD |
PMID:24356939 PMID:30559759 |
|
NCBI chr 4:35,784,995...35,803,474
Ensembl chr 4:35,785,237...35,803,423
|
|
G |
Aspa |
aspartoacylase |
decreases expression |
EXP |
ochratoxin A results in decreased expression of ASPA mRNA |
CTD |
PMID:12700408 |
|
NCBI chr10:57,891,704...57,945,267
Ensembl chr10:57,892,104...57,945,272
|
|
G |
Asxl1 |
ASXL transcriptional regulator 1 |
multiple interactions decreases expression decreases acetylation |
ISO |
[ochratoxin A results in decreased acetylation of ASXL1 promoter] which results in decreased expression of ASXL1 mRNA ochratoxin A results in decreased expression of ASXL1 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 3:141,814,012...141,881,526
Ensembl chr 3:141,813,433...141,881,538
|
|
G |
Atf3 |
activating transcription factor 3 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of ATF3 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr13:102,751,278...102,800,520
Ensembl chr13:102,751,321...102,764,631
|
|
G |
Atf4 |
activating transcription factor 4 |
decreases expression increases expression |
ISO |
ochratoxin A results in decreased expression of ATF4 mRNA ochratoxin A results in increased expression of ATF4 protein |
CTD |
PMID:30559759 PMID:33465424 |
|
NCBI chr 7:111,804,135...111,806,457
Ensembl chr 7:111,804,183...111,806,446
|
|
G |
Atf6 |
activating transcription factor 6 |
increases expression |
ISO |
ochratoxin A results in increased expression of ATF6 mRNA; ochratoxin A results in increased expression of ATF6 protein |
CTD |
PMID:30559759 PMID:36058351 |
|
NCBI chr13:82,927,579...83,106,381
Ensembl chr13:82,930,034...83,107,177
|
|
G |
Atp1a4 |
ATPase Na+/K+ transporting subunit alpha 4 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of ATP1A4 mRNA |
CTD |
PMID:16251485 |
|
NCBI chr13:84,683,766...84,719,790
Ensembl chr13:84,683,768...84,719,687
|
|
G |
Atp1b1 |
ATPase Na+/K+ transporting subunit beta 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of ATP1B1 mRNA |
CTD |
PMID:30008028 |
|
NCBI chr13:76,786,580...76,807,096
Ensembl chr13:76,786,578...76,807,459
|
|
G |
Atp2a2 |
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 |
increases expression decreases expression |
EXP ISO |
ochratoxin A results in increased expression of ATP2A2 mRNA ochratoxin A results in decreased expression of ATP2A2 mRNA |
CTD |
PMID:16251485 PMID:19287073 PMID:22124623 |
|
NCBI chr12:34,072,710...34,122,142
Ensembl chr12:34,072,683...34,122,101
|
|
G |
Atp2c1 |
ATPase secretory pathway Ca2+ transporting 1 |
multiple interactions increases expression increases acetylation |
ISO |
[ochratoxin A results in increased acetylation of ATP2C1 promoter] which results in increased expression of ATP2C1 mRNA ochratoxin A results in increased expression of ATP2C1 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 8:106,034,777...106,155,854
Ensembl chr 8:106,034,636...106,156,006
|
|
G |
Atp5f1a |
ATP synthase F1 subunit alpha |
increases expression |
EXP |
ochratoxin A results in increased expression of ATP5F1A protein |
CTD |
PMID:31369848 |
|
NCBI chr18:71,292,406...71,300,342
Ensembl chr18:71,292,374...71,300,794
|
|
G |
Atp5f1b |
ATP synthase F1 subunit beta |
increases expression |
ISO |
ochratoxin A results in increased expression of ATP5F1B mRNA ochratoxin A results in increased expression of ATP5F1B protein |
CTD |
PMID:17316727 PMID:19445961 |
|
NCBI chr 7:515,454...521,858
Ensembl chr 7:515,460...567,273
|
|
G |
Atp5f1d |
ATP synthase F1 subunit delta |
increases expression decreases expression |
ISO EXP |
ochratoxin A results in increased expression of ATP5F1D mRNA ochratoxin A results in decreased expression of ATP5F1D protein |
CTD |
PMID:17316727 PMID:31369848 |
|
NCBI chr 7:9,560,604...9,565,919
Ensembl chr 7:9,560,608...9,565,929
|
|
G |
Atp5pf |
ATP synthase peripheral stalk subunit F6 |
increases expression |
ISO |
ochratoxin A results in increased expression of ATP5PF mRNA |
CTD |
PMID:17316727 |
|
NCBI chr11:23,881,594...23,889,581
Ensembl chr11:23,881,592...23,889,119
|
|
G |
Atp6v0c |
ATPase H+ transporting V0 subunit C |
multiple interactions increases acetylation increases expression |
ISO |
[ochratoxin A results in increased acetylation of ATP6V0C promoter] which results in increased expression of ATP6V0C mRNA ochratoxin A results in increased expression of ATP6V0C mRNA |
CTD |
PMID:29098329 |
|
NCBI chr10:13,196,204...13,202,580
Ensembl chr10:13,196,204...13,201,500
|
|
G |
Atp9a |
ATPase phospholipid transporting 9A (putative) |
increases expression |
EXP |
ochratoxin A results in increased expression of ATP9A mRNA |
CTD |
PMID:16251485 |
|
NCBI chr 3:157,360,354...157,467,628
Ensembl chr 3:157,360,359...157,467,818
|
|
G |
Atpaf1 |
ATP synthase mitochondrial F1 complex assembly factor 1 |
increases expression |
ISO |
ochratoxin A results in increased expression of ATPAF1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 5:129,265,789...129,292,463
Ensembl chr 5:129,266,404...129,293,556
|
|
G |
Aurka |
aurora kinase A |
multiple interactions increases expression |
ISO |
TRP53 gene mutant form promotes the reaction [ochratoxin A results in increased expression of AURKA mRNA] |
CTD |
PMID:25636497 |
|
NCBI chr 3:161,128,309...161,144,524
Ensembl chr 3:161,128,313...161,144,390
|
|
G |
Aurkb |
aurora kinase B |
increases activity increases expression |
EXP |
ochratoxin A results in increased activity of AURKB protein ochratoxin A results in increased expression of AURKB mRNA |
CTD |
PMID:19237604 PMID:19717638 |
|
NCBI chr10:53,744,290...53,750,831
Ensembl chr10:53,745,142...53,750,837
|
|
G |
Avil |
advillin |
increases expression |
ISO EXP |
ochratoxin A results in increased expression of AVIL mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 7:62,825,459...62,844,103
Ensembl chr 7:62,826,025...62,844,071
|
|
G |
Azgp1 |
alpha-2-glycoprotein 1, zinc-binding |
decreases expression |
EXP |
ochratoxin A results in decreased expression of AZGP1 mRNA |
CTD |
PMID:18417182 |
|
NCBI chr12:16,930,990...16,939,333
Ensembl chr12:16,931,024...16,939,091
|
|
G |
Azi2 |
5-azacytidine induced 2 |
increases expression |
ISO |
ochratoxin A results in increased expression of AZI2 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 8:117,773,248...117,797,844
Ensembl chr 8:117,773,279...117,797,847
|
|
G |
B3gnt2 |
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2 |
decreases expression increases expression |
ISO EXP |
ochratoxin A results in decreased expression of B3GNT2 mRNA ochratoxin A results in increased expression of B3GNT2 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr14:96,808,473...96,833,674
Ensembl chr14:96,806,664...96,835,273
|
|
G |
B4galt7 |
beta-1,4-galactosyltransferase 7 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of B4GALT7 mRNA |
CTD |
PMID:19287073 |
|
NCBI chr17:9,018,514...9,027,591
Ensembl chr17:9,018,935...9,027,573
|
|
G |
Baat |
bile acid CoA:amino acid N-acyltransferase |
decreases expression |
ISO |
ochratoxin A results in decreased expression of BAAT mRNA |
CTD |
PMID:30008028 |
|
NCBI chr 5:63,851,668...63,860,641
Ensembl chr 5:63,850,705...63,860,685
|
|
G |
Bad |
BCL2-associated agonist of cell death |
increases expression multiple interactions |
EXP ISO |
ochratoxin A results in increased expression of BAD mRNA BNIP3L protein inhibits the reaction [ochratoxin A results in increased expression of BAD mRNA] |
CTD |
PMID:19562491 PMID:24755393 |
|
NCBI chr 1:204,133,502...204,142,829
Ensembl chr 1:204,131,501...204,142,823
|
|
G |
Bag3 |
BAG cochaperone 3 |
multiple interactions decreases expression |
ISO |
[Citrinin co-treated with ochratoxin A] results in decreased expression of BAG3 mRNA; [Citrinin co-treated with ochratoxin A] results in increased expression of BAG3 mRNA ochratoxin A results in decreased expression of BAG3 mRNA |
CTD |
PMID:30428381 |
|
NCBI chr 1:183,103,038...183,126,862
Ensembl chr 1:183,102,871...183,126,858
|
|
G |
Bak1 |
BCL2-antagonist/killer 1 |
increases expression decreases expression multiple interactions |
EXP ISO |
ochratoxin A results in increased expression of BAK1 mRNA ochratoxin A results in decreased expression of BAK1 mRNA; ochratoxin A results in decreased expression of BAK1 protein [Citrinin co-treated with ochratoxin A] results in decreased expression of BAK1 mRNA |
CTD |
PMID:19367635 PMID:23358140 PMID:30428381 |
|
NCBI chr20:5,100,480...5,109,669
Ensembl chr20:5,100,480...5,109,264
|
|
G |
Bard1 |
BRCA1 associated RING domain 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of BARD1 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 9:72,616,070...72,694,553
Ensembl chr 9:72,623,155...72,694,265
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
decreases expression increases response to substance increases expression affects localization multiple interactions |
ISO EXP |
ochratoxin A results in decreased expression of BAX mRNA; ochratoxin A results in decreased expression of BAX protein BAX protein results in increased susceptibility to ochratoxin A ochratoxin A results in increased expression of BAX mRNA; ochratoxin A results in increased expression of BAX protein ochratoxin A affects the localization of BAX protein [Aflatoxin M1 co-treated with ochratoxin A] results in increased expression of BAX protein; BNIP3L protein inhibits the reaction [ochratoxin A results in decreased expression of BAX mRNA]; Oleanolic Acid inhibits the reaction [ochratoxin A results in increased expression of BAX protein]; TRAP1 protein affects the reaction [ochratoxin A results in increased expression of BAX protein]; TRAP1 protein affects the reaction [Oleanolic Acid inhibits the reaction [ochratoxin A results in increased expression of BAX protein]]; Ursolic Acid inhibits the reaction [ochratoxin A results in increased expression of BAX protein] [fumonisin B1 co-treated with ochratoxin A] results in increased expression of BAX protein; fumonisin B1 promotes the reaction [ochratoxin A results in increased expression of BAX mRNA] |
CTD |
PMID:19367635 PMID:20549612 PMID:23208426 PMID:24755393 PMID:31154016 PMID:33465424 PMID:34101318 PMID:34126166 PMID:36397609 PMID:36587836 More...
|
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bbc3 |
Bcl-2 binding component 3 |
decreases expression increases expression multiple interactions |
ISO EXP |
ochratoxin A results in decreased expression of BBC3 mRNA; ochratoxin A results in decreased expression of BBC3 protein ochratoxin A results in increased expression of BBC3 mRNA [NFE2L2 protein affects the susceptibility to ochratoxin A] which results in increased expression of BBC3 protein; ochratoxin A promotes the reaction [NFE2L2 protein affects the expression of BBC3 mRNA]; sulforaphane inhibits the reaction [ochratoxin A results in increased expression of BBC3 mRNA] |
CTD |
PMID:19367635 PMID:23208426 PMID:28710020 PMID:30763683 |
|
NCBI chr 1:77,013,281...77,022,509
Ensembl chr 1:77,014,543...77,022,509
|
|
G |
Bbox1 |
gamma-butyrobetaine hydroxylase 1 |
affects expression |
ISO |
ochratoxin A affects the expression of BBOX1 mRNA |
CTD |
PMID:30008028 |
|
NCBI chr 3:96,822,654...96,871,786
Ensembl chr 3:96,822,655...96,871,458
|
|
G |
Bcam |
basal cell adhesion molecule (Lutheran blood group) |
increases expression decreases methylation |
EXP |
ochratoxin A results in increased expression of BCAM mRNA ochratoxin A results in decreased methylation of BCAM gene |
CTD |
PMID:37162024 |
|
NCBI chr 1:79,415,016...79,429,403
Ensembl chr 1:79,415,017...79,429,403
|
|
G |
Bckdk |
branched chain ketoacid dehydrogenase kinase |
decreases expression |
EXP |
ochratoxin A results in decreased expression of BCKDK mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 1:182,515,335...182,520,007
Ensembl chr 1:182,515,327...182,536,633
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
decreases expression decreases response to substance increases expression multiple interactions |
EXP ISO |
ochratoxin A results in decreased expression of BCL2 mRNA BCL2 protein results in decreased susceptibility to ochratoxin A ochratoxin A results in decreased expression of BCL2 mRNA; ochratoxin A results in decreased expression of BCL2 protein ochratoxin A results in increased expression of BCL2 mRNA [Aflatoxin M1 co-treated with ochratoxin A] results in decreased expression of BCL2 protein; Oleanolic Acid inhibits the reaction [ochratoxin A results in decreased expression of BCL2 protein]; TRAP1 protein affects the reaction [ochratoxin A results in decreased expression of BCL2 protein]; TRAP1 protein affects the reaction [Oleanolic Acid inhibits the reaction [ochratoxin A results in decreased expression of BCL2 protein]]; Ursolic Acid inhibits the reaction [ochratoxin A results in decreased expression of BCL2 protein] fumonisin B1 promotes the reaction [ochratoxin A results in decreased expression of BCL2 mRNA]; fumonisin B1 promotes the reaction [ochratoxin A results in decreased expression of BCL2 protein] |
CTD |
PMID:12700408 PMID:20549612 PMID:23208426 PMID:24755393 PMID:33465424 PMID:34101318 PMID:34126166 PMID:36397609 PMID:36587836 More...
|
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bcl2a1 |
BCL2-related protein A1 |
increases expression |
EXP |
ochratoxin A results in increased expression of BCL2A1 mRNA |
CTD |
PMID:19562491 |
|
NCBI chr 8:89,716,914...89,724,998
Ensembl chr 8:89,716,914...89,724,998
|
|
G |
Bcl2l1 |
Bcl2-like 1 |
decreases expression decreases response to substance increases expression |
ISO EXP |
ochratoxin A results in decreased expression of BCL2L1 mRNA; ochratoxin A results in decreased expression of BCL2L1 protein BCL2L1 protein results in decreased susceptibility to ochratoxin A ochratoxin A results in increased expression of BCL2L1 mRNA |
CTD |
PMID:15056805 PMID:20549612 PMID:23208426 PMID:24755393 PMID:30763683 |
|
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479
|
|
G |
Bcl2l11 |
Bcl2-like 11 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of BCL2L11 mRNA |
CTD |
PMID:30559759 PMID:30763683 |
|
NCBI chr 3:115,366,783...115,404,068
Ensembl chr 3:115,366,646...115,404,068
|
|
G |
Bcl2l12 |
Bcl2 like 12 |
decreases expression multiple interactions |
ISO |
ochratoxin A results in decreased expression of BCL2L12 mRNA [Citrinin co-treated with ochratoxin A] results in decreased expression of BCL2L12 mRNA |
CTD |
PMID:30428381 |
|
NCBI chr 1:95,472,272...95,480,991
Ensembl chr 1:95,472,272...95,480,991
|
|
G |
Bcl6 |
BCL6, transcription repressor |
decreases expression |
EXP |
ochratoxin A results in decreased expression of BCL6 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr11:76,854,090...76,877,389
Ensembl chr11:76,854,090...76,877,389
|
|
G |
Bdh2 |
3-hydroxybutyrate dehydrogenase 2 |
increases expression |
ISO |
ochratoxin A results in increased expression of BDH2 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 2:223,702,410...223,723,076
Ensembl chr 2:223,702,412...223,723,072
|
|
G |
Bdnf |
brain-derived neurotrophic factor |
increases expression |
EXP |
ochratoxin A results in increased expression of BDNF mRNA |
CTD |
PMID:27346841 |
|
NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615
|
|
G |
Becn1 |
beclin 1 |
increases expression multiple interactions |
ISO |
ochratoxin A results in increased expression of BECN1 protein 4-phenylbutyric acid inhibits the reaction [ochratoxin A results in increased expression of BECN1 protein] |
CTD |
PMID:36058351 |
|
NCBI chr10:86,231,387...86,246,742
Ensembl chr10:86,231,388...86,246,742
|
|
G |
Bex1 |
brain expressed X-linked 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of BEX2 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr X:99,219,014...99,220,518
Ensembl chr X:99,219,014...99,220,958
|
|
G |
Bhmt |
betaine-homocysteine S-methyltransferase |
decreases expression |
EXP |
ochratoxin A results in decreased expression of BHMT mRNA |
CTD |
PMID:12700408 |
|
NCBI chr 2:24,859,871...24,879,449
Ensembl chr 2:24,859,873...24,879,742
|
|
G |
Bid |
BH3 interacting domain death agonist |
decreases expression |
ISO |
ochratoxin A results in decreased expression of BID mRNA |
CTD |
PMID:24755393 |
|
NCBI chr 4:154,113,198...154,136,353
Ensembl chr 4:154,113,198...154,134,720
|
|
G |
Bik |
BCL2-interacting killer |
increases expression |
EXP |
ochratoxin A results in increased expression of BIK mRNA |
CTD |
PMID:23208426 PMID:23358140 |
|
NCBI chr 7:114,672,277...114,691,296
Ensembl chr 7:114,672,277...114,691,296
|
|
G |
Birc3 |
baculoviral IAP repeat-containing 3 |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of BIRC3 mRNA; ochratoxin A results in decreased expression of BIRC3 mRNA |
CTD |
PMID:24356939 PMID:30763683 |
|
NCBI chr 8:5,000,844...5,028,470
Ensembl chr 8:5,000,845...5,015,802
|
|
G |
Birc5 |
baculoviral IAP repeat-containing 5 |
increases expression decreases expression |
EXP ISO |
ochratoxin A results in increased expression of BIRC5 mRNA; ochratoxin A results in increased expression of BIRC5 protein ochratoxin A results in decreased expression of BIRC5 mRNA |
CTD |
PMID:19237604 PMID:19562491 PMID:27193732 |
|
NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380
|
|
G |
Blcap |
BLCAP, apoptosis inducing factor |
decreases expression |
ISO |
ochratoxin A results in decreased expression of BLCAP mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 3:146,222,699...146,232,859
Ensembl chr 3:146,222,240...146,232,909
|
|
G |
Blvra |
biliverdin reductase A |
decreases expression |
ISO |
ochratoxin A results in decreased expression of BLVRA mRNA |
CTD |
PMID:32905824 |
|
NCBI chr 3:114,340,778...114,366,048
Ensembl chr 3:114,340,838...114,366,033
|
|
G |
Blvrb |
biliverdin reductase B |
decreases expression |
ISO |
ochratoxin A results in decreased expression of BLVRB mRNA |
CTD |
PMID:32905824 |
|
NCBI chr 1:82,738,646...82,756,312
Ensembl chr 1:82,738,695...82,770,375
|
|
G |
Bmp4 |
bone morphogenetic protein 4 |
increases acetylation increases expression multiple interactions |
ISO |
ochratoxin A results in increased acetylation of BMP4 promoter ochratoxin A results in increased expression of BMP4 mRNA [ochratoxin A results in increased acetylation of BMP4 promoter] which results in increased expression of BMP4 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr15:19,618,538...19,633,494
Ensembl chr15:19,618,542...19,623,306
|
|
G |
Bnip2 |
BCL2 interacting protein 2 |
increases expression |
EXP |
ochratoxin A results in increased expression of BNIP2 mRNA |
CTD |
PMID:19562491 |
|
NCBI chr 8:70,640,436...70,661,782
Ensembl chr 8:70,640,445...70,675,590
|
|
G |
Bnip3 |
BCL2 interacting protein 3 |
increases expression |
EXP |
ochratoxin A results in increased expression of BNIP3 mRNA |
CTD |
PMID:19562491 |
|
NCBI chr 1:193,708,164...193,725,348
Ensembl chr 1:193,708,167...193,725,359
|
|
G |
Bnip3l |
BCL2 interacting protein 3 like |
multiple interactions increases response to substance |
ISO |
BNIP3L protein inhibits the reaction [ochratoxin A results in decreased expression of AIFM1 mRNA]; BNIP3L protein inhibits the reaction [ochratoxin A results in decreased expression of BAX mRNA]; BNIP3L protein inhibits the reaction [ochratoxin A results in decreased expression of SDHA mRNA]; BNIP3L protein inhibits the reaction [ochratoxin A results in decreased expression of SDHA protein]; BNIP3L protein inhibits the reaction [ochratoxin A results in increased expression of BAD mRNA]; BNIP3L protein promotes the reaction [ochratoxin A results in decreased expression of CASP9 mRNA] BNIP3L protein results in increased susceptibility to ochratoxin A |
CTD |
PMID:24755393 |
|
NCBI chr15:41,174,594...41,197,730
Ensembl chr15:41,174,594...41,197,803
|
|
G |
Brca1 |
BRCA1, DNA repair associated |
increases expression |
EXP |
ochratoxin A results in increased expression of BRCA1 mRNA |
CTD |
PMID:37162024 |
|
NCBI chr10:86,417,441...86,477,762
Ensembl chr10:86,418,000...86,477,304
|
|
G |
Brcc3 |
BRCA1/BRCA2-containing complex subunit 3 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of BRCC3 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 9:1,986,942...1,989,484
Ensembl chr 9:1,986,575...1,991,080
|
|
G |
Brd4 |
bromodomain containing 4 |
increases expression |
EXP |
ochratoxin A results in increased expression of BRD4 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 7:11,216,446...11,296,029
Ensembl chr 7:11,216,446...11,295,539
|
|
G |
Brf1 |
BRF1, RNA polymerase III transcription initiation factor subunit |
decreases expression |
EXP |
ochratoxin A results in decreased expression of BRF1 mRNA |
CTD |
PMID:18417182 |
|
NCBI chr 6:132,034,378...132,081,313
Ensembl chr 6:132,037,272...132,081,278
|
|
G |
Brip1 |
BRCA1 interacting helicase 1 |
increases expression |
EXP |
ochratoxin A results in increased expression of BRIP1 mRNA |
CTD |
PMID:23358140 PMID:24243707 |
|
NCBI chr10:70,907,266...71,031,502
Ensembl chr10:70,907,371...71,030,324
|
|
G |
Bsnd |
barttin CLCNK type accessory subunit beta |
increases expression decreases methylation |
EXP |
ochratoxin A results in increased expression of BSND mRNA ochratoxin A results in decreased methylation of BSND gene |
CTD |
PMID:37162024 |
|
NCBI chr 5:121,251,774...121,260,571
Ensembl chr 5:121,251,774...121,260,571
|
|
G |
Btg1 |
BTG anti-proliferation factor 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of BTG1 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 7:31,341,391...31,343,649
Ensembl chr 7:31,341,027...31,343,649
|
|
G |
Bub1b |
BUB1 mitotic checkpoint serine/threonine kinase B |
increases expression |
EXP |
ochratoxin A results in increased expression of BUB1B mRNA |
CTD |
PMID:19237604 |
|
NCBI chr 3:105,563,089...105,615,547
Ensembl chr 3:105,563,138...105,615,547
|
|
G |
C1qa |
complement C1q A chain |
affects expression |
EXP |
ochratoxin A affects the expression of C1QA mRNA |
CTD |
PMID:32468156 |
|
NCBI chr 5:149,133,635...149,136,482
Ensembl chr 5:149,133,636...149,136,534
|
|
G |
C1qb |
complement C1q B chain |
increases expression |
EXP |
ochratoxin A results in increased expression of C1QB mRNA |
CTD |
PMID:16251485 |
|
NCBI chr 5:149,118,843...149,124,394
Ensembl chr 5:149,118,846...149,124,407
|
|
G |
C2h3orf33 |
similar to human chromosome 3 open reading frame 33 |
decreases expression increases methylation |
EXP |
ochratoxin A results in decreased expression of C2H3ORF33 mRNA ochratoxin A results in increased methylation of C2H3ORF33 gene |
CTD |
PMID:37162024 |
|
NCBI chr 2:148,376,598...148,404,343
Ensembl chr 2:148,380,581...148,404,387
|
|
G |
C2h5orf34 |
similar to human chromosome 5 open reading frame 34 |
decreases expression increases methylation |
EXP |
ochratoxin A results in decreased expression of C2H5ORF34 mRNA ochratoxin A results in increased methylation of C2H5ORF34 gene |
CTD |
PMID:37162024 |
|
NCBI chr 2:51,553,223...51,577,090
Ensembl chr 2:51,555,432...51,577,085
|
|
G |
C8h15orf39 |
similar to human chromosome 15 open reading frame 39 |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of C15ORF39 mRNA; ochratoxin A results in decreased expression of C15ORF39 mRNA |
CTD |
PMID:24356939 |
|
NCBI chr 8:57,646,324...57,655,896
Ensembl chr 8:57,645,756...57,655,941
|
|
G |
C9 |
complement C9 |
increases expression |
ISO |
ochratoxin A results in increased expression of C9 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 2:55,573,094...55,621,345
Ensembl chr 2:55,572,992...55,621,338
|
|
G |
Cabp1 |
calcium binding protein 1 |
multiple interactions increases expression increases acetylation |
ISO |
[ochratoxin A results in increased acetylation of CABP1 promoter] which results in increased expression of CABP1 mRNA ochratoxin A results in increased expression of CABP1 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr12:41,385,234...41,448,930
Ensembl chr12:41,378,897...41,448,927
|
|
G |
Cacng5 |
calcium voltage-gated channel auxiliary subunit gamma 5 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of CACNG5 mRNA |
CTD |
PMID:30449730 |
|
NCBI chr10:92,827,441...92,869,632
Ensembl chr10:92,829,196...92,869,614
|
|
G |
Calb1 |
calbindin 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of CALB1 protein |
CTD |
PMID:31369848 |
|
NCBI chr 5:29,375,624...29,402,532
Ensembl chr 5:29,375,642...29,402,431
|
|
G |
Calm1 |
calmodulin 1 |
increases expression |
EXP |
ochratoxin A results in increased expression of CALM1 mRNA |
CTD |
PMID:18417182 |
|
NCBI chr 6:119,487,691...119,495,759
Ensembl chr 6:119,487,621...119,498,227
|
|
G |
Camk2a |
calcium/calmodulin-dependent protein kinase II alpha |
increases expression |
EXP |
ochratoxin A results in increased expression of CAMK2A mRNA |
CTD |
PMID:19237604 |
|
NCBI chr18:54,378,642...54,441,120
Ensembl chr18:54,378,784...54,438,994
|
|
G |
Camk2b |
calcium/calmodulin-dependent protein kinase II beta |
increases expression |
EXP |
ochratoxin A results in increased expression of CAMK2B mRNA |
CTD |
PMID:23358140 |
|
NCBI chr14:80,845,206...80,934,172
Ensembl chr14:80,845,238...80,933,994
|
|
G |
Capn6 |
calpain 6 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of CAPN6 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr X:107,380,774...107,405,489
Ensembl chr X:107,380,774...107,405,489
|
|
G |
Capza1 |
capping actin protein of muscle Z-line subunit alpha 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of CAPZA1 protein |
CTD |
PMID:31276768 |
|
NCBI chr 2:192,319,696...192,364,755
Ensembl chr 2:192,319,702...192,364,480
|
|
G |
Capzb |
capping actin protein of muscle Z-line subunit beta |
increases acetylation increases expression multiple interactions |
ISO |
ochratoxin A results in increased acetylation of CAPZB promoter ochratoxin A results in increased expression of CAPZB mRNA [ochratoxin A results in increased acetylation of CAPZB promoter] which results in increased expression of CAPZB mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 5:151,435,600...151,535,409
Ensembl chr 5:151,434,871...151,535,409
|
|
G |
Car10 |
carbonic anhydrase 10 |
increases expression |
ISO |
ochratoxin A results in increased expression of CA10 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr10:78,055,875...78,556,490
Ensembl chr10:78,054,114...78,555,834
|
|
G |
Casp1 |
caspase 1 |
increases expression increases cleavage |
ISO |
ochratoxin A results in increased expression of CASP1 mRNA ochratoxin A results in increased cleavage of CASP1 protein |
CTD |
PMID:33543323 |
|
NCBI chr 8:2,587,812...2,597,403
Ensembl chr 8:2,587,831...2,597,383
|
|
G |
Casp12 |
caspase 12 |
increases expression |
EXP |
ochratoxin A results in increased expression of CASP12 mRNA |
CTD |
PMID:23208426 |
|
NCBI chr 8:2,642,296...2,669,549
Ensembl chr 8:2,642,434...2,674,037
|
|
G |
Casp2 |
caspase 2 |
multiple interactions decreases expression |
ISO |
[Citrinin co-treated with ochratoxin A] results in decreased expression of CASP2 mRNA ochratoxin A results in decreased expression of CASP2 mRNA |
CTD |
PMID:30428381 |
|
NCBI chr 4:71,149,632...71,167,388
Ensembl chr 4:71,149,669...71,167,379
|
|
G |
Casp3 |
caspase 3 |
increases cleavage decreases expression multiple interactions increases activity increases expression |
ISO EXP |
ochratoxin A results in increased cleavage of CASP3 protein ochratoxin A results in decreased expression of CASP3 mRNA [Aflatoxin M1 co-treated with ochratoxin A] results in increased expression of CASP3 protein; Citrinin inhibits the reaction [ochratoxin A results in increased activity of CASP3 protein]; ochratoxin A results in increased cleavage of and results in increased activity of CASP3 protein; Oleanolic Acid inhibits the reaction [ochratoxin A results in increased cleavage of CASP3 protein]; U 0126 inhibits the reaction [ochratoxin A results in increased activity of CASP3 protein]; Wortmannin promotes the reaction [ochratoxin A results in increased activity of CASP3 protein] ochratoxin A analog results in increased activity of CASP3 protein; ochratoxin A results in increased activity of CASP3 protein ochratoxin A results in increased expression of CASP3 mRNA; ochratoxin A results in increased expression of CASP3 protein SLC22A2 protein affects the reaction [ochratoxin A results in increased expression of CASP3 mRNA]; SLC22A2 protein promotes the reaction [ochratoxin A results in increased expression of CASP3 protein] [fumonisin B1 co-treated with ochratoxin A] results in increased cleavage of CASP3 protein; fumonisin B1 promotes the reaction [ochratoxin A results in increased expression of CASP3 mRNA] |
CTD |
PMID:12700408 PMID:15056805 PMID:17316727 PMID:19367635 PMID:19815060 PMID:20060447 PMID:20549612 PMID:24755393 PMID:25002221 PMID:27193732 PMID:27422291 PMID:29673704 PMID:30120945 PMID:33465424 PMID:34101318 PMID:34126166 PMID:36397609 More...
|
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp7 |
caspase 7 |
increases expression decreases expression multiple interactions increases activity |
EXP ISO |
ochratoxin A results in increased expression of CASP7 mRNA ochratoxin A results in decreased expression of CASP7 mRNA U 0126 inhibits the reaction [ochratoxin A results in increased activity of CASP7 protein]; wortmannin promotes the reaction [ochratoxin A results in increased activity of CASP7 protein] |
CTD |
PMID:17316727 PMID:19562491 PMID:25002221 |
|
NCBI chr 1:255,437,438...255,476,737
Ensembl chr 1:255,437,172...255,476,729
|
|
G |
Casp8 |
caspase 8 |
decreases expression increases activity |
ISO |
ochratoxin A results in decreased expression of CASP8 mRNA ochratoxin A results in increased activity of CASP8 protein |
CTD |
PMID:17316727 PMID:24755393 PMID:27193732 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Casp9 |
caspase 9 |
multiple interactions increases activity increases cleavage decreases expression increases expression |
ISO EXP |
BNIP3L protein promotes the reaction [ochratoxin A results in decreased expression of CASP9 mRNA]; ochratoxin A results in increased cleavage of and results in increased activity of CASP9 protein; Oleanolic Acid inhibits the reaction [ochratoxin A results in increased cleavage of CASP9 protein] ochratoxin A results in increased activity of CASP9 protein [fumonisin B1 co-treated with ochratoxin A] results in increased cleavage of CASP9 protein; fumonisin B1 promotes the reaction [ochratoxin A results in increased expression of CASP9 mRNA] |
CTD |
PMID:15056805 PMID:17316727 PMID:19367635 PMID:19562491 PMID:20549612 PMID:24755393 PMID:33465424 PMID:36397609 More...
|
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cat |
catalase |
decreases expression increases expression decreases activity multiple interactions |
EXP ISO |
ochratoxin A results in decreased expression of CAT mRNA ochratoxin A results in increased expression of CAT mRNA ochratoxin A results in decreased activity of CAT protein [fumonisin B1 co-treated with ochratoxin A] results in increased activity of CAT protein; Quercetin inhibits the reaction [ochratoxin A results in decreased activity of CAT protein] [Chitosan analog co-treated with Quercetin] inhibits the reaction [ochratoxin A results in decreased activity of CAT protein]; Chitosan analog inhibits the reaction [ochratoxin A results in decreased activity of CAT protein] [NFE2L2 protein affects the susceptibility to ochratoxin A] which results in decreased expression of CAT mRNA |
CTD |
PMID:12700408 PMID:17316727 PMID:25532488 PMID:27923682 PMID:28710020 PMID:37633472 More...
|
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Ccdc113 |
coiled-coil domain containing 113 |
decreases methylation |
EXP |
ochratoxin A results in decreased methylation of CCDC113 gene |
CTD |
PMID:26431795 |
|
NCBI chr19:9,497,000...9,516,917
Ensembl chr19:9,496,886...9,516,923
|
|
G |
Ccdc97 |
coiled-coil domain containing 97 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of CCDC97 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 1:81,219,225...81,227,017
Ensembl chr 1:81,219,230...81,226,986
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
affects expression |
EXP |
ochratoxin A affects the expression of CCL5 mRNA |
CTD |
PMID:32468156 |
|
NCBI chr10:68,322,826...68,327,380
Ensembl chr10:68,322,829...68,327,377
|
|
G |
Ccn1 |
cellular communication network factor 1 |
increases expression decreases methylation |
EXP |
ochratoxin A results in increased expression of CCN1 mRNA ochratoxin A results in decreased methylation of CCN1 gene |
CTD |
PMID:37162024 |
|
NCBI chr 2:234,562,410...234,565,370
Ensembl chr 2:234,562,408...234,565,484
|
|
G |
Ccn2 |
cellular communication network factor 2 |
increases expression decreases expression |
EXP |
ochratoxin A results in increased expression of CCN2 mRNA ochratoxin A results in decreased expression of CCN2 mRNA |
CTD |
PMID:19717638 PMID:23358140 |
|
NCBI chr 1:20,802,199...20,805,315
Ensembl chr 1:20,802,199...20,805,734
|
|
G |
Ccn4 |
cellular communication network factor 4 |
increases expression |
ISO |
ochratoxin A analog results in increased expression of CCN4 mRNA; ochratoxin A results in increased expression of CCN4 mRNA |
CTD |
PMID:27422291 |
|
NCBI chr 7:98,645,238...98,677,253
Ensembl chr 7:98,645,182...98,677,248
|
|
G |
Ccna2 |
cyclin A2 |
increases expression decreases acetylation multiple interactions decreases expression |
EXP ISO |
ochratoxin A results in increased expression of CCNA2 mRNA ochratoxin A results in decreased acetylation of CCNA2 promoter [ochratoxin A results in decreased acetylation of CCNA2 promoter] which results in decreased expression of CCNA2 mRNA ochratoxin A results in decreased expression of CCNA2 mRNA |
CTD |
PMID:18417182 PMID:19237604 PMID:23358140 PMID:24243707 PMID:29098329 PMID:38301995 More...
|
|
NCBI chr 2:119,427,239...119,433,645
Ensembl chr 2:119,426,089...119,433,577
|
|
G |
Ccnb1 |
cyclin B1 |
multiple interactions decreases expression increases expression |
ISO EXP |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [ochratoxin A inhibits the reaction [CDK1 protein binds to CCNB1 protein]]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [ochratoxin A results in decreased expression of CCNB1 protein]; 4-phenylbutyric acid inhibits the reaction [ochratoxin A results in decreased expression of CCNB1 protein]; [Citrinin co-treated with ochratoxin A] results in decreased expression of CCNB1 mRNA; MAPK1 protein promotes the reaction [ochratoxin A inhibits the reaction [CDK1 protein binds to CCNB1 protein]]; MAPK1 protein promotes the reaction [ochratoxin A results in decreased expression of CCNB1 protein]; MAPK14 protein promotes the reaction [ochratoxin A inhibits the reaction [CDK1 protein binds to CCNB1 protein]]; MAPK14 protein promotes the reaction [ochratoxin A results in decreased expression of CCNB1 protein]; ochratoxin A inhibits the reaction [CCNB1 protein binds to CDK1 protein]; ochratoxin A inhibits the reaction [CDK1 protein binds to CCNB1 protein]; SB 203580 inhibits the reaction [ochratoxin A inhibits the reaction [CDK1 protein binds to CCNB1 protein]]; SB 203580 inhibits the reaction [ochratoxin A results in decreased expression of CCNB1 protein] ochratoxin A results in decreased expression of CCNB1 mRNA; ochratoxin A results in decreased expression of CCNB1 protein ochratoxin A results in increased expression of CCNB1 mRNA |
CTD |
PMID:19237604 PMID:19717638 PMID:20060447 PMID:22230261 PMID:23358140 PMID:30428381 PMID:36058351 PMID:38301995 More...
|
|
NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
|
|
G |
Ccnb2 |
cyclin B2 |
increases expression |
EXP |
ochratoxin A results in increased expression of CCNB2 mRNA |
CTD |
PMID:19237604 PMID:19717638 |
|
NCBI chr 8:71,087,594...71,100,794
Ensembl chr 8:71,087,595...71,100,874
|
|
G |
Ccnd1 |
cyclin D1 |
multiple interactions increases expression |
ISO |
ochratoxin A promotes the reaction [FOS protein binds to CCND1 promoter]; ochratoxin A promotes the reaction [RELA protein binds to CCND1 promoter] ochratoxin A results in increased expression of CCND1 mRNA; ochratoxin A results in increased expression of CCND1 protein |
CTD |
PMID:23172667 |
|
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Ccnd2 |
cyclin D2 |
decreases expression multiple interactions |
EXP |
ochratoxin A results in decreased expression of CCND2 mRNA SHH protein modified form inhibits the reaction [ochratoxin A results in decreased expression of CCND2 mRNA] |
CTD |
PMID:21703336 |
|
NCBI chr 4:159,966,883...159,989,261
Ensembl chr 4:159,962,363...159,989,495
|
|
G |
Ccne1 |
cyclin E1 |
increases expression multiple interactions decreases expression |
EXP ISO |
ochratoxin A results in increased expression of CCNE1 mRNA TRP53 gene mutant form promotes the reaction [ochratoxin A results in increased expression of CCNE1 mRNA] ochratoxin A results in decreased expression of CCNE1 mRNA [Citrinin co-treated with ochratoxin A] results in decreased expression of CCNE1 mRNA |
CTD |
PMID:19237604 PMID:23358140 PMID:25636497 PMID:30428381 PMID:31154016 PMID:37162024 PMID:38301995 More...
|
|
NCBI chr 1:90,781,947...90,791,188
Ensembl chr 1:90,781,949...90,791,101
|
|
G |
Ccne2 |
cyclin E2 |
increases expression decreases expression |
EXP ISO |
ochratoxin A results in increased expression of CCNE2 mRNA ochratoxin A results in decreased expression of CCNE2 mRNA |
CTD |
PMID:19237604 PMID:30763683 |
|
NCBI chr 5:24,285,078...24,298,258
Ensembl chr 5:24,284,922...24,297,632
|
|
G |
Ccng1 |
cyclin G1 |
decreases expression increases expression multiple interactions |
ISO EXP |
ochratoxin A results in decreased expression of CCNG1 mRNA ochratoxin A results in increased expression of CCNG1 mRNA [Citrinin co-treated with ochratoxin A] results in decreased expression of CCNG1 mRNA; [Citrinin co-treated with ochratoxin A] results in decreased expression of CCNG1 protein |
CTD |
PMID:19287073 PMID:23358140 PMID:30428381 |
|
NCBI chr10:25,176,231...25,182,604
Ensembl chr10:25,176,234...25,181,641
|
|
G |
Ccng2 |
cyclin G2 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of CCNG2 mRNA |
CTD |
PMID:24356939 |
|
NCBI chr14:14,804,321...14,812,819
Ensembl chr14:14,804,322...14,812,830
|
|
G |
Cct8 |
chaperonin containing TCP1 subunit 8 |
affects expression |
ISO |
ochratoxin A affects the expression of CCT8 protein |
CTD |
PMID:26861962 |
|
NCBI chr11:26,710,370...26,722,079
Ensembl chr11:26,710,370...26,722,079
|
|
G |
Cd22 |
CD22 molecule |
increases expression multiple interactions increases acetylation |
ISO |
ochratoxin A results in increased expression of CD22 mRNA [ochratoxin A results in increased acetylation of CD22 promoter] which results in increased expression of CD22 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 1:86,116,376...86,132,782
Ensembl chr 1:86,117,459...86,132,322
|
|
G |
Cd24 |
CD24 molecule |
decreases expression |
ISO |
ochratoxin A results in decreased expression of CD24 mRNA |
CTD |
PMID:19287073 |
|
NCBI chr20:47,074,353...47,079,662
Ensembl chr20:47,073,512...47,079,662
|
|
G |
Cd2bp2 |
Cd2 (cytoplasmic tail) binding protein 2 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of CD2BP2 mRNA |
CTD |
PMID:19287073 PMID:22124623 |
|
NCBI chr 1:181,809,399...181,815,269
Ensembl chr 1:181,809,406...181,813,448
|
|
G |
Cd44 |
CD44 molecule |
increases expression |
EXP |
ochratoxin A results in increased expression of CD44 mRNA |
CTD |
PMID:23358140 PMID:37162024 |
|
NCBI chr 3:89,155,850...89,244,615
Ensembl chr 3:89,157,058...89,244,620
|
|
G |
Cd69 |
Cd69 molecule |
decreases expression |
ISO |
ochratoxin A results in decreased expression of CD69 mRNA |
CTD |
PMID:24356939 |
|
NCBI chr 4:162,725,446...162,733,364
Ensembl chr 4:162,725,446...162,733,542
|
|
G |
Cd74 |
CD74 molecule |
increases expression |
EXP |
ochratoxin A results in increased expression of CD74 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr18:54,256,757...54,266,003
Ensembl chr18:54,256,778...54,266,003
|
|
G |
Cd81 |
Cd81 molecule |
increases acetylation multiple interactions increases expression |
ISO |
ochratoxin A results in increased acetylation of CD81 promoter [ochratoxin A results in increased acetylation of CD81 promoter] which results in increased expression of CD81 mRNA ochratoxin A results in increased expression of CD81 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 1:198,235,861...198,251,660
Ensembl chr 1:198,241,484...198,251,660
|
|
G |
Cd86 |
CD86 molecule |
increases expression |
EXP |
ochratoxin A results in increased expression of CD86 mRNA |
CTD |
PMID:24792326 |
|
NCBI chr11:64,142,193...64,200,816
Ensembl chr11:64,163,828...64,200,818
|
|
G |
Cdc20 |
cell division cycle 20 |
increases expression |
EXP |
ochratoxin A results in increased expression of CDC20 mRNA |
CTD |
PMID:19237604 |
|
NCBI chr 5:131,966,203...131,970,406
Ensembl chr 5:131,966,215...131,970,512
|
|
G |
Cdc23 |
cell division cycle 23 |
decreases expression multiple interactions |
ISO |
ochratoxin A results in decreased expression of CDC23 mRNA [Citrinin co-treated with ochratoxin A] results in decreased expression of CDC23 mRNA |
CTD |
PMID:30428381 |
|
NCBI chr18:26,236,891...26,260,611
Ensembl chr18:26,236,890...26,291,163
|
|
G |
Cdc25a |
cell division cycle 25A |
decreases expression multiple interactions |
ISO |
ochratoxin A results in decreased expression of CDC25A mRNA [Citrinin co-treated with ochratoxin A] results in decreased expression of CDC25A mRNA |
CTD |
PMID:30428381 PMID:30763683 |
|
NCBI chr 8:109,864,356...109,882,734
Ensembl chr 8:109,864,478...109,882,701
|
|
G |
Cdc25c |
cell division cycle 25C |
multiple interactions decreases expression |
ISO |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [ochratoxin A results in decreased expression of CDC25C protein modified form]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [ochratoxin A results in decreased expression of CDC25C protein]; 4-phenylbutyric acid inhibits the reaction [ochratoxin A results in decreased expression of CDC25C protein]; [Citrinin co-treated with ochratoxin A] results in decreased expression of CDC25C mRNA; MAPK1 protein promotes the reaction [ochratoxin A results in decreased expression of CDC25C protein modified form]; MAPK1 protein promotes the reaction [ochratoxin A results in decreased expression of CDC25C protein]; MAPK14 protein promotes the reaction [ochratoxin A results in decreased expression of CDC25C protein modified form]; MAPK14 protein promotes the reaction [ochratoxin A results in decreased expression of CDC25C protein]; SB 203580 inhibits the reaction [ochratoxin A results in decreased expression of CDC25C protein modified form]; SB 203580 inhibits the reaction [ochratoxin A results in decreased expression of CDC25C protein] ochratoxin A results in decreased expression of CDC25C mRNA; ochratoxin A results in decreased expression of CDC25C protein; ochratoxin A results in decreased expression of CDC25C protein modified form |
CTD |
PMID:20060447 PMID:22230261 PMID:30428381 PMID:36058351 |
|
NCBI chr18:26,335,156...26,356,199
Ensembl chr18:26,335,834...26,356,185
|
|
G |
Cdc26 |
cell division cycle 26 |
multiple interactions decreases expression |
ISO |
[Citrinin co-treated with ochratoxin A] results in decreased expression of CDC26 mRNA ochratoxin A results in decreased expression of CDC26 mRNA |
CTD |
PMID:30428381 |
|
NCBI chr 5:75,844,852...75,859,830
|
|
G |
Cdc34 |
cell division cycle 34, ubiqiutin conjugating enzyme |
decreases expression multiple interactions |
ISO |
ochratoxin A results in decreased expression of CDC34 mRNA [Citrinin co-treated with ochratoxin A] results in decreased expression of CDC34 mRNA |
CTD |
PMID:30428381 |
|
NCBI chr 7:10,017,588...10,023,586
Ensembl chr 7:10,017,588...10,023,186
|
|
G |
Cdc42ep1 |
CDC42 effector protein 1 |
increases expression |
EXP |
ochratoxin A results in increased expression of CDC42EP1 mRNA |
CTD |
PMID:19717638 |
|
NCBI chr 7:110,395,287...110,403,203
Ensembl chr 7:110,395,332...110,403,200
|
|
G |
Cdc42se1 |
CDC42 small effector 1 |
increases expression |
EXP |
ochratoxin A results in increased expression of CDC42SE1 mRNA |
CTD |
PMID:19717638 |
|
NCBI chr 2:182,805,691...182,813,520
Ensembl chr 2:182,804,925...182,814,028
|
|
G |
Cdc6 |
cell division cycle 6 |
multiple interactions decreases expression increases expression |
ISO EXP |
[Citrinin co-treated with ochratoxin A] results in decreased expression of CDC6 mRNA ochratoxin A results in decreased expression of CDC6 mRNA ochratoxin A results in increased expression of CDC6 mRNA |
CTD |
PMID:30428381 PMID:30763683 PMID:38301995 |
|
NCBI chr10:83,864,189...83,878,011
Ensembl chr10:83,864,638...83,878,011
|
|
G |
Cdc7 |
cell division cycle 7 |
decreases expression multiple interactions |
ISO |
ochratoxin A results in decreased expression of CDC7 mRNA [Citrinin co-treated with ochratoxin A] results in decreased expression of CDC7 mRNA |
CTD |
PMID:30428381 |
|
NCBI chr14:2,804,660...2,824,796
Ensembl chr14:2,804,661...2,824,778
|
|
G |
Cdca8 |
cell division cycle associated 8 |
increases expression |
EXP |
ochratoxin A results in increased expression of CDCA8 mRNA |
CTD |
PMID:38301995 |
|
NCBI chr 5:137,176,414...137,198,686
Ensembl chr 5:137,176,417...137,198,629
|
|
G |
Cdh1 |
cadherin 1 |
decreases expression multiple interactions |
EXP ISO |
ochratoxin A results in decreased expression of CDH1 mRNA ochratoxin A results in decreased expression of CDH1 mRNA; ochratoxin A results in decreased expression of CDH1 protein 4-(4-(3-(pyridin-2-yl)-1H-pyrazol-4-yl)pyridin-2-yl)-N-(tetrahydro-2H-pyran-4-yl)benzamide inhibits the reaction [ochratoxin A results in decreased expression of CDH1 protein]; [Citrinin co-treated with ochratoxin A] results in decreased expression of CDH1 mRNA; [ochratoxin A co-treated with Citrinin] results in decreased expression of CDH1 protein |
CTD |
PMID:16857307 PMID:29673704 PMID:32617660 PMID:35543154 |
|
NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775
|
|
G |
Cdk1 |
cyclin-dependent kinase 1 |
multiple interactions decreases expression increases expression |
ISO EXP |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [ochratoxin A inhibits the reaction [CDK1 protein binds to CCNB1 protein]]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [ochratoxin A results in decreased expression of CDK1 protein modified form]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [ochratoxin A results in decreased expression of CDK1 protein]; 4-phenylbutyric acid inhibits the reaction [ochratoxin A results in decreased expression of CDK1 protein]; [Citrinin co-treated with ochratoxin A] results in decreased expression of CDK1 mRNA; MAPK1 protein promotes the reaction [ochratoxin A inhibits the reaction [CDK1 protein binds to CCNB1 protein]]; MAPK1 protein promotes the reaction [ochratoxin A results in decreased expression of CDK1 protein modified form]; MAPK1 protein promotes the reaction [ochratoxin A results in decreased expression of CDK1 protein]; MAPK14 protein promotes the reaction [ochratoxin A inhibits the reaction [CDK1 protein binds to CCNB1 protein]]; MAPK14 protein promotes the reaction [ochratoxin A results in decreased expression of CDK1 protein modified form]; MAPK14 protein promotes the reaction [ochratoxin A results in decreased expression of CDK1 protein]; ochratoxin A inhibits the reaction [CCNB1 protein binds to CDK1 protein]; ochratoxin A inhibits the reaction [CDK1 protein binds to CCNB1 protein]; SB 203580 inhibits the reaction [ochratoxin A inhibits the reaction [CDK1 protein binds to CCNB1 protein]]; SB 203580 inhibits the reaction [ochratoxin A results in decreased expression of CDK1 protein modified form]; SB 203580 inhibits the reaction [ochratoxin A results in decreased expression of CDK1 protein] ochratoxin A results in decreased expression of CDK1 mRNA; ochratoxin A results in decreased expression of CDK1 protein; ochratoxin A results in decreased expression of CDK1 protein modified form ochratoxin A results in increased expression of CDK1 mRNA TRP53 gene mutant form promotes the reaction [ochratoxin A results in increased expression of CDK1 mRNA] ochratoxin A results in increased expression of CDK1 mRNA; ochratoxin A results in increased expression of CDK1 protein SLC22A2 protein affects the reaction [ochratoxin A results in increased expression of CDK1 protein] |
CTD |
PMID:19237604 PMID:19717638 PMID:20060447 PMID:22230261 PMID:24243707 PMID:25636497 PMID:30120945 PMID:30428381 PMID:36058351 More...
|
|
NCBI chr20:19,266,226...19,281,417
Ensembl chr20:19,266,248...19,281,408
|
|
G |
Cdk10 |
cyclin-dependent kinase 10 |
multiple interactions decreases expression |
ISO |
[Citrinin co-treated with ochratoxin A] results in decreased expression of CDK10 mRNA ochratoxin A results in decreased expression of CDK10 mRNA |
CTD |
PMID:30428381 |
|
NCBI chr19:51,260,012...51,273,009
Ensembl chr19:51,261,356...51,269,078
|
|
G |
Cdk14 |
cyclin-dependent kinase 14 |
decreases expression decreases acetylation multiple interactions |
ISO |
ochratoxin A results in decreased expression of CDK14 mRNA ochratoxin A results in decreased acetylation of CDK14 promoter [ochratoxin A results in decreased acetylation of CDK14 promoter] which results in decreased expression of CDK14 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 4:28,666,416...29,258,865
Ensembl chr 4:28,666,843...29,258,861
|
|
G |
Cdk2 |
cyclin dependent kinase 2 |
increases expression decreases expression |
EXP ISO |
ochratoxin A results in increased expression of CDK2 mRNA ochratoxin A results in decreased expression of CDK2 protein |
CTD |
PMID:23358140 PMID:28286205 |
|
NCBI chr 7:1,129,878...1,137,431
Ensembl chr 7:1,129,811...1,137,403
|
|
G |
Cdk4 |
cyclin-dependent kinase 4 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of CDK4 mRNA |
CTD |
PMID:31154016 |
|
NCBI chr 7:62,886,124...62,889,562
Ensembl chr 7:62,883,105...62,942,403
|
|
G |
Cdk5r1 |
cyclin-dependent kinase 5 regulatory subunit 1 |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of CDK5R1 mRNA; ochratoxin A results in decreased expression of CDK5R1 mRNA |
CTD |
PMID:26314263 |
|
NCBI chr10:65,484,266...65,485,467
Ensembl chr10:65,483,941...65,488,456
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
decreases expression increases expression multiple interactions decreases methylation |
ISO EXP |
ochratoxin A results in decreased expression of CDKN1A mRNA; ochratoxin A results in decreased expression of CDKN1A protein ochratoxin A results in increased expression of CDKN1A mRNA; ochratoxin A results in increased expression of CDKN1A protein TRP53 gene mutant form inhibits the reaction [ochratoxin A results in increased expression of CDKN1A mRNA] ochratoxin A results in decreased methylation of CDKN1A gene |
CTD |
PMID:16251485 PMID:17316727 PMID:18417182 PMID:19237604 PMID:19367635 PMID:23208426 PMID:23358140 PMID:25636497 PMID:28710020 PMID:30008028 PMID:30559759 PMID:30763683 PMID:32910239 PMID:37162024 PMID:38301995 More...
|
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
multiple interactions increases expression decreases expression |
ISO |
[Citrinin co-treated with ochratoxin A] results in decreased expression of CDKN1B mRNA; [Citrinin co-treated with ochratoxin A] results in increased expression of CDKN1B mRNA ochratoxin A results in increased expression of CDKN1B mRNA ochratoxin A results in decreased expression of CDKN1B mRNA |
CTD |
PMID:30428381 PMID:30763683 |
|
NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982
|
|
G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
increases expression |
ISO |
ochratoxin A results in increased expression of CDKN2A protein |
CTD |
PMID:28286205 |
|
NCBI chr 5:103,984,949...103,992,143
Ensembl chr 5:103,984,949...104,003,149
|
|
G |
Cdkn2b |
cyclin-dependent kinase inhibitor 2B |
decreases acetylation decreases expression |
ISO |
ochratoxin A results in decreased acetylation of CDKN2B promoter ochratoxin A results in decreased expression of CDKN2B mRNA |
CTD |
PMID:29098329 PMID:30763683 |
|
NCBI chr 5:104,009,839...104,019,082
Ensembl chr 5:104,010,680...104,019,050
|
|
G |
Cdo1 |
cysteine dioxygenase type 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of CDO1 mRNA |
CTD |
PMID:18417182 |
|
NCBI chr18:39,432,473...39,447,253
Ensembl chr18:39,432,474...39,447,296
|
|
G |
Cebpa |
CCAAT/enhancer binding protein alpha |
decreases expression |
ISO |
ochratoxin A results in decreased expression of CEBPA |
CTD |
PMID:20590410 |
|
NCBI chr 1:87,759,631...87,762,303
Ensembl chr 1:87,759,433...87,762,412
|
|
G |
Cebpb |
CCAAT/enhancer binding protein beta |
decreases expression |
ISO EXP |
ochratoxin A metabolite results in decreased expression of CEBPB mRNA; ochratoxin A results in decreased expression of CEBPB mRNA |
CTD |
PMID:19287073 PMID:23358140 PMID:24356939 |
|
NCBI chr 3:156,398,035...156,399,466
Ensembl chr 3:156,397,052...156,399,473
|
|
G |
Cebpg |
CCAAT/enhancer binding protein gamma |
increases expression |
EXP |
ochratoxin A results in increased expression of CEBPG mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 1:87,683,060...87,692,772
Ensembl chr 1:87,684,019...87,694,569
|
|
G |
Cebpz |
CCAAT/enhancer binding protein zeta |
decreases expression |
EXP |
ochratoxin A results in decreased expression of CEBPZ mRNA |
CTD |
PMID:18417182 |
|
NCBI chr 6:16,119,871...16,137,600
Ensembl chr 6:16,119,872...16,137,600
|
|
G |
Cenps |
centromere protein S |
decreases methylation |
EXP |
ochratoxin A results in decreased methylation of CENPS gene |
CTD |
PMID:26431795 |
|
NCBI chr 5:159,563,917...159,573,534
|
|
G |
Cep55 |
centrosomal protein 55 |
decreases acetylation decreases expression multiple interactions increases expression |
ISO EXP |
ochratoxin A results in decreased acetylation of CEP55 promoter ochratoxin A results in decreased expression of CEP55 mRNA [ochratoxin A results in decreased acetylation of CEP55 promoter] which results in decreased expression of CEP55 mRNA ochratoxin A results in increased expression of CEP55 mRNA |
CTD |
PMID:29098329 PMID:38301995 |
|
NCBI chr 1:235,832,823...235,848,401
Ensembl chr 1:235,832,878...235,848,394
|
|
G |
Ces1d |
carboxylesterase 1D |
decreases expression |
EXP |
ochratoxin A results in decreased expression of CES1 mRNA |
CTD |
PMID:16251485 |
|
NCBI chr19:13,873,490...13,912,035
Ensembl chr19:13,796,623...13,912,035
|
|
G |
Ces3a |
carboxylesterase 3a |
decreases expression |
EXP |
ochratoxin A results in decreased expression of CES3 mRNA |
CTD |
PMID:16251485 PMID:17483316 |
|
NCBI chr19:32,992,386...33,000,562
|
|
G |
Cfap53 |
cilia and flagella associated protein 53 |
decreases acetylation |
ISO |
ochratoxin A results in decreased acetylation of CFAP53 promoter |
CTD |
PMID:29098329 |
|
NCBI chr18:67,884,651...67,955,873
Ensembl chr18:67,869,855...67,952,318
|
|
G |
Cfap95 |
cilia and flagella associated protein 95 |
decreases methylation |
EXP |
ochratoxin A results in decreased methylation of CFAP95 gene |
CTD |
PMID:26431795 |
|
NCBI chr 1:221,123,786...221,242,963
Ensembl chr 1:221,131,813...221,242,963
|
|
G |
Cflar |
CASP8 and FADD-like apoptosis regulator |
decreases expression |
EXP |
ochratoxin A results in decreased expression of CFLAR mRNA |
CTD |
PMID:18417182 |
|
NCBI chr 9:60,185,338...60,236,173
Ensembl chr 9:60,185,452...60,237,034
|
|
G |
Chac1 |
ChaC glutathione-specific gamma-glutamylcyclotransferase 1 |
affects expression decreases expression |
ISO |
ochratoxin A affects the expression of CHAC1 mRNA ochratoxin A metabolite results in decreased expression of CHAC1 mRNA |
CTD |
PMID:23824090 PMID:24356939 |
|
NCBI chr 3:106,342,302...106,345,526
Ensembl chr 3:106,342,302...106,345,526
|
|
G |
Chd1l |
chromodomain helicase DNA binding protein 1-like |
decreases expression |
EXP |
ochratoxin A results in decreased expression of CHD1L mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 2:185,138,526...185,217,498
Ensembl chr 2:185,139,308...185,217,595
|
|
G |
Chd8 |
chromodomain helicase DNA binding protein 8 |
increases expression |
EXP |
ochratoxin A results in increased expression of CHD8 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr15:24,905,789...24,965,461
Ensembl chr15:24,905,789...24,951,285
|
|
G |
Chek1 |
checkpoint kinase 1 |
increases expression decreases acetylation |
EXP ISO |
ochratoxin A results in increased expression of CHEK1 mRNA ochratoxin A results in decreased acetylation of CHEK1 promoter |
CTD |
PMID:19237604 PMID:23358140 PMID:24243707 PMID:29098329 |
|
NCBI chr 8:36,420,565...36,443,477
Ensembl chr 8:36,420,569...36,441,009
|
|
G |
Chka |
choline kinase alpha |
decreases expression |
ISO |
ochratoxin A results in decreased expression of CHKA mRNA |
CTD |
PMID:32910239 |
|
NCBI chr 1:201,076,804...201,125,517
Ensembl chr 1:201,076,860...201,125,516
|
|
G |
Chmp7 |
charged multivesicular body protein 7 |
decreases acetylation |
ISO |
ochratoxin A results in decreased acetylation of CHMP7 promoter |
CTD |
PMID:29098329 |
|
NCBI chr15:44,790,983...44,806,216
Ensembl chr15:44,790,996...44,806,216
|
|
G |
Chrd |
chordin |
decreases expression |
EXP |
ochratoxin A results in decreased expression of CHRD mRNA |
CTD |
PMID:18417182 |
|
NCBI chr11:80,171,994...80,181,166
Ensembl chr11:80,171,994...80,180,673
|
|
G |
Chrna10 |
cholinergic receptor nicotinic alpha 10 subunit |
decreases methylation increases expression |
EXP |
ochratoxin A results in decreased methylation of CHRNA10 gene ochratoxin A results in increased expression of CHRNA10 mRNA |
CTD |
PMID:37162024 |
|
NCBI chr 1:156,487,279...156,494,277
Ensembl chr 1:156,487,279...156,491,476
|
|
G |
Chrnb2 |
cholinergic receptor nicotinic beta 2 subunit |
decreases expression |
EXP |
ochratoxin A results in decreased expression of CHRNB2 mRNA |
CTD |
PMID:27346841 |
|
NCBI chr 2:175,181,402...175,189,619
Ensembl chr 2:175,181,402...175,189,619
|
|
G |
Chrne |
cholinergic receptor nicotinic epsilon subunit |
decreases expression |
EXP |
ochratoxin A results in decreased expression of CHRNE mRNA |
CTD |
PMID:12700408 |
|
NCBI chr10:55,331,211...55,339,923
Ensembl chr10:55,331,212...55,335,530
|
|
G |
Cib1 |
calcium and integrin binding 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of CIB1 mRNA |
CTD |
PMID:18417182 |
|
NCBI chr 1:134,178,331...134,183,895
Ensembl chr 1:134,178,331...134,213,423
|
|
G |
Cideb |
cell death-inducing DFFA-like effector b |
increases expression |
EXP |
ochratoxin A results in increased expression of CIDEB mRNA |
CTD |
PMID:19562491 |
|
NCBI chr15:29,252,208...29,256,482
Ensembl chr15:29,252,213...29,256,605
|
|
G |
Cidec |
cell death-inducing DFFA-like effector c |
decreases expression |
EXP |
ochratoxin A results in decreased expression of CIDEC mRNA |
CTD |
PMID:18417182 PMID:30449730 |
|
NCBI chr 4:146,569,288...146,582,173
Ensembl chr 4:146,569,289...146,582,173
|
|
G |
Cirbp |
cold inducible RNA binding protein |
decreases expression |
ISO EXP |
ochratoxin A results in decreased expression of CIRBP mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 7:9,533,857...9,538,899
Ensembl chr 7:9,424,178...9,538,818
|
|
G |
Cisd2 |
CDGSH iron sulfur domain 2 |
increases expression |
EXP |
ochratoxin A results in increased expression of CISD2 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 2:223,828,937...223,853,768
Ensembl chr 2:223,828,937...223,868,946
|
|
G |
Cks1b |
CDC28 protein kinase regulatory subunit 1B |
increases expression |
EXP |
ochratoxin A results in increased expression of CKS1B mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 2:174,833,025...174,837,614
Ensembl chr 2:174,833,050...174,837,636
|
|
G |
Cks2 |
CDC28 protein kinase regulatory subunit 2 |
increases expression |
EXP |
ochratoxin A results in increased expression of CKS2 mRNA |
CTD |
PMID:18417182 |
|
NCBI chr17:13,570,611...13,575,770
|
|
G |
Clasp2 |
cytoplasmic linker associated protein 2 |
decreases acetylation decreases expression multiple interactions |
ISO |
ochratoxin A results in decreased acetylation of CLASP2 promoter ochratoxin A results in decreased expression of CLASP2 mRNA [ochratoxin A results in decreased acetylation of CLASP2 promoter] which results in decreased expression of CLASP2 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 8:113,677,345...113,859,957
Ensembl chr 8:113,677,284...113,858,731
|
|
G |
Clcf1 |
cardiotrophin-like cytokine factor 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of CLCF1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 1:201,507,763...201,517,607
Ensembl chr 1:201,507,859...201,517,605
|
|
G |
Cldn1 |
claudin 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of CLDN1 protein |
CTD |
PMID:30763683 |
|
NCBI chr11:74,421,569...74,436,728
Ensembl chr11:74,421,569...74,436,724
|
|
G |
Cldn2 |
claudin 2 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of CLDN2 mRNA |
CTD |
PMID:28710020 PMID:30008028 |
|
NCBI chr X:103,459,870...103,473,794
Ensembl chr X:103,459,780...103,474,838
|
|
G |
Cldn23 |
claudin 23 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of CLDN23 mRNA |
CTD |
PMID:30763683 |
|
NCBI chr16:56,413,677...56,415,401
Ensembl chr16:56,413,381...56,415,523
|
|
G |
Cldn3 |
claudin 3 |
multiple interactions decreases expression |
ISO |
illite affects the reaction [ochratoxin A results in decreased expression of CLDN3 mRNA] [ochratoxin A results in increased susceptibility to Antigens] which results in decreased expression of CLDN3 mRNA |
CTD |
PMID:27153755 PMID:28935500 |
|
NCBI chr12:21,708,538...21,710,010
Ensembl chr12:21,708,398...21,711,001
|
|
G |
Cldn4 |
claudin 4 |
multiple interactions decreases expression |
ISO |
illite affects the reaction [ochratoxin A results in decreased expression of CLDN4 mRNA] |
CTD |
PMID:27153755 PMID:30763683 |
|
NCBI chr12:21,751,638...21,753,436
Ensembl chr12:21,751,331...21,753,436
|
|
G |
Cldnd1 |
claudin domain containing 1 |
increases expression |
EXP |
ochratoxin A results in increased expression of CLDND1 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr11:41,883,120...41,889,471
Ensembl chr11:41,883,134...41,889,354
|
|
G |
Clic4 |
chloride intracellular channel 4 |
increases expression |
ISO |
ochratoxin A metabolite results in increased expression of CLIC4 mRNA; ochratoxin A results in increased expression of CLIC4 mRNA |
CTD |
PMID:26314263 |
|
NCBI chr 5:147,453,702...147,513,455
Ensembl chr 5:147,453,712...147,513,452
|
|
G |
Clip2 |
CAP-GLY domain containing linker protein 2 |
increases acetylation |
ISO |
ochratoxin A results in increased acetylation of CLIP2 promoter |
CTD |
PMID:29098329 |
|
NCBI chr12:22,163,044...22,227,023
Ensembl chr12:22,163,218...22,227,023
|
|
G |
Clpx |
caseinolytic mitochondrial matrix peptidase chaperone subunit X |
decreases expression increases methylation |
EXP |
ochratoxin A results in decreased expression of CLPX mRNA ochratoxin A results in increased methylation of CLPX gene |
CTD |
PMID:37162024 |
|
NCBI chr 8:65,805,460...65,845,643
Ensembl chr 8:65,805,511...65,845,082
|
|
G |
Clu |
clusterin |
increases expression |
EXP |
ochratoxin A results in increased expression of CLU mRNA; ochratoxin A results in increased expression of CLU protein |
CTD |
PMID:12700408 PMID:18308701 PMID:23358140 PMID:25218026 |
|
NCBI chr15:40,161,068...40,200,315
Ensembl chr15:40,174,617...40,200,315
|
|
G |
Cmpk1 |
cytidine/uridine monophosphate kinase 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of CMPK1 protein |
CTD |
PMID:19445961 |
|
NCBI chr 5:128,480,301...128,507,830
Ensembl chr 5:128,480,301...128,507,830
|
|
G |
Cmtm8 |
CKLF-like MARVEL transmembrane domain containing 8 |
increases acetylation |
ISO |
ochratoxin A results in increased acetylation of CMTM8 promoter |
CTD |
PMID:29098329 |
|
NCBI chr 8:114,481,730...114,547,107
Ensembl chr 8:114,481,982...114,547,083
|
|
G |
Cndp1 |
carnosine dipeptidase 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of CNDP1 mRNA |
CTD |
PMID:19717638 |
|
NCBI chr18:77,984,886...78,030,837
Ensembl chr18:77,984,907...78,007,765
|
|
G |
Cnn3 |
calponin 3 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of CNN3 protein |
CTD |
PMID:19445961 |
|
NCBI chr 2:209,518,948...209,550,107
Ensembl chr 2:209,518,948...209,550,104
|
|
G |
Cnot2 |
CCR4-NOT transcription complex, subunit 2 |
decreases acetylation decreases expression multiple interactions |
ISO |
ochratoxin A results in decreased acetylation of CNOT2 promoter ochratoxin A results in decreased expression of CNOT2 mRNA [ochratoxin A results in decreased acetylation of CNOT2 promoter] which results in decreased expression of CNOT2 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 7:52,130,445...52,222,338
Ensembl chr 7:52,130,441...52,223,575
|
|
G |
Cnr1 |
cannabinoid receptor 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of CNR1 mRNA |
CTD |
PMID:30449730 |
|
NCBI chr 5:48,408,543...48,436,099
Ensembl chr 5:48,408,574...48,435,099
|
|
G |
Cntf |
ciliary neurotrophic factor |
increases expression |
EXP |
ochratoxin A results in increased expression of CNTF mRNA |
CTD |
PMID:12700408 PMID:18417182 |
|
NCBI chr 1:209,887,854...209,889,877
Ensembl chr 1:209,887,854...209,889,877
|
|
G |
Cntn4 |
contactin 4 |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of CNTN4 mRNA; ochratoxin A results in decreased expression of CNTN4 mRNA |
CTD |
PMID:26314263 |
|
NCBI chr 4:138,624,584...139,622,499
Ensembl chr 4:139,099,152...139,621,090
|
|
G |
Cntnap4 |
contactin associated protein family member 4 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of CNTNAP4 mRNA |
CTD |
PMID:30449730 |
|
NCBI chr19:40,568,684...40,861,879
Ensembl chr19:40,568,684...40,854,656
|
|
G |
Coch |
cochlin |
increases acetylation increases expression multiple interactions |
ISO |
ochratoxin A results in increased acetylation of COCH promoter ochratoxin A results in increased expression of COCH mRNA [ochratoxin A results in increased acetylation of COCH promoter] which results in increased expression of COCH mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 6:69,031,139...69,045,124
Ensembl chr 6:69,031,167...69,045,109
|
|
G |
Col17a1 |
collagen type XVII alpha 1 chain |
decreases expression |
EXP |
ochratoxin A results in decreased expression of COL17A1 mRNA |
CTD |
PMID:30449730 |
|
NCBI chr 1:246,530,589...246,577,559
Ensembl chr 1:246,531,367...246,577,632
|
|
G |
Col24a1 |
collagen type XXIV alpha 1 chain |
decreases expression |
EXP |
ochratoxin A results in decreased expression of COL24A1 mRNA |
CTD |
PMID:30449730 |
|
NCBI chr 2:234,212,256...234,469,445
Ensembl chr 2:234,212,324...234,469,441
|
|
G |
Col2a1 |
collagen type II alpha 1 chain |
decreases expression |
EXP |
ochratoxin A results in decreased expression of COL2A1 mRNA |
CTD |
PMID:12700408 |
|
NCBI chr 7:129,098,489...129,127,560
Ensembl chr 7:129,098,786...129,127,546
|
|
G |
Col3a1 |
collagen type III alpha 1 chain |
multiple interactions |
ISO |
[Citrinin co-treated with ochratoxin A] results in decreased expression of COL3A1 mRNA; [Citrinin co-treated with ochratoxin A] results in increased expression of and results in increased secretion of COL3A1 protein |
CTD |
PMID:29673704 |
|
NCBI chr 9:47,374,611...47,410,547
Ensembl chr 9:47,374,593...47,410,547
|
|
G |
Col6a1 |
collagen type VI alpha 1 chain |
increases acetylation increases expression multiple interactions |
ISO |
ochratoxin A results in increased acetylation of COL6A1 promoter ochratoxin A results in increased expression of COL6A1 mRNA [ochratoxin A results in increased acetylation of COL6A1 promoter] which results in increased expression of COL6A1 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr20:11,906,105...11,924,599
Ensembl chr20:11,905,957...11,924,597
|
|
G |
Col6a5 |
collagen type VI alpha 5 chain |
decreases methylation |
EXP |
ochratoxin A results in decreased methylation of COL6A5 gene |
CTD |
PMID:26431795 |
|
NCBI chr 8:106,483,806...106,584,114
Ensembl chr 8:106,483,799...106,584,113
|
|
G |
Commd10 |
COMM domain containing 10 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of COMMD10 mRNA |
CTD |
PMID:19287073 |
|
NCBI chr18:39,741,219...39,874,801
Ensembl chr18:39,741,298...39,874,903
|
|
G |
Commd2 |
COMM domain containing 2 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of COMMD2 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 2:141,848,661...141,852,907
Ensembl chr 2:141,848,680...141,852,888
|
|
G |
Commd5 |
COMM domain containing 5 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of COMMD5 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 7:108,621,766...108,623,616
Ensembl chr 7:108,598,673...108,624,764
|
|
G |
Copg2 |
COPI coat complex subunit gamma 2 |
increases methylation |
EXP |
ochratoxin A results in increased methylation of COPG2 gene |
CTD |
PMID:26431795 |
|
NCBI chr 4:59,366,086...59,501,591
Ensembl chr 4:59,366,086...59,501,618
|
|
G |
Copz2 |
COPI coat complex subunit zeta 2 |
multiple interactions increases acetylation increases expression |
ISO |
[ochratoxin A results in increased acetylation of COPZ2 promoter] which results in increased expression of COPZ2 mRNA ochratoxin A results in increased expression of COPZ2 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr10:81,832,441...81,845,514
Ensembl chr10:81,832,418...81,845,514
|
|
G |
Coq7 |
coenzyme Q7, hydroxylase |
decreases expression |
ISO |
ochratoxin A results in decreased expression of COQ7 mRNA |
CTD |
PMID:19287073 |
|
NCBI chr 1:172,836,359...172,851,173
Ensembl chr 1:172,835,188...172,851,158
|
|
G |
Cotl1 |
coactosin-like F-actin binding protein 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of COTL1 protein |
CTD |
PMID:31369848 |
|
NCBI chr19:47,871,689...47,906,010
Ensembl chr19:47,871,694...47,911,689
|
|
G |
Cox5b |
cytochrome c oxidase subunit 5B |
increases expression decreases expression |
ISO EXP |
ochratoxin A results in increased expression of COX5B mRNA ochratoxin A results in decreased expression of COX5B protein |
CTD |
PMID:17316727 PMID:31369848 |
|
NCBI chr 9:38,921,980...38,923,806
Ensembl chr 9:38,921,967...38,925,052
|
|
G |
Cox7a2l |
cytochrome c oxidase subunit 7A2 like |
increases expression |
ISO |
ochratoxin A results in increased expression of COX7A2L mRNA |
CTD |
PMID:17316727 |
|
NCBI chr 6:11,184,064...11,198,287
Ensembl chr 6:11,184,285...11,198,273
|
|
G |
Cox7c |
cytochrome c oxidase subunit 7C |
increases expression |
ISO |
ochratoxin A results in increased expression of COX7C protein |
CTD |
PMID:26861962 |
|
NCBI chr 2:16,841,771...16,843,796
Ensembl chr 2:16,840,837...16,843,760
|
|
G |
Cox8a |
cytochrome c oxidase subunit 8A |
increases expression |
ISO |
ochratoxin A results in increased expression of COX8A mRNA |
CTD |
PMID:17316727 |
|
NCBI chr 1:204,402,118...204,404,439
|
|
G |
Cp |
ceruloplasmin |
increases expression |
EXP |
ochratoxin A results in increased expression of CP mRNA |
CTD |
PMID:12700408 |
|
NCBI chr 2:102,439,433...102,498,075
Ensembl chr 2:102,439,624...102,498,075
|
|
G |
Cpne4 |
copine 4 |
decreases methylation |
EXP |
ochratoxin A results in decreased methylation of CPNE4 gene |
CTD |
PMID:26431795 |
|
NCBI chr 8:105,177,376...105,653,075
Ensembl chr 8:105,177,376...105,653,068
|
|
G |
Cps1 |
carbamoyl-phosphate synthase 1 |
increases expression |
ISO |
ochratoxin A results in increased expression of CPS1 protein |
CTD |
PMID:26861962 |
|
NCBI chr 9:68,614,153...68,737,037
Ensembl chr 9:68,614,153...68,737,033
|
|
G |
Crhr1 |
corticotropin releasing hormone receptor 1 |
multiple interactions increases expression increases acetylation |
ISO |
[ochratoxin A results in increased acetylation of CRHR1 promoter] which results in increased expression of CRHR1 mRNA ochratoxin A results in increased expression of CRHR1 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr10:89,040,186...89,083,481
Ensembl chr10:89,040,203...89,083,481
|
|
G |
Crlf1 |
cytokine receptor-like factor 1 |
increases expression multiple interactions increases acetylation |
ISO |
ochratoxin A results in increased expression of CRLF1 mRNA [ochratoxin A results in increased acetylation of CRLF1 promoter] which results in increased expression of CRLF1 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr16:18,924,722...18,936,049
Ensembl chr16:18,924,722...18,935,997
|
|
G |
Cry2 |
cryptochrome circadian regulator 2 |
increases expression |
EXP |
ochratoxin A results in increased expression of CRY2 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 3:78,374,995...78,405,001
Ensembl chr 3:78,374,995...78,404,965
|
|
G |
Cryab |
crystallin, alpha B |
decreases expression |
EXP |
ochratoxin A results in decreased expression of CRYAB mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 8:51,093,441...51,099,161
Ensembl chr 8:51,093,441...51,099,157
|
|
G |
Crygd |
crystallin, gamma D |
decreases expression |
EXP |
ochratoxin A results in decreased expression of CRYGD mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 9:66,442,057...66,443,668
Ensembl chr 9:66,442,054...66,444,067
|
|
G |
Crym |
crystallin, mu |
decreases expression increases expression |
EXP |
ochratoxin A results in decreased expression of CRYM mRNA; ochratoxin A results in decreased expression of CRYM protein ochratoxin A results in increased expression of CRYM protein |
CTD |
PMID:12700408 PMID:18417182 PMID:31369848 |
|
NCBI chr 1:174,560,423...174,575,660
Ensembl chr 1:174,560,416...174,575,633
|
|
G |
Cs |
citrate synthase |
decreases expression |
ISO |
ochratoxin A results in decreased expression of CS protein |
CTD |
PMID:26861962 |
|
NCBI chr 7:758,074...791,421
Ensembl chr 7:758,345...791,421
|
|
G |
Csdc2 |
cold shock domain containing C2 |
decreases methylation increases expression |
EXP |
ochratoxin A results in decreased methylation of CSDC2 gene ochratoxin A results in increased expression of CSDC2 mRNA |
CTD |
PMID:37162024 |
|
NCBI chr 7:113,451,998...113,466,464
Ensembl chr 7:113,451,998...113,466,463
|
|
G |
Csnk2a1 |
casein kinase 2 alpha 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of CSNK2A1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 3:140,709,984...140,756,757
Ensembl chr 3:140,709,991...140,756,696
|
|
G |
Cspg4 |
chondroitin sulfate proteoglycan 4 |
multiple interactions decreases expression |
EXP |
SHH protein inhibits the reaction [ochratoxin A results in decreased expression of CSPG4 mRNA] |
CTD |
PMID:24792326 |
|
NCBI chr 8:57,264,962...57,300,010
Ensembl chr 8:57,264,962...57,300,010
|
|
G |
Csrp2 |
cysteine and glycine-rich protein 2 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of CSRP2 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 7:46,349,109...46,367,743
Ensembl chr 7:46,348,686...46,367,745
|
|
G |
Cst3 |
cystatin C |
increases expression |
EXP |
ochratoxin A results in increased expression of CST3 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 3:136,336,923...136,340,796
Ensembl chr 3:136,336,920...136,340,822
|
|
G |
Csta |
cystatin A |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of CSTA mRNA |
CTD |
PMID:24356939 |
|
NCBI chr11:64,620,483...64,631,488
Ensembl chr11:64,620,483...64,631,488
|
|
G |
Cstf3 |
cleavage stimulation factor subunit 3 |
increases expression |
EXP |
ochratoxin A results in increased expression of CSTF3 mRNA |
CTD |
PMID:18417182 |
|
NCBI chr 3:90,966,415...91,037,669
Ensembl chr 3:90,966,354...91,042,196
|
|
G |
Ctbs |
chitobiase |
increases expression |
ISO |
ochratoxin A results in increased expression of CTBS mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 2:235,340,520...235,355,091
Ensembl chr 2:235,340,547...235,355,091
|
|
G |
Cth |
cystathionine gamma-lyase |
decreases expression |
EXP ISO |
ochratoxin A results in decreased expression of CTH mRNA |
CTD |
PMID:23358140 PMID:30559759 |
|
NCBI chr 2:246,975,888...247,002,234
Ensembl chr 2:246,975,894...247,002,234
|
|
G |
Ctnna1 |
catenin alpha 1 |
increases expression |
EXP ISO |
ochratoxin A results in increased expression of CTNNA1 mRNA ochratoxin A metabolite results in increased expression of CTNNA1 mRNA; ochratoxin A results in increased expression of CTNNA1 mRNA |
CTD |
PMID:22124623 PMID:26314263 |
|
NCBI chr18:26,728,246...26,860,911
Ensembl chr18:26,728,485...26,860,910
|
|
G |
Ctnnb1 |
catenin beta 1 |
increases expression multiple interactions |
ISO EXP |
ochratoxin A metabolite results in increased expression of CTNNB1 mRNA; ochratoxin A results in increased expression of CTNNB1 mRNA ochratoxin A results in increased expression of CTNNB1 protein ochratoxin A results in increased expression of and affects the localization of CTNNB1 protein |
CTD |
PMID:26314263 PMID:31369848 PMID:32617660 |
|
NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111
|
|
G |
Ctnnd1 |
catenin delta 1 |
decreases expression decreases acetylation multiple interactions |
ISO |
ochratoxin A results in decreased expression of CTNND1 mRNA ochratoxin A results in decreased acetylation of CTNND1 promoter [ochratoxin A results in decreased acetylation of CTNND1 promoter] which results in decreased expression of CTNND1 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 3:69,683,328...69,734,550
Ensembl chr 3:69,683,313...69,734,516
|
|
G |
Ctsa |
cathepsin A |
decreases expression |
EXP |
ochratoxin A results in decreased expression of CTSA protein |
CTD |
PMID:31369848 |
|
NCBI chr 3:153,569,106...153,574,983
Ensembl chr 3:153,568,381...153,576,215
|
|
G |
Ctsk |
cathepsin K |
decreases expression |
ISO |
ochratoxin A results in decreased expression of CTSK mRNA |
CTD |
PMID:30763683 |
|
NCBI chr 2:183,058,586...183,069,551
Ensembl chr 2:183,058,569...183,069,550
|
|
G |
Cubn |
cubilin |
decreases acetylation |
ISO |
ochratoxin A results in decreased acetylation of CUBN promoter |
CTD |
PMID:29098329 |
|
NCBI chr17:76,385,046...76,593,133
Ensembl chr17:76,385,060...76,593,231
|
|
G |
Cul2 |
cullin 2 |
increases methylation |
EXP |
ochratoxin A results in increased methylation of CUL2 gene |
CTD |
PMID:26431795 |
|
NCBI chr17:54,169,093...54,210,197
Ensembl chr17:54,169,086...54,209,968
|
|
G |
Cul7 |
cullin 7 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of CUL7 mRNA |
CTD |
PMID:19287073 |
|
NCBI chr 9:14,319,102...14,333,035
Ensembl chr 9:14,319,108...14,332,741
|
|
G |
Cx3cr1 |
C-X3-C motif chemokine receptor 1 |
increases expression |
ISO |
ochratoxin A metabolite results in increased expression of CX3CR1 mRNA; ochratoxin A results in increased expression of CX3CR1 mRNA |
CTD |
PMID:24356939 |
|
NCBI chr 8:119,785,726...119,799,431
Ensembl chr 8:119,782,595...119,800,014
|
|
G |
Cxcr4 |
C-X-C motif chemokine receptor 4 |
increases expression decreases expression |
EXP ISO |
ochratoxin A results in increased expression of CXCR4 mRNA ochratoxin A metabolite results in decreased expression of CXCR4 mRNA; ochratoxin A results in decreased expression of CXCR4 mRNA |
CTD |
PMID:19717638 PMID:26314263 |
|
NCBI chr13:40,077,976...40,081,883
Ensembl chr13:40,077,976...40,081,883
|
|
G |
Cyb5r3 |
cytochrome b5 reductase 3 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of CYB5R3 mRNA |
CTD |
PMID:19287073 |
|
NCBI chr 7:114,306,686...114,324,247
Ensembl chr 7:114,306,685...114,324,298
|
|
G |
Cyb5r4 |
cytochrome b5 reductase 4 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of CYB5R4 mRNA |
CTD |
PMID:18417182 |
|
NCBI chr 8:87,975,596...88,048,356
Ensembl chr 8:87,981,116...88,045,832
|
|
G |
Cyba |
cytochrome b-245 alpha chain |
increases expression increases acetylation multiple interactions |
ISO EXP |
ochratoxin A results in increased expression of CYBA mRNA ochratoxin A results in increased acetylation of CYBA promoter [ochratoxin A results in increased acetylation of CYBA promoter] which results in increased expression of CYBA mRNA |
CTD |
PMID:17316727 PMID:23358140 PMID:29098329 |
|
NCBI chr19:50,487,598...50,495,669
Ensembl chr19:50,487,597...50,495,721
|
|
G |
Cybb |
cytochrome b-245 beta chain |
increases expression |
EXP |
ochratoxin A results in increased expression of CYBB mRNA |
CTD |
PMID:23358140 |
|
NCBI chr X:13,358,101...13,392,570
Ensembl chr X:13,359,430...13,392,586
|
|
G |
Cycs |
cytochrome c, somatic |
affects localization decreases expression increases expression multiple interactions |
ISO EXP |
ochratoxin A affects the localization of CYCS protein ochratoxin A results in decreased expression of CYCS mRNA ochratoxin A results in increased expression of CYCS protein Oleanolic Acid inhibits the reaction [ochratoxin A results in increased expression of CYCS protein]; TRAP1 protein affects the reaction [ochratoxin A results in increased expression of CYCS protein] ochratoxin A results in increased expression of CYCS mRNA fumonisin B1 promotes the reaction [ochratoxin A results in increased expression of CYCS mRNA] |
CTD |
PMID:20549612 PMID:23358140 PMID:33465424 PMID:36397609 |
|
NCBI chr 4:79,651,894...79,653,994
Ensembl chr 4:79,651,378...79,654,054 Ensembl chr18:79,651,378...79,654,054
|
|
G |
Cygb |
cytoglobin |
increases expression |
EXP |
ochratoxin A results in increased expression of CYGB mRNA |
CTD |
PMID:23358140 |
|
NCBI chr10:101,877,675...101,887,442
Ensembl chr10:101,877,676...101,887,442
|
|
G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
increases expression |
ISO |
ochratoxin A results in increased expression of CYP19A1 protein |
CTD |
PMID:23296098 |
|
NCBI chr 8:54,552,978...54,580,375
Ensembl chr 8:54,553,165...54,580,758
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
decreases expression increases response to substance increases expression |
EXP ISO |
ochratoxin A results in decreased expression of CYP1A1 mRNA CYP1A1 protein results in increased susceptibility to ochratoxin A ochratoxin A results in increased expression of CYP1A1 mRNA; ochratoxin A results in increased expression of CYP1A1 protein |
CTD |
PMID:8542584 PMID:17316727 PMID:19717638 PMID:21781659 PMID:21834667 PMID:26505656 PMID:30291945 More...
|
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
increases expression increases response to substance |
ISO |
ochratoxin A results in increased expression of CYP1A2 mRNA; ochratoxin A results in increased expression of CYP1A2 protein CYP1A2 protein results in increased susceptibility to ochratoxin A |
CTD |
PMID:8542584 PMID:11189750 PMID:21781659 PMID:21834667 PMID:30291945 |
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Cyp24a1 |
cytochrome P450, family 24, subfamily a, polypeptide 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of CYP24A1 mRNA |
CTD |
PMID:30449730 |
|
NCBI chr 3:159,275,947...159,290,383
Ensembl chr 3:159,275,947...159,290,383
|
|
G |
Cyp2b3 |
cytochrome P450, family 2, subfamily b, polypeptide 3 |
decreases expression increases expression |
ISO |
ochratoxin A results in decreased expression of CYP2B6 mRNA ochratoxin A results in increased expression of CYP2B6 mRNA |
CTD |
PMID:21834667 PMID:26505656 |
|
NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143
|
|
G |
Cyp2c11 |
cytochrome P450, subfamily 2, polypeptide 11 |
decreases expression increases expression affects methylation |
EXP |
ochratoxin A results in decreased expression of CYP2C mRNA; ochratoxin A results in decreased expression of CYP2C11 mRNA ochratoxin A results in increased expression of CYP2C mRNA ochratoxin A affects the methylation of CYP2C11 promoter |
CTD |
PMID:16251485 PMID:18417182 PMID:30449730 |
|
NCBI chr 1:236,762,719...236,799,069
Ensembl chr 1:236,762,842...236,799,066
|
|
G |
Cyp2c13 |
cytochrome P450, family 2, subfamily c, polypeptide 13 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of CYP2C13 mRNA |
CTD |
PMID:16251485 |
|
NCBI chr 1:238,786,764...238,867,195
Ensembl chr 1:238,786,765...238,867,191
|
|
G |
Cyp2d1 |
cytochrome P450, family 2, subfamily d, polypeptide 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of CYP2D1 mRNA |
CTD |
PMID:30449730 |
|
NCBI chr 7:113,908,950...113,913,420
Ensembl chr 7:113,908,947...113,922,084
|
|
G |
Cyp2d4 |
cytochrome P450, family 2, subfamily d, polypeptide 4 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of CYP2D4 mRNA |
CTD |
PMID:12700408 |
|
NCBI chr 7:113,882,584...113,891,754
Ensembl chr 7:113,881,618...113,891,759
|
|
G |
Cyp2d5 |
cytochrome P450, family 2, subfamily d, polypeptide 5 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of CYP2D5 mRNA |
CTD |
PMID:30449730 |
|
NCBI chr 7:113,899,905...113,904,458
Ensembl chr 7:113,899,890...113,904,495
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
increases response to substance |
ISO |
CYP2E1 protein results in increased susceptibility to ochratoxin A |
CTD |
PMID:11189750 |
|
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
|
|
G |
Cyp2f4 |
cytochrome P450, family 2, subfamily f, polypeptide 4 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of CYP2F4 mRNA |
CTD |
PMID:17483316 |
|
NCBI chr 1:82,416,107...82,429,897
Ensembl chr 1:82,416,130...82,429,896
|
|
G |
Cyp2j4 |
cytochrome P450, family 2, subfamily j, polypeptide 4 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of CYP2J4 mRNA |
CTD |
PMID:18417182 |
|
NCBI chr 5:111,179,981...111,207,490
Ensembl chr 5:111,178,703...111,244,794
|
|
G |
Cyp39a1 |
cytochrome P450, family 39, subfamily a, polypeptide 1 |
increases expression |
ISO |
ochratoxin A results in increased expression of CYP39A1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 9:17,230,455...17,306,775
Ensembl chr 9:17,230,455...17,306,775
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
decreases expression increases response to substance multiple interactions increases expression |
ISO |
ochratoxin A results in decreased expression of CYP3A4 mRNA CYP3A4 protein results in increased susceptibility to ochratoxin A ochratoxin A inhibits the reaction [Rifampin results in increased expression of CYP3A4 mRNA]; ochratoxin A inhibits the reaction [Rifampin results in increased expression of CYP3A4 protein] ochratoxin A results in increased expression of CYP3A4 mRNA; ochratoxin A results in increased expression of CYP3A4 protein |
CTD |
PMID:8542584 PMID:21781659 PMID:21834667 PMID:26341324 PMID:26505656 PMID:30291945 More...
|
|
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Cyp3a9 |
cytochrome P450, family 3, subfamily a, polypeptide 9 |
increases response to substance increases expression decreases expression |
ISO |
CYP3A5 protein results in increased susceptibility to ochratoxin A ochratoxin A results in increased expression of CYP3A5 mRNA ochratoxin A results in decreased expression of CYP3A5 mRNA |
CTD |
PMID:11189750 PMID:21834667 PMID:26505656 |
|
NCBI chr12:16,806,222...16,846,428
Ensembl chr12:16,806,207...16,846,422
|
|
G |
Cyp4a8 |
cytochrome P450, family 4, subfamily a, polypeptide 8 |
increases expression |
EXP |
ochratoxin A results in increased expression of CYP4A8 mRNA |
CTD |
PMID:17483316 |
|
NCBI chr 5:128,702,130...128,733,476
Ensembl chr 5:128,702,131...128,733,476
|
|
G |
Dcun1d5 |
defective in cullin neddylation 1 domain containing 5 |
increases expression |
ISO EXP |
ochratoxin A results in increased expression of DCUN1D5 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 8:4,412,266...4,433,380
Ensembl chr 8:4,412,221...4,433,367
|
|
G |
Dcx |
doublecortin |
multiple interactions decreases expression |
EXP |
SHH protein modified form inhibits the reaction [ochratoxin A results in decreased expression of DCX mRNA] |
CTD |
PMID:21703336 |
|
NCBI chr X:107,430,767...107,573,612
Ensembl chr X:107,430,767...107,507,476
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
increases expression decreases expression decreases methylation multiple interactions |
EXP ISO |
ochratoxin A results in increased expression of DDIT3 mRNA ochratoxin A metabolite results in decreased expression of DDIT3 mRNA; ochratoxin A results in decreased expression of DDIT3 mRNA ochratoxin A results in increased expression of DDIT3 mRNA; ochratoxin A results in increased expression of DDIT3 protein ochratoxin A results in decreased methylation of DDIT3 promoter ochratoxin A promotes the reaction [bardoxolone methyl results in increased expression of DDIT3 protein]; Oleanolic Acid inhibits the reaction [ochratoxin A results in increased expression of DDIT3 protein]; TRAP1 protein affects the reaction [ochratoxin A results in increased expression of DDIT3 protein]; TRAP1 protein affects the reaction [Oleanolic Acid inhibits the reaction [ochratoxin A results in increased expression of DDIT3 protein]]; Ursolic Acid inhibits the reaction [ochratoxin A promotes the reaction [bardoxolone methyl results in increased expression of DDIT3 protein]]; Ursolic Acid inhibits the reaction [ochratoxin A results in increased expression of DDIT3 protein] |
CTD |
PMID:12700408 PMID:24356939 PMID:30008028 PMID:30559759 PMID:30763683 PMID:33465424 PMID:36058351 PMID:36587836 More...
|
|
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
|
|
G |
Ddit4 |
DNA-damage-inducible transcript 4 |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of DDIT4 mRNA; ochratoxin A results in decreased expression of DDIT4 mRNA |
CTD |
PMID:24356939 |
|
NCBI chr20:27,891,989...27,894,088
Ensembl chr20:27,891,998...27,894,105
|
|
G |
Ddt |
D-dopachrome tautomerase |
decreases expression |
EXP |
ochratoxin A results in decreased expression of DDT mRNA |
CTD |
PMID:12700408 |
|
NCBI chr20:12,884,216...12,886,687
Ensembl chr20:12,884,243...12,888,482
|
|
G |
Ddx21 |
DExD-box helicase 21 |
multiple interactions decreases expression decreases acetylation |
ISO |
[ochratoxin A results in decreased acetylation of DDX21 promoter] which results in decreased expression of DDX21 mRNA ochratoxin A results in decreased expression of DDX21 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr20:30,534,319...30,554,513
Ensembl chr20:30,534,319...30,554,543
|
|
G |
Ddx24 |
DEAD-box helicase 24 |
increases expression |
ISO |
ochratoxin A results in increased expression of DDX24 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 6:122,564,767...122,582,032
Ensembl chr 6:122,564,767...122,581,927
|
|
G |
Ddx50 |
DExD-box helicase 50 |
decreases expression decreases acetylation multiple interactions |
ISO |
ochratoxin A results in decreased expression of DDX50 mRNA ochratoxin A results in decreased acetylation of DDX50 promoter [ochratoxin A results in decreased acetylation of DDX50 promoter] which results in decreased expression of DDX50 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr20:30,561,623...30,591,324
Ensembl chr20:30,560,544...30,591,152
|
|
G |
Dffa |
DNA fragmentation factor subunit alpha |
decreases expression |
EXP |
ochratoxin A results in decreased expression of DFFA protein |
CTD |
PMID:19562491 |
|
NCBI chr 5:159,540,715...159,553,639
Ensembl chr 5:159,540,715...159,553,633
|
|
G |
Dffb |
DNA fragmentation factor subunit beta |
increases expression |
EXP |
ochratoxin A results in increased expression of DFFB mRNA |
CTD |
PMID:19562491 |
|
NCBI chr 5:164,522,446...164,534,733
Ensembl chr 5:164,522,463...164,534,628
|
|
G |
Dgcr6 |
DiGeorge syndrome critical region gene 6 |
increases acetylation multiple interactions increases expression |
ISO |
ochratoxin A results in increased acetylation of DGCR6 promoter [ochratoxin A results in increased acetylation of DGCR6 promoter] which results in increased expression of DGCR6 mRNA ochratoxin A results in increased expression of DGCR6 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr11:82,927,725...82,932,823
Ensembl chr11:82,927,725...82,932,823
|
|
G |
Dgkg |
diacylglycerol kinase, gamma |
decreases methylation |
EXP |
ochratoxin A results in decreased methylation of DGKG gene |
CTD |
PMID:26431795 |
|
NCBI chr11:78,384,212...78,579,158
Ensembl chr11:78,384,458...78,577,212
|
|
G |
Dhcr24 |
24-dehydrocholesterol reductase |
decreases expression |
EXP |
ochratoxin A results in decreased expression of DHCR24 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 5:121,344,552...121,371,124
Ensembl chr 5:121,344,575...121,371,137
|
|
G |
Dhcr7 |
7-dehydrocholesterol reductase |
decreases expression |
ISO |
ochratoxin A results in decreased expression of DHCR7 mRNA |
CTD |
PMID:19287073 |
|
NCBI chr 1:199,015,081...199,031,055
Ensembl chr 1:199,015,081...199,031,055
|
|
G |
Dhrs7 |
dehydrogenase/reductase 7 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of DHRS7 mRNA |
CTD |
PMID:30449730 |
|
NCBI chr 6:91,332,259...91,347,856
Ensembl chr 6:91,251,323...91,347,892
|
|
G |
Diablo |
diablo, IAP-binding mitochondrial protein |
decreases expression |
ISO |
ochratoxin A results in decreased expression of DIABLO mRNA |
CTD |
PMID:17316727 |
|
NCBI chr12:33,055,784...33,070,401
Ensembl chr12:33,055,263...33,070,387
|
|
G |
Dido1 |
death inducer-obliterator 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of DIDO1 mRNA |
CTD |
PMID:19287073 |
|
NCBI chr 3:167,772,535...167,825,894
Ensembl chr 3:167,772,770...167,817,218
|
|
G |
Dipk1a |
divergent protein kinase domain 1A |
increases expression |
ISO |
ochratoxin A results in increased expression of FAM69A mRNA |
CTD |
PMID:30559759 |
|
NCBI chr14:1,772,412...1,843,508
Ensembl chr14:1,772,422...1,843,743
|
|
G |
Dis3l2 |
DIS3-like 3'-5' exoribonuclease 2 |
increases expression |
ISO |
ochratoxin A results in increased expression of DIS3L2 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 9:87,355,409...87,736,616
Ensembl chr 9:87,356,457...87,736,616
|
|
G |
Dld |
dihydrolipoamide dehydrogenase |
increases expression |
ISO |
ochratoxin A results in increased expression of DLD mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 6:47,904,153...47,924,814
Ensembl chr 6:47,903,914...47,924,795
|
|
G |
Dlg2 |
discs large MAGUK scaffold protein 2 |
increases methylation |
EXP |
ochratoxin A results in increased methylation of DLG2 gene |
CTD |
PMID:26431795 |
|
NCBI chr 1:144,451,653...146,503,949
Ensembl chr 1:144,451,472...146,499,475
|
|
G |
Dll3 |
delta like canonical Notch ligand 3 |
decreases expression multiple interactions |
EXP |
ochratoxin A results in decreased expression of DLL3 mRNA SHH protein modified form inhibits the reaction [ochratoxin A results in decreased expression of DLL3 mRNA] |
CTD |
PMID:21703336 |
|
NCBI chr 1:83,562,011...83,570,008
Ensembl chr 1:83,562,014...83,569,750
|
|
G |
Dlx5 |
distal-less homeobox 5 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of DLX5 mRNA |
CTD |
PMID:20036863 |
|
NCBI chr 4:34,999,139...35,003,504
Ensembl chr 4:34,999,139...35,003,407
|
|
G |
Dmrt1 |
doublesex and mab-3 related transcription factor 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of DMRT1 |
CTD |
PMID:22069556 |
|
NCBI chr 1:223,142,859...223,241,333
Ensembl chr 1:223,142,859...223,241,333
|
|
G |
Dmtf1 |
cyclin D binding myb-like transcription factor 1 |
decreases acetylation decreases expression multiple interactions |
ISO |
ochratoxin A results in decreased acetylation of DMTF1 promoter ochratoxin A results in decreased expression of DMTF1 mRNA [ochratoxin A results in decreased acetylation of DMTF1 promoter] which results in decreased expression of DMTF1 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 4:24,909,937...24,950,786
Ensembl chr 4:24,910,534...24,950,967
|
|
G |
Dnaja2 |
DnaJ heat shock protein family (Hsp40) member A2 |
decreases acetylation multiple interactions decreases expression |
ISO |
ochratoxin A results in decreased acetylation of DNAJA2 promoter [ochratoxin A results in decreased acetylation of DNAJA2 promoter] which results in decreased expression of DNAJA2 mRNA ochratoxin A results in decreased expression of DNAJA2 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr19:21,497,792...21,516,904
Ensembl chr19:21,497,729...21,516,901
|
|
G |
Dnajb4 |
DnaJ heat shock protein family (Hsp40) member B4 |
increases expression |
ISO |
ochratoxin A metabolite results in increased expression of DNAJB4 mRNA; ochratoxin A results in increased expression of DNAJB4 mRNA |
CTD |
PMID:24356939 |
|
NCBI chr 2:241,129,346...241,159,272
Ensembl chr 2:241,130,340...241,159,089
|
|
G |
Dnajb6 |
DnaJ heat shock protein family (Hsp40) member B6 |
increases expression |
EXP |
ochratoxin A results in increased expression of DNAJB6 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 4:5,452,683...5,556,679
Ensembl chr 4:5,452,683...5,556,659
|
|
G |
Dnajc4 |
DnaJ heat shock protein family (Hsp40) member C4 |
multiple interactions increases expression increases acetylation |
ISO |
[ochratoxin A results in increased acetylation of DNAJC4 promoter] which results in increased expression of DNAJC4 mRNA ochratoxin A results in increased expression of DNAJC4 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 1:204,178,189...204,182,412
Ensembl chr 1:204,178,191...204,182,387
|
|
G |
Dnal4 |
dynein, axonemal, light chain 4 |
increases expression |
EXP |
ochratoxin A results in increased expression of DNAL4 mRNA |
CTD |
PMID:19717638 |
|
NCBI chr 7:111,312,424...111,325,283
Ensembl chr 7:111,312,427...111,325,283
|
|
G |
Dnase1l3 |
deoxyribonuclease 1L3 |
increases expression |
EXP |
ochratoxin A results in increased expression of DNASE1L3 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr15:16,922,335...16,948,322
Ensembl chr15:16,922,335...16,948,317
|
|
G |
Dock1 |
dedicator of cyto-kinesis 1 |
increases methylation |
EXP |
ochratoxin A results in increased methylation of DOCK1 gene |
CTD |
PMID:26431795 |
|
NCBI chr 1:189,467,143...189,983,777
Ensembl chr 1:189,467,143...189,983,768
|
|
G |
Dock3 |
dedicator of cyto-kinesis 3 |
decreases methylation |
EXP |
ochratoxin A results in decreased methylation of DOCK3 gene |
CTD |
PMID:26431795 |
|
NCBI chr 8:107,552,462...107,903,527
Ensembl chr 8:107,552,463...107,903,514
|
|
G |
Dock6 |
dedicator of cytokinesis 6 |
increases expression |
EXP |
ochratoxin A results in increased expression of DOCK6 mRNA |
CTD |
PMID:19717638 |
|
NCBI chr 8:20,342,430...20,394,660
Ensembl chr 8:20,342,089...20,394,552
|
|
G |
Dolk |
dolichol kinase |
decreases expression |
EXP |
ochratoxin A results in decreased expression of DOLK mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 3:13,557,826...13,559,864
Ensembl chr 3:13,557,817...13,559,917
|
|
G |
Dpagt1 |
dolichyl-phosphate N-acetylglucosaminephosphotransferase 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of DPAGT1 mRNA |
CTD |
PMID:19287073 |
|
NCBI chr 8:44,664,055...44,671,102
Ensembl chr 8:44,664,071...44,671,087
|
|
G |
Dppa3 |
developmental pluripotency-associated 3 |
increases expression |
EXP |
ochratoxin A results in increased expression of DPPA3 mRNA |
CTD |
PMID:30449730 |
|
NCBI chr 4:155,851,461...155,854,845
Ensembl chr 4:155,815,296...155,854,861 Ensembl chr 5:155,815,296...155,854,861
|
|
G |
Dpy19l1 |
dpy-19 like C-mannosyltransferase 1 |
increases expression |
ISO |
ochratoxin A results in increased expression of DPY19L1 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 8:22,933,163...23,021,461
Ensembl chr 8:22,933,163...23,021,751
|
|
G |
Dsc2 |
desmocollin 2 |
decreases expression increases expression multiple interactions |
EXP |
ochratoxin A results in decreased expression of DSC2 mRNA ochratoxin A results in increased expression of DSC2 mRNA [ochratoxin A co-treated with Ethanol] results in increased expression of DSC2 mRNA |
CTD |
PMID:16622519 PMID:16857307 |
|
NCBI chr18:11,450,392...11,482,476
Ensembl chr18:11,450,390...11,482,392
|
|
G |
E2f1 |
E2F transcription factor 1 |
increases expression multiple interactions increases acetylation |
ISO |
ochratoxin A results in increased expression of E2F1 mRNA [ochratoxin A results in increased acetylation of E2F1 promoter] which results in increased expression of E2F1 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 3:143,064,535...143,075,362
Ensembl chr 3:143,049,478...143,075,361
|
|
G |
E2f2 |
E2F transcription factor 2 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of E2F2 mRNA |
CTD |
PMID:30763683 |
|
NCBI chr 5:148,399,193...148,422,595
Ensembl chr 5:148,399,642...148,421,217
|
|
G |
E2f3 |
E2F transcription factor 3 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of E2F3 mRNA |
CTD |
PMID:30763683 |
|
NCBI chr17:34,601,756...34,679,139
Ensembl chr17:34,601,830...34,676,253
|
|
G |
Eci1 |
enoyl-CoA delta isomerase 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of ECI1 mRNA |
CTD |
PMID:19287073 |
|
NCBI chr10:13,456,715...13,470,061
Ensembl chr10:13,456,563...13,470,061
|
|
G |
Ect2 |
epithelial cell transforming 2 |
decreases expression decreases acetylation multiple interactions |
ISO |
ochratoxin A results in decreased expression of ECT2 mRNA ochratoxin A results in decreased acetylation of ECT2 promoter [ochratoxin A results in decreased acetylation of ECT2 promoter] which results in decreased expression of ECT2 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 2:109,975,813...110,037,911
Ensembl chr 2:109,975,813...110,037,911
|
|
G |
Edn1 |
endothelin 1 |
increases expression |
ISO |
ochratoxin A results in increased expression of EDN1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr17:22,454,924...22,460,812
Ensembl chr17:22,454,420...22,460,885
|
|
G |
Eef1a1 |
eukaryotic translation elongation factor 1 alpha 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of EEF1A1 mRNA |
CTD |
PMID:16251485 |
|
NCBI chr 8:79,341,554...79,344,784
Ensembl chr 8:79,341,557...79,344,839
|
|
G |
Eef1a2 |
eukaryotic translation elongation factor 1 alpha 2 |
increases expression |
EXP |
ochratoxin A results in increased expression of EEF1A2 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 3:168,265,893...168,275,071
Ensembl chr 3:168,195,357...168,275,071
|
|
G |
Eef1d |
eukaryotic translation elongation factor 1 delta |
increases expression |
ISO |
ochratoxin A results in increased expression of EEF1D protein |
CTD |
PMID:19445961 |
|
NCBI chr 7:107,581,930...107,596,735
Ensembl chr 7:107,581,930...107,608,799
|
|
G |
Eef2 |
eukaryotic translation elongation factor 2 |
increases expression |
ISO |
ochratoxin A results in increased expression of EEF2 protein |
CTD |
PMID:26861962 |
|
NCBI chr 7:8,533,248...8,538,518
Ensembl chr 7:8,533,116...8,559,183
|
|
G |
Eepd1 |
endonuclease/exonuclease/phosphatase family domain containing 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of EEPD1 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 8:23,957,258...24,064,343
Ensembl chr 8:23,957,255...24,064,340
|
|
G |
Efcab14 |
EF-hand calcium binding domain 14 |
increases expression |
ISO |
ochratoxin A results in increased expression of EFCAB14 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 5:129,218,139...129,258,628
Ensembl chr 5:129,218,424...129,258,625
|
|
G |
Efcab5 |
EF-hand calcium binding domain 5 |
decreases methylation |
EXP |
ochratoxin A results in decreased methylation of EFCAB5 gene |
CTD |
PMID:26431795 |
|
NCBI chr10:61,926,419...62,042,745
Ensembl chr10:61,926,953...62,042,749
|
|
G |
Efemp1 |
EGF containing fibulin extracellular matrix protein 1 |
increases expression |
ISO |
ochratoxin A results in increased expression of EFEMP1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr14:102,610,813...102,690,027
Ensembl chr14:102,610,908...102,690,018
|
|
G |
Egfr |
epidermal growth factor receptor |
increases phosphorylation |
ISO |
ochratoxin A results in increased phosphorylation of EGFR protein |
CTD |
PMID:23172667 |
|
NCBI chr14:91,176,979...91,349,722
Ensembl chr14:91,177,067...91,344,382
|
|
G |
Ehbp1 |
EH domain binding protein 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of EHBP1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr14:96,093,327...96,380,502
Ensembl chr14:96,093,327...96,345,332
|
|
G |
Ehd4 |
EH-domain containing 4 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of EHD4 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 3:107,058,191...107,121,985
Ensembl chr 3:107,058,958...107,122,002
|
|
G |
Eif1 |
eukaryotic translation initiation factor 1 |
increases expression |
ISO |
ochratoxin A results in increased expression of EIF1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr10:85,246,751...85,248,842
Ensembl chr10:85,246,764...85,427,327
|
|
G |
Eif2a |
eukaryotic translation initiation factor 2A |
increases expression |
ISO |
ochratoxin A results in increased expression of EIF2A protein |
CTD |
PMID:36058351 |
|
NCBI chr 2:142,761,303...142,794,767
Ensembl chr 2:142,761,416...142,795,068
|
|
G |
Eif2ak3 |
eukaryotic translation initiation factor 2 alpha kinase 3 |
decreases expression increases phosphorylation multiple interactions increases expression |
ISO |
ochratoxin A results in decreased expression of EIF2AK3 mRNA ochratoxin A results in increased phosphorylation of EIF2AK3 protein Ursolic Acid inhibits the reaction [ochratoxin A results in increased phosphorylation of EIF2AK3 protein] ochratoxin A results in increased expression of EIF2AK3 protein |
CTD |
PMID:30763683 PMID:33465424 PMID:36058351 PMID:36587836 |
|
NCBI chr 4:102,805,495...102,866,914
Ensembl chr 4:102,805,510...102,866,911
|
|
G |
Eif2s1 |
eukaryotic translation initiation factor 2 subunit alpha |
increases phosphorylation multiple interactions |
ISO |
ochratoxin A results in increased phosphorylation of EIF2S1 protein Ursolic Acid inhibits the reaction [ochratoxin A results in increased phosphorylation of EIF2S1 protein] |
CTD |
PMID:33465424 PMID:36587836 |
|
NCBI chr 6:97,672,829...97,697,499
Ensembl chr 6:97,672,766...97,706,225
|
|
G |
Eif2s2 |
eukaryotic translation initiation factor 2 subunit beta |
increases expression |
ISO |
ochratoxin A results in increased expression of EIF2S2 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 3:143,374,652...143,395,460
Ensembl chr 3:143,373,686...143,395,432
|
|
G |
Eif3a |
eukaryotic translation initiation factor 3, subunit A |
decreases expression |
ISO |
ochratoxin A results in decreased expression of EIF3A protein |
CTD |
PMID:19445961 |
|
NCBI chr 1:259,902,767...259,932,976
Ensembl chr 1:259,902,680...259,932,976
|
|
G |
Eif4ebp1 |
eukaryotic translation initiation factor 4E binding protein 1 |
increases expression |
EXP |
ochratoxin A results in increased expression of EIF4EBP1 mRNA |
CTD |
PMID:16251485 |
|
NCBI chr16:64,792,595...64,805,984
Ensembl chr16:64,790,226...64,805,984
|
|
G |
Elk1 |
ETS transcription factor ELK1 |
increases phosphorylation |
EXP |
ochratoxin A results in increased phosphorylation of ELK1 protein |
CTD |
PMID:17651772 |
|
NCBI chr X:1,138,826...1,155,713
Ensembl chr X:1,139,756...1,155,713
|
|
G |
Elmo2 |
engulfment and cell motility 2 |
increases expression |
EXP |
ochratoxin A results in increased expression of ELMO2 mRNA |
CTD |
PMID:19717638 |
|
NCBI chr 3:154,023,661...154,061,259
Ensembl chr 3:154,023,661...154,061,185
|
|
G |
Eml4 |
EMAP like 4 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of EML4 mRNA |
CTD |
PMID:19287073 |
|
NCBI chr 6:11,219,545...11,334,824
Ensembl chr 6:11,219,566...11,334,879
|
|
G |
Emp1 |
epithelial membrane protein 1 |
increases expression |
EXP |
ochratoxin A results in increased expression of EMP1 mRNA |
CTD |
PMID:19717638 |
|
NCBI chr 4:168,212,901...168,233,039
Ensembl chr 4:168,212,861...168,232,904
|
|
G |
Emp3 |
epithelial membrane protein 3 |
increases expression |
EXP |
ochratoxin A results in increased expression of EMP3 mRNA |
CTD |
PMID:19717638 |
|
NCBI chr 1:96,388,651...96,391,946
Ensembl chr 1:96,388,652...96,391,988
|
|
G |
Emx2 |
empty spiracles homeobox 2 |
decreases expression multiple interactions |
ISO |
ochratoxin A results in decreased expression of EMX2 mRNA Folic Acid inhibits the reaction [ochratoxin A results in decreased expression of EMX2 mRNA] |
CTD |
PMID:17688467 |
|
NCBI chr 1:258,626,584...258,633,594
Ensembl chr 1:258,626,584...258,633,594
|
|
G |
Endog |
endonuclease G |
decreases expression |
EXP |
ochratoxin A results in decreased expression of ENDOG protein |
CTD |
PMID:19562491 |
|
NCBI chr 3:13,449,113...13,451,715
Ensembl chr 3:13,449,086...13,451,932
|
|
G |
Eno1 |
enolase 1 |
increases expression |
EXP |
ochratoxin A results in increased expression of ENO1 protein |
CTD |
PMID:31369848 |
|
NCBI chr 5:160,719,951...160,731,337
Ensembl chr 5:160,719,951...160,731,336
|
|
G |
Eno2 |
enolase 2 |
increases expression |
EXP |
ochratoxin A results in increased expression of ENO2 mRNA |
CTD |
PMID:19717638 |
|
NCBI chr 4:157,572,085...157,580,971
Ensembl chr 4:157,572,088...157,580,980
|
|
G |
Ensa |
endosulfine alpha |
decreases expression |
ISO |
ochratoxin A results in decreased expression of ENSA mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 2:183,185,552...183,192,888
Ensembl chr 2:183,185,552...183,194,847
|
|
G |
Ep300 |
E1A binding protein p300 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of EP300 mRNA |
CTD |
PMID:30763683 |
|
NCBI chr 7:113,108,476...113,178,529
Ensembl chr 7:113,106,247...113,136,088 Ensembl chr 7:113,106,247...113,136,088
|
|
G |
Epas1 |
endothelial PAS domain protein 1 |
multiple interactions decreases expression |
ISO |
EPAS1 protein inhibits the reaction [ochratoxin A results in decreased expression of VEGFA protein] ochratoxin A results in decreased expression of EPAS1 protein |
CTD |
PMID:21554934 |
|
NCBI chr 6:7,790,236...7,871,717
Ensembl chr 6:7,790,647...7,871,228
|
|
G |
Ephb1 |
Eph receptor B1 |
multiple interactions increases acetylation increases expression |
ISO |
[ochratoxin A results in increased acetylation of EPHB1 promoter] which results in increased expression of EPHB1 mRNA ochratoxin A results in increased expression of EPHB1 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 8:102,507,549...102,944,839
Ensembl chr 8:102,507,549...102,944,839
|
|
G |
Ephb6 |
Eph receptor B6 |
increases expression multiple interactions increases acetylation |
ISO |
ochratoxin A results in increased expression of EPHB6 mRNA [ochratoxin A results in increased acetylation of EPHB6 promoter] which results in increased expression of EPHB6 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 4:70,491,973...70,507,230
Ensembl chr 4:70,491,973...70,507,230
|
|
G |
Ephx1 |
epoxide hydrolase 1 |
increases expression |
ISO |
ochratoxin A results in increased expression of EPHX1 mRNA |
CTD |
PMID:32905824 |
|
NCBI chr13:92,714,315...92,744,105
Ensembl chr13:92,714,315...92,790,235
|
|
G |
Epo |
erythropoietin |
affects expression |
ISO |
ochratoxin A affects the expression of EPO mRNA |
CTD |
PMID:30876885 |
|
NCBI chr12:19,204,258...19,207,948
Ensembl chr12:19,204,508...19,207,946
|
|
G |
Eprs1 |
glutamyl-prolyl-tRNA synthetase 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of EPRS1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr13:96,901,548...96,971,966
Ensembl chr13:96,901,575...96,971,966
|
|
G |
Erbb4 |
erb-b2 receptor tyrosine kinase 4 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of ERBB4 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 9:69,523,733...70,596,743
Ensembl chr 9:69,531,481...70,596,595
|
|
G |
Ereg |
epiregulin |
increases expression |
ISO |
ochratoxin A results in increased expression of EREG mRNA |
CTD |
PMID:30008028 |
|
NCBI chr14:17,027,287...17,041,062
Ensembl chr14:17,027,287...17,041,062
|
|
G |
Ern1 |
endoplasmic reticulum to nucleus signaling 1 |
multiple interactions increases expression |
ISO |
Ursolic Acid inhibits the reaction [ochratoxin A results in increased expression of ERN1 protein] |
CTD |
PMID:36587836 |
|
NCBI chr10:91,326,889...91,421,201
Ensembl chr10:91,330,654...91,421,029
|
|
G |
Ero1a |
endoplasmic reticulum oxidoreductase 1 alpha |
decreases expression |
ISO |
ochratoxin A results in decreased expression of ERO1A mRNA |
CTD |
PMID:30559759 |
|
NCBI chr15:18,495,037...18,530,440
Ensembl chr15:18,492,945...18,530,478
|
|
G |
Erp44 |
endoplasmic reticulum protein 44 |
increases acetylation increases expression multiple interactions |
ISO |
ochratoxin A results in increased acetylation of ERP44 promoter ochratoxin A results in increased expression of ERP44 mRNA [ochratoxin A results in increased acetylation of ERP44 promoter] which results in increased expression of ERP44 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 5:62,516,550...62,610,762
Ensembl chr 5:62,516,551...62,610,761
|
|
G |
Espl1 |
extra spindle pole bodies like 1, separase |
increases expression |
EXP |
ochratoxin A results in increased expression of ESPL1 mRNA |
CTD |
PMID:19237604 PMID:38301995 |
|
NCBI chr 7:133,424,027...133,450,984
Ensembl chr 7:133,424,130...133,450,984
|
|
G |
Esrrg |
estrogen-related receptor gamma |
increases expression |
ISO |
ochratoxin A results in increased expression of ESRRG mRNA |
CTD |
PMID:30559759 |
|
NCBI chr13:99,167,656...99,788,016
Ensembl chr13:99,564,669...99,783,397
|
|
G |
Etfdh |
electron transfer flavoprotein dehydrogenase |
decreases expression |
EXP |
ochratoxin A results in decreased expression of ETFDH mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 2:164,740,547...164,762,754
Ensembl chr 2:164,729,749...164,762,745
|
|
G |
Etv1 |
ETS variant transcription factor 1 |
increases expression |
ISO |
ochratoxin A results in increased expression of ETV1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 6:55,590,149...55,681,784
Ensembl chr 6:55,590,234...55,681,775
|
|
G |
Etv5 |
ETS variant transcription factor 5 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of ETV5 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr11:78,608,618...78,666,221
Ensembl chr11:78,608,710...78,666,215
|
|
G |
Evi2a |
ecotropic viral integration site 2A |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of EVI2A mRNA; ochratoxin A results in decreased expression of EVI2A mRNA |
CTD |
PMID:24356939 |
|
NCBI chr10:64,485,760...64,489,660
Ensembl chr10:64,485,200...64,489,843
|
|
G |
Exo1 |
exonuclease 1 |
increases expression |
EXP |
ochratoxin A results in increased expression of EXO1 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr13:87,809,725...87,834,654
Ensembl chr13:87,809,810...87,834,654
|
|
G |
Exosc5 |
exosome component 5 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of EXOSC5 mRNA |
CTD |
PMID:18417182 |
|
NCBI chr 1:81,168,128...81,177,266
Ensembl chr 1:81,166,023...81,177,265
|
|
G |
Eya3 |
EYA transcriptional coactivator and phosphatase 3 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of EYA3 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 5:144,806,523...144,934,522
Ensembl chr 5:144,806,577...144,934,518
|
|
G |
Ezr |
ezrin |
increases expression increases phosphorylation decreases expression |
ISO EXP |
ochratoxin A metabolite results in increased expression of EZR mRNA; ochratoxin A results in increased expression of EZR mRNA ochratoxin A results in increased phosphorylation of EZR protein ochratoxin A results in decreased expression of EZR mRNA ochratoxin A results in increased expression of EZR protein |
CTD |
PMID:26314263 PMID:28286205 PMID:30763683 PMID:31369848 |
|
NCBI chr 1:46,967,961...47,011,505
Ensembl chr 1:46,967,658...47,011,505
|
|
G |
F11r |
F11 receptor |
increases expression |
ISO |
ochratoxin A metabolite results in increased expression of F11R mRNA; ochratoxin A results in increased expression of F11R mRNA |
CTD |
PMID:26314263 |
|
NCBI chr13:83,873,797...83,897,388
Ensembl chr13:83,873,797...83,897,402
|
|
G |
F2 |
coagulation factor II, thrombin |
decreases expression |
EXP |
ochratoxin A results in decreased expression of F2 mRNA |
CTD |
PMID:16251485 |
|
NCBI chr 3:77,596,196...77,609,486
Ensembl chr 3:77,596,198...77,609,486
|
|
G |
F3 |
coagulation factor III, tissue factor |
multiple interactions increases expression |
ISO EXP |
ochratoxin A inhibits the reaction [IL1B protein results in increased expression of F3 protein]; ochratoxin A inhibits the reaction [Lipopolysaccharides results in increased activity of F3 protein]; ochratoxin A inhibits the reaction [Lipopolysaccharides results in increased expression of F3 mRNA]; ochratoxin A inhibits the reaction [Lipopolysaccharides results in increased expression of F3 protein]; ochratoxin A inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of F3 protein]; ochratoxin A inhibits the reaction [TNF protein results in increased expression of F3 protein] ochratoxin A results in increased expression of F3 mRNA |
CTD |
PMID:12700408 PMID:18289624 PMID:23358140 |
|
NCBI chr 2:209,827,061...209,838,666
Ensembl chr 2:209,826,959...209,838,668
|
|
G |
F5 |
coagulation factor V |
decreases expression |
ISO |
ochratoxin A results in decreased expression of F5 mRNA |
CTD |
PMID:19287073 |
|
NCBI chr13:76,513,509...76,583,106
Ensembl chr13:76,513,255...76,582,317
|
|
G |
Fabp4 |
fatty acid binding protein 4 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of FABP4 |
CTD |
PMID:20590410 |
|
NCBI chr 2:91,580,879...91,585,567
Ensembl chr 2:91,580,885...91,585,578
|
|
G |
Fabp5 |
fatty acid binding protein 5 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of FABP5 mRNA |
CTD |
PMID:16251485 |
|
NCBI chr 2:91,765,056...91,768,716
Ensembl chr 2:91,765,056...91,853,773
|
|
G |
Fadd |
Fas associated via death domain |
decreases expression |
ISO |
ochratoxin A results in decreased expression of FADD mRNA |
CTD |
PMID:17316727 PMID:30763683 |
|
NCBI chr 1:199,743,200...199,745,746
Ensembl chr 1:199,739,994...199,745,653
|
|
G |
Fads1 |
fatty acid desaturase 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of FADS1 mRNA |
CTD |
PMID:19287073 |
|
NCBI chr 1:206,827,724...206,842,734
Ensembl chr 1:206,827,765...206,842,734
|
|
G |
Fahd1 |
fumarylacetoacetate hydrolase domain containing 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of FAHD1 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr10:13,873,539...13,874,978
Ensembl chr10:13,873,527...13,875,012
|
|
G |
Fam114a1 |
family with sequence similarity 114, member A1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of FAM114A1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr14:43,275,693...43,346,154
Ensembl chr14:43,275,701...43,346,174
|
|
G |
Fanca |
FA complementation group A |
increases expression |
EXP |
ochratoxin A results in increased expression of FANCA mRNA |
CTD |
PMID:38301995 |
|
NCBI chr19:51,304,126...51,362,586
Ensembl chr19:51,304,021...51,362,527
|
|
G |
Fancb |
FA complementation group B |
increases expression |
EXP |
ochratoxin A results in increased expression of FANCB mRNA |
CTD |
PMID:38301995 |
|
NCBI chr X:29,403,771...29,420,484
Ensembl chr X:29,403,771...29,420,192
|
|
G |
Fancc |
FA complementation group C |
decreases expression |
EXP |
ochratoxin A results in decreased expression of FANCC mRNA |
CTD |
PMID:23358140 |
|
NCBI chr17:1,680,660...1,822,610
Ensembl chr17:1,681,324...1,829,376
|
|
G |
Fas |
Fas cell surface death receptor |
increases expression decreases expression |
EXP ISO |
ochratoxin A results in increased expression of FAS mRNA ochratoxin A results in decreased expression of FAS mRNA |
CTD |
PMID:17316727 PMID:19562491 |
|
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
|
|
G |
Faslg |
Fas ligand |
increases expression |
EXP |
ochratoxin A results in increased expression of FASLG mRNA |
CTD |
PMID:19562491 |
|
NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215
|
|
G |
Fastk |
Fas-activated serine/threonine kinase |
decreases expression |
EXP |
ochratoxin A results in decreased expression of FASTK mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 4:10,732,273...10,736,332
Ensembl chr 4:10,732,256...10,737,430
|
|
G |
Fbn2 |
fibrillin 2 |
multiple interactions increases expression increases acetylation |
ISO |
[ochratoxin A results in increased acetylation of FBN2 promoter] which results in increased expression of FBN2 mRNA ochratoxin A results in increased expression of FBN2 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr18:51,499,670...51,703,976
Ensembl chr18:51,499,737...51,703,976
|
|
G |
Fbp1 |
fructose-bisphosphatase 1 |
increases expression |
EXP |
ochratoxin A results in increased expression of FBP1 protein |
CTD |
PMID:31369848 |
|
NCBI chr17:2,207,271...2,230,076
Ensembl chr17:2,208,031...2,230,071
|
|
G |
Fbp2 |
fructose-bisphosphatase 2 |
increases expression |
EXP |
ochratoxin A results in increased expression of FBP2 mRNA |
CTD |
PMID:16251485 |
|
NCBI chr17:2,236,088...2,253,702
Ensembl chr17:2,236,336...2,253,698
|
|
G |
Fbxo15 |
F-box protein 15 |
increases expression |
ISO |
ochratoxin A results in increased expression of FBXO15 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr18:78,319,577...78,634,695
Ensembl chr18:78,319,534...78,390,765
|
|
G |
Fbxo22 |
F-box protein 22 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of FBXO22 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 8:55,579,906...55,595,981
Ensembl chr 8:55,579,891...55,596,148
|
|
G |
Fbxo32 |
F-box protein 32 |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of FBXO32 mRNA |
CTD |
PMID:24356939 |
|
NCBI chr 7:89,731,428...89,764,997
Ensembl chr 7:89,730,232...89,765,436
|
|
G |
Fcer1g |
Fc epsilon receptor Ig |
increases expression |
EXP |
ochratoxin A results in increased expression of FCER1G mRNA |
CTD |
PMID:22124623 |
|
NCBI chr13:83,649,447...83,654,248
Ensembl chr13:83,649,449...83,671,443
|
|
G |
Fech |
ferrochelatase |
decreases expression |
ISO |
ochratoxin A results in decreased expression of FECH mRNA |
CTD |
PMID:32905824 |
|
NCBI chr18:57,945,123...57,978,327
Ensembl chr18:57,945,122...57,979,348
|
|
G |
Fgb |
fibrinogen beta chain |
decreases expression |
ISO |
ochratoxin A results in decreased expression of FGB protein |
CTD |
PMID:31276768 |
|
NCBI chr 2:168,394,901...168,402,863
Ensembl chr 2:168,394,916...168,405,979
|
|
G |
Fgd1 |
FYVE, RhoGEF and PH domain containing 1 |
increases expression |
EXP |
ochratoxin A results in increased expression of FGD1 mRNA |
CTD |
PMID:17483316 |
|
NCBI chr X:20,023,746...20,066,734
Ensembl chr X:20,023,746...20,066,566
|
|
G |
Fgf18 |
fibroblast growth factor 18 |
increases expression |
ISO EXP |
ochratoxin A results in increased expression of FGF18 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr10:17,706,011...17,737,702
Ensembl chr10:17,706,174...17,736,818
|
|
G |
Fgf8 |
fibroblast growth factor 8 |
multiple interactions |
ISO |
[GLI3 gene mutant form co-treated with ochratoxin A] results in increased expression of FGF8 mRNA; Folic Acid inhibits the reaction [[GLI3 gene mutant form co-treated with ochratoxin A] results in increased expression of FGF8 mRNA]; ochratoxin A promotes the reaction [GLI3 gene mutant form results in increased expression of FGF8 protein] |
CTD |
PMID:16922921 PMID:17688467 |
|
NCBI chr 1:244,584,477...244,590,578
Ensembl chr 1:244,584,652...244,590,359
|
|
G |
Fkbp1a |
FKBP prolyl isomerase 1A |
increases expression increases acetylation multiple interactions |
ISO |
ochratoxin A results in increased expression of FKBP1A mRNA ochratoxin A results in increased acetylation of FKBP1A promoter [ochratoxin A results in increased acetylation of FKBP1A promoter] which results in increased expression of FKBP1A mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 3:140,040,359...140,060,107
Ensembl chr 3:140,040,278...140,060,743
|
|
G |
Fkbp1b |
FKBP prolyl isomerase 1B |
decreases expression |
EXP |
ochratoxin A results in decreased expression of FKBP1B mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 6:27,832,128...27,850,600
Ensembl chr 6:27,838,802...27,848,653
|
|
G |
Fkbp5 |
FKBP prolyl isomerase 5 |
increases expression |
EXP |
ochratoxin A results in increased expression of FKBP5 mRNA |
CTD |
PMID:30449730 |
|
NCBI chr20:6,457,207...6,575,404
Ensembl chr20:6,457,216...6,541,674
|
|
G |
Fkbp8 |
FKBP prolyl isomerase 8 |
increases acetylation multiple interactions increases expression |
ISO |
ochratoxin A results in increased acetylation of FKBP8 promoter [ochratoxin A results in increased acetylation of FKBP8 promoter] which results in increased expression of FKBP8 mRNA ochratoxin A results in increased expression of FKBP8 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr16:18,895,608...18,902,648
Ensembl chr16:18,893,576...18,902,612
|
|
G |
Fn1 |
fibronectin 1 |
increases expression multiple interactions decreases expression |
ISO |
ochratoxin A results in increased expression of FN1 mRNA; ochratoxin A results in increased expression of FN1 protein NFE2L2 protein affects the reaction [ochratoxin A results in increased expression of FN1 mRNA] ochratoxin A results in decreased expression of FN1 mRNA 4-(4-(3-(pyridin-2-yl)-1H-pyrazol-4-yl)pyridin-2-yl)-N-(tetrahydro-2H-pyran-4-yl)benzamide inhibits the reaction [ochratoxin A results in increased expression of FN1 mRNA]; 4-(4-(3-(pyridin-2-yl)-1H-pyrazol-4-yl)pyridin-2-yl)-N-(tetrahydro-2H-pyran-4-yl)benzamide inhibits the reaction [ochratoxin A results in increased expression of FN1 protein]; SMAD2 affects the reaction [ochratoxin A results in increased expression of FN1 mRNA]; SMAD2 affects the reaction [ochratoxin A results in increased expression of FN1 protein]; SMAD3 affects the reaction [ochratoxin A results in increased expression of FN1 mRNA]; SMAD3 affects the reaction [ochratoxin A results in increased expression of FN1 protein] |
CTD |
PMID:28710020 PMID:30559759 PMID:32617660 PMID:35543154 |
|
NCBI chr 9:73,196,044...73,264,695
Ensembl chr 9:73,196,044...73,264,678
|
|
G |
Fndc10 |
fibronectin type III domain containing 10 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of FNDC10 mRNA |
CTD |
PMID:30449730 |
|
NCBI chr 5:166,299,587...166,311,477
Ensembl chr 5:166,300,122...166,310,326
|
|
G |
Fndc3b |
fibronectin type III domain containing 3B |
decreases expression |
ISO |
ochratoxin A results in decreased expression of FNDC3B mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 2:110,311,439...110,617,504
Ensembl chr 2:110,312,694...110,547,830
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
increases expression multiple interactions decreases expression |
ISO EXP |
ochratoxin A results in increased expression of FOS mRNA ochratoxin A promotes the reaction [FOS protein binds to CCND1 promoter]; ochratoxin A promotes the reaction [FOS protein binds to PTGS2 promoter] ochratoxin A results in increased expression of FOS protein ochratoxin A results in decreased expression of FOS mRNA |
CTD |
PMID:17316727 PMID:19237604 PMID:23172667 PMID:23358140 PMID:30763683 PMID:37162024 More...
|
|
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
Frat1 |
FRAT regulator of WNT signaling pathway 1 |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of FRAT1 mRNA; ochratoxin A results in decreased expression of FRAT1 mRNA |
CTD |
PMID:24356939 |
|
NCBI chr 1:240,638,309...240,640,857
Ensembl chr 1:240,638,296...240,640,945
|
|
G |
Frmd3 |
FERM domain containing 3 |
increases expression |
ISO |
ochratoxin A results in increased expression of FRMD3 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 5:87,764,755...88,031,091
Ensembl chr 5:87,764,604...88,031,091
|
|
G |
Frzb |
frizzled-related protein |
increases expression |
ISO EXP |
ochratoxin A results in increased expression of FRZB mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 3:65,332,274...65,365,208
Ensembl chr 3:65,332,277...65,365,208
|
|
G |
Fsd1l |
fibronectin type III and SPRY domain containing 1-like |
decreases expression |
ISO |
ochratoxin A results in decreased expression of FSD1L mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 5:68,258,877...68,334,931
Ensembl chr 5:68,258,932...68,334,928
|
|
G |
Fth1 |
ferritin heavy chain 1 |
increases expression |
ISO |
ochratoxin A results in increased expression of FTH1 mRNA |
CTD |
PMID:30559759 PMID:32905824 |
|
NCBI chr 1:206,627,142...206,629,430
Ensembl chr 1:206,627,103...206,725,424
|
|
G |
Fubp1 |
far upstream element binding protein 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of FUBP1 protein |
CTD |
PMID:26861962 |
|
NCBI chr 2:241,159,481...241,186,591
Ensembl chr 2:241,159,512...241,186,602
|
|
G |
Fuca1 |
alpha-L-fucosidase 1 |
increases expression |
ISO |
ochratoxin A results in increased expression of FUCA1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 5:148,152,718...148,169,972
Ensembl chr 5:148,152,700...148,169,972
|
|
G |
Fut4-ps1 |
fucosyltransferase 4, pseudogene 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of FUT6 mRNA |
CTD |
PMID:19287073 |
|
NCBI chr 9:1,569,605...1,572,022
|
|
G |
G2e3 |
G2/M-phase specific E3 ubiquitin protein ligase |
increases expression |
ISO |
ochratoxin A results in increased expression of G2E3 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 6:68,763,847...68,795,305
Ensembl chr 6:68,764,185...68,793,924
|
|
G |
G6pc1 |
glucose-6-phosphatase catalytic subunit 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of G6PC1 mRNA |
CTD |
PMID:26341324 |
|
NCBI chr10:86,307,400...86,318,766
Ensembl chr10:86,257,668...86,333,804
|
|
G |
G6pd |
glucose-6-phosphate dehydrogenase |
decreases expression |
ISO |
ochratoxin A results in decreased expression of G6PD mRNA |
CTD |
PMID:32905824 |
|
NCBI chr X:152,201,081...152,220,863
Ensembl chr X:152,201,098...152,220,801
|
|
G |
Gabbr2 |
gamma-aminobutyric acid type B receptor subunit 2 |
increases expression |
EXP |
ochratoxin A results in increased expression of GABBR2 mRNA |
CTD |
PMID:18417182 |
|
NCBI chr 5:60,947,517...61,288,104
Ensembl chr 5:60,947,526...61,288,104
|
|
G |
Gadd45a |
growth arrest and DNA-damage-inducible, alpha |
increases expression decreases expression |
EXP ISO |
ochratoxin A results in increased expression of GADD45A mRNA ochratoxin A results in decreased expression of GADD45 mRNA; ochratoxin A results in decreased expression of GADD45A mRNA |
CTD |
PMID:12700408 PMID:17316727 PMID:30008028 PMID:30559759 PMID:30763683 |
|
NCBI chr 4:96,154,789...96,157,091
Ensembl chr 4:96,154,789...96,157,115
|
|
G |
Gadd45b |
growth arrest and DNA-damage-inducible, beta |
decreases expression |
ISO |
ochratoxin A results in decreased expression of GADD45B mRNA |
CTD |
PMID:30763683 |
|
NCBI chr 7:8,778,004...8,780,306
Ensembl chr 7:8,778,007...8,780,046
|
|
G |
Gadd45g |
growth arrest and DNA-damage-inducible, gamma |
decreases expression |
ISO |
ochratoxin A results in decreased expression of GADD45G mRNA |
CTD |
PMID:30763683 |
|
NCBI chr17:13,376,842...13,378,587
Ensembl chr17:13,376,839...13,378,610
|
|
G |
Gal |
galanin and GMAP prepropeptide |
increases activity |
EXP ISO |
ochratoxin A results in increased activity of GAL protein |
CTD |
PMID:28286205 |
|
NCBI chr 1:200,650,439...200,655,302
Ensembl chr 1:200,650,439...200,654,959
|
|
G |
Galnt11 |
polypeptide N-acetylgalactosaminyltransferase 11 |
increases acetylation |
ISO |
ochratoxin A results in increased acetylation of GALNT11 promoter |
CTD |
PMID:29098329 |
|
NCBI chr 4:9,837,629...9,871,141
Ensembl chr 4:9,837,629...9,871,140
|
|
G |
Gars1 |
glycyl-tRNA synthetase 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of GARS1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 4:84,171,596...84,212,609
Ensembl chr 4:84,171,596...84,212,609
|
|
G |
Gbp1 |
guanylate binding protein 1 |
decreases acetylation decreases expression multiple interactions |
ISO |
ochratoxin A results in decreased acetylation of GBP1 promoter ochratoxin A results in decreased expression of GBP1 mRNA [ochratoxin A results in decreased acetylation of GBP1 promoter] which results in decreased expression of GBP1 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 2:231,398,136...231,432,773
Ensembl chr 2:231,398,163...231,432,131 Ensembl chr 2:231,398,163...231,432,131
|
|
G |
Gc |
GC, vitamin D binding protein |
decreases expression |
EXP |
ochratoxin A results in decreased expression of GC mRNA |
CTD |
PMID:18417182 PMID:30449730 |
|
NCBI chr14:18,632,146...18,667,563
Ensembl chr14:18,632,135...18,667,567
|
|
G |
Gcfc2 |
GC-rich sequence DNA-binding factor 2 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of GCFC2 mRNA |
CTD |
PMID:19287073 |
|
NCBI chr 4:114,481,613...114,519,268
Ensembl chr 4:114,481,607...114,519,962
|
|
G |
Gck |
glucokinase |
decreases methylation increases expression |
EXP |
ochratoxin A results in decreased methylation of GCK gene ochratoxin A results in increased expression of GCK mRNA |
CTD |
PMID:37162024 |
|
NCBI chr14:80,785,060...80,829,842
Ensembl chr14:80,785,060...80,826,995
|
|
G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
multiple interactions decreases expression increases expression affects expression |
EXP ISO |
[cafestol co-treated with kahweol] inhibits the reaction [ochratoxin A results in decreased expression of GCLC protein] ochratoxin A results in decreased expression of GCLC mRNA; ochratoxin A results in decreased expression of GCLC protein AHR protein affects the reaction [ochratoxin A results in increased expression of GCLC mRNA]; NR1I2 protein affects the reaction [ochratoxin A results in increased expression of GCLC mRNA] ochratoxin A affects the expression of GCLC mRNA |
CTD |
PMID:16251485 PMID:17110534 PMID:18417182 PMID:23358140 PMID:30291945 PMID:32468156 PMID:32905824 More...
|
|
NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
|
|
G |
Gclm |
glutamate cysteine ligase, modifier subunit |
decreases expression affects expression |
EXP ISO |
ochratoxin A results in decreased expression of GCLM mRNA ochratoxin A affects the expression of GCLM mRNA |
CTD |
PMID:16251485 PMID:18417182 PMID:30008028 PMID:30559759 |
|
NCBI chr 2:210,347,482...210,367,537
Ensembl chr 2:210,347,482...210,367,535
|
|
G |
Gcnt3 |
glucosaminyl (N-acetyl) transferase 3, mucin type |
decreases expression |
ISO |
ochratoxin A results in decreased expression of GCNT3 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 8:70,689,173...70,696,476
Ensembl chr 8:70,686,844...70,699,562
|
|
G |
Gen1 |
GEN1 Holliday junction 5' flap endonuclease |
decreases expression increases methylation |
EXP |
ochratoxin A results in decreased expression of GEN1 mRNA ochratoxin A results in increased methylation of GEN1 gene |
CTD |
PMID:37162024 |
|
NCBI chr 6:33,947,599...33,978,461
Ensembl chr 6:33,948,206...33,978,401
|
|
G |
Gfap |
glial fibrillary acidic protein |
multiple interactions decreases expression |
EXP |
15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [ochratoxin A results in decreased expression of GFAP mRNA]; 8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [ochratoxin A results in decreased expression of GFAP mRNA]; SHH protein inhibits the reaction [ochratoxin A results in decreased expression of GFAP mRNA] ochratoxin A results in decreased expression of GFAP mRNA; ochratoxin A results in decreased expression of GFAP protein |
CTD |
PMID:15994020 PMID:22954530 PMID:24792326 |
|
NCBI chr10:87,852,891...87,861,631
Ensembl chr10:87,852,890...87,861,589
|
|
G |
Ggt1 |
gamma-glutamyltransferase 1 |
decreases activity decreases expression |
EXP |
ochratoxin A results in decreased activity of GGT1 protein ochratoxin A results in decreased expression of GGT1 mRNA |
CTD |
PMID:2569870 PMID:12700408 PMID:16251485 PMID:23358140 |
|
NCBI chr20:13,074,695...13,104,095
Ensembl chr20:13,074,700...13,108,442
|
|
G |
Ggt5 |
gamma-glutamyltransferase 5 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of GGT5 mRNA |
CTD |
PMID:16251485 |
|
NCBI chr20:13,043,255...13,071,523
Ensembl chr20:13,043,257...13,071,450
|
|
G |
Ggt6 |
gamma-glutamyl transferase 6 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of GGT6 mRNA |
CTD |
PMID:17483316 |
|
NCBI chr10:57,051,977...57,054,900
Ensembl chr10:57,051,825...57,067,260
|
|
G |
Ghr |
growth hormone receptor |
decreases expression |
EXP |
ochratoxin A results in decreased expression of GHR mRNA |
CTD |
PMID:18417182 |
|
NCBI chr 2:52,541,452...52,804,960
Ensembl chr 2:52,542,594...52,804,735
|
|
G |
Gja1 |
gap junction protein, alpha 1 |
affects phosphorylation decreases expression increases phosphorylation |
EXP ISO |
ochratoxin A affects the phosphorylation of GJA1 protein ochratoxin A results in decreased expression of GJA1 mRNA ochratoxin A results in increased phosphorylation of GJA1 protein |
CTD |
PMID:11711124 PMID:16857307 |
|
NCBI chr20:35,756,007...35,768,481
Ensembl chr20:35,755,991...35,768,582
|
|
G |
Gjb1 |
gap junction protein, beta 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of GJB1 mRNA |
CTD |
PMID:16857307 PMID:19237604 |
|
NCBI chr X:66,501,848...66,509,783
Ensembl chr X:66,501,820...66,509,925
|
|
G |
Gjb2 |
gap junction protein, beta 2 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of GJB2 mRNA |
CTD |
PMID:16857307 |
|
NCBI chr15:31,260,390...31,278,222
Ensembl chr15:31,260,357...31,278,177
|
|
G |
Gk |
glycerol kinase |
decreases expression |
EXP |
ochratoxin A results in decreased expression of GK mRNA |
CTD |
PMID:12700408 |
|
NCBI chr X:50,162,089...50,238,707
Ensembl chr X:50,163,123...50,238,631
|
|
G |
Glb1l |
galactosidase, beta 1-like |
decreases expression increases methylation |
EXP |
ochratoxin A results in decreased expression of GLB1L mRNA ochratoxin A results in increased methylation of GLB1L gene |
CTD |
PMID:37162024 |
|
NCBI chr 9:76,693,325...76,705,548
Ensembl chr 9:76,695,173...76,705,510
|
|
G |
Gli1 |
GLI family zinc finger 1 |
decreases expression multiple interactions |
EXP |
ochratoxin A results in decreased expression of GLI1 mRNA SHH protein modified form inhibits the reaction [ochratoxin A results in decreased expression of GLI1 mRNA] |
CTD |
PMID:21703336 |
|
NCBI chr 7:63,156,926...63,169,579
Ensembl chr 7:63,156,926...63,169,251
|
|
G |
Gli3 |
GLI family zinc finger 3 |
multiple interactions affects response to substance increases response to substance |
ISO |
[GLI3 gene mutant form co-treated with ochratoxin A] results in increased expression of FGF8 mRNA; Folic Acid inhibits the reaction [[GLI3 gene mutant form co-treated with ochratoxin A] results in increased expression of FGF8 mRNA]; ochratoxin A promotes the reaction [GLI3 gene mutant form results in increased expression of FGF8 protein] GLI3 gene affects the susceptibility to ochratoxin A GLI3 gene mutant form results in increased susceptibility to ochratoxin A |
CTD |
PMID:16922921 PMID:17688467 PMID:20201966 |
|
NCBI chr17:49,438,567...49,709,712
Ensembl chr17:49,438,567...49,709,712
|
|
G |
Glrx |
glutaredoxin |
decreases expression |
ISO |
ochratoxin A results in decreased expression of GLRX mRNA |
CTD |
PMID:32905824 |
|
NCBI chr 2:5,341,873...5,351,686
Ensembl chr 2:5,341,885...5,351,680
|
|
G |
Gls |
glutaminase |
decreases expression |
ISO |
ochratoxin A results in decreased expression of GLS mRNA |
CTD |
PMID:32905824 |
|
NCBI chr 9:49,344,616...49,416,900
Ensembl chr 9:49,344,781...49,416,900
|
|
G |
Glul |
glutamate-ammonia ligase |
decreases activity decreases expression |
EXP |
ochratoxin A results in decreased activity of GLUL protein ochratoxin A results in decreased expression of GLUL mRNA |
CTD |
PMID:12700408 PMID:20558201 |
|
NCBI chr13:65,969,053...66,035,121
Ensembl chr13:66,025,630...66,035,108
|
|
G |
Glyat |
glycine-N-acyltransferase |
decreases expression |
EXP |
ochratoxin A results in decreased expression of GLYAT mRNA |
CTD |
PMID:18417182 |
|
NCBI chr 1:209,704,213...209,724,949
Ensembl chr 1:209,704,268...209,724,942
|
|
G |
Gng13 |
G protein subunit gamma 13 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of GNG13 mRNA |
CTD |
PMID:18417182 PMID:30449730 |
|
NCBI chr10:14,741,179...14,743,083
Ensembl chr10:14,741,239...14,743,083
|
|
G |
Gng5 |
G protein subunit gamma 5 |
increases expression |
EXP |
ochratoxin A results in increased expression of GNG5 mRNA |
CTD |
PMID:18417182 |
|
NCBI chr 2:235,394,680...235,403,177
Ensembl chr 1:77,292,043...77,292,513
|
|
G |
Gnmt |
glycine N-methyltransferase |
decreases expression |
EXP |
ochratoxin A results in decreased expression of GNMT mRNA |
CTD |
PMID:17483316 |
|
NCBI chr 9:14,254,675...14,258,028
Ensembl chr 9:14,254,675...14,258,434
|
|
G |
Gnrh1 |
gonadotropin releasing hormone 1 |
increases expression |
EXP ISO |
ochratoxin A results in increased expression of GNRH1 mRNA ochratoxin A metabolite results in increased expression of GNRH1 mRNA; ochratoxin A results in increased expression of GNRH1 mRNA |
CTD |
PMID:22124623 PMID:24356939 |
|
NCBI chr15:41,972,482...41,976,690
Ensembl chr15:41,972,905...41,973,581 Ensembl chr15:41,972,905...41,973,581
|
|
G |
Gp5 |
glycoprotein V (platelet) |
increases expression |
EXP ISO |
ochratoxin A results in increased expression of GP5 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr11:70,443,613...70,446,705
Ensembl chr11:70,443,613...70,446,705
|
|
G |
Gpc1 |
glypican 1 |
multiple interactions increases expression increases acetylation |
ISO |
[ochratoxin A results in increased acetylation of GPC1 promoter] which results in increased expression of GPC1 mRNA ochratoxin A results in increased expression of GPC1 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 9:93,396,234...93,424,047
Ensembl chr 9:93,396,234...93,424,047
|
|
G |
Gpi |
glucose-6-phosphate isomerase |
decreases expression |
ISO |
ochratoxin A results in decreased expression of GPI protein |
CTD |
PMID:26861962 |
|
NCBI chr 1:86,828,211...86,856,077
Ensembl chr 1:86,828,216...86,856,086
|
|
G |
Gpr17 |
G protein-coupled receptor 17 |
increases expression |
ISO |
ochratoxin A metabolite results in increased expression of GPR17 mRNA; ochratoxin A results in increased expression of GPR17 mRNA |
CTD |
PMID:23824090 PMID:24356939 |
|
NCBI chr18:23,576,232...23,583,153
Ensembl chr18:23,577,242...23,582,966
|
|
G |
Gpr18 |
G protein-coupled receptor 18 |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of GPR18 mRNA; ochratoxin A results in decreased expression of GPR18 mRNA |
CTD |
PMID:24356939 |
|
NCBI chr15:98,997,427...99,001,177
Ensembl chr15:98,997,259...99,001,470
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
increases expression multiple interactions |
ISO |
ochratoxin A results in increased expression of GPT protein [1-aminobenzotriazole co-treated with ochratoxin A] results in increased activity of GPT protein |
CTD |
PMID:35543154 PMID:36227364 |
|
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
|
|
G |
Gpt2 |
glutamic--pyruvic transaminase 2 |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of GPT2 mRNA |
CTD |
PMID:24356939 |
|
NCBI chr19:21,526,800...21,561,314
Ensembl chr19:21,517,621...21,560,610
|
|
G |
Gpx1 |
glutathione peroxidase 1 |
increases expression decreases expression multiple interactions increases acetylation increases activity |
ISO EXP |
ochratoxin A results in increased expression of GPX1 mRNA ochratoxin A results in decreased expression of GPX1 mRNA [Chitosan analog co-treated with Quercetin] inhibits the reaction [ochratoxin A results in decreased expression of GPX1 mRNA]; Chitosan analog inhibits the reaction [ochratoxin A results in decreased expression of GPX1 mRNA]; Quercetin inhibits the reaction [ochratoxin A results in decreased expression of GPX1 mRNA] ochratoxin A results in increased acetylation of GPX1 promoter [fumonisin B1 co-treated with ochratoxin A] affects the activity of GPX1 protein; [ochratoxin A results in increased acetylation of GPX1 promoter] which results in increased expression of GPX1 mRNA ochratoxin A results in increased activity of GPX1 protein |
CTD |
PMID:17316727 PMID:23358140 PMID:24120684 PMID:27923682 PMID:29098329 PMID:32905824 PMID:37633472 More...
|
|
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
|
|
G |
Gpx2 |
glutathione peroxidase 2 |
increases expression |
EXP |
ochratoxin A results in increased expression of GPX2 mRNA |
CTD |
PMID:24120684 |
|
NCBI chr 6:95,493,589...95,496,877
Ensembl chr 6:95,493,589...95,496,877
|
|
G |
Gpx3 |
glutathione peroxidase 3 |
increases expression |
ISO |
ochratoxin A results in increased expression of GPX3 mRNA |
CTD |
PMID:17316727 |
|
NCBI chr10:39,028,624...39,036,695
Ensembl chr10:39,028,570...39,037,035
|
|
G |
Gpx4 |
glutathione peroxidase 4 |
multiple interactions increases expression increases acetylation |
ISO |
[ochratoxin A results in increased acetylation of GPX4 promoter] which results in increased expression of GPX4 mRNA ochratoxin A results in increased expression of GPX4 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 7:9,650,186...9,652,982
Ensembl chr 7:9,650,185...9,652,982
|
|
G |
Gpx7 |
glutathione peroxidase 7 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of GPX7 mRNA |
CTD |
PMID:32905824 |
|
NCBI chr 5:123,145,151...123,153,141
Ensembl chr 5:123,144,331...123,153,004
|
|
G |
Gpx8 |
glutathione peroxidase 8 |
increases expression |
EXP |
ochratoxin A results in increased expression of GPX8 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 2:44,676,448...44,680,042
Ensembl chr 2:44,676,454...44,680,195
|
|
G |
Gria1 |
glutamate ionotropic receptor AMPA type subunit 1 |
increases expression |
EXP |
ochratoxin A results in increased expression of GRIA1 mRNA |
CTD |
PMID:27346841 |
|
NCBI chr10:41,210,713...41,527,283
Ensembl chr10:41,210,713...41,527,283
|
|
G |
Gria2 |
glutamate ionotropic receptor AMPA type subunit 2 |
increases expression |
EXP |
ochratoxin A results in increased expression of GRIA2 mRNA |
CTD |
PMID:27346841 |
|
NCBI chr 2:165,949,379...166,069,510
Ensembl chr 2:165,947,521...166,069,510
|
|
G |
Grin1 |
glutamate ionotropic receptor NMDA type subunit 1 |
increases expression multiple interactions increases acetylation decreases expression |
ISO |
ochratoxin A results in increased expression of GRIN1 mRNA [ochratoxin A results in increased acetylation of GRIN1 promoter] which results in increased expression of GRIN1 mRNA ochratoxin A results in decreased expression of GRIN1 mRNA |
CTD |
PMID:29098329 PMID:34748853 |
|
NCBI chr 3:8,103,680...8,130,603
Ensembl chr 3:8,103,680...8,130,603
|
|
G |
Grin2a |
glutamate ionotropic receptor NMDA type subunit 2A |
increases expression |
EXP |
ochratoxin A results in increased expression of GRIN2A mRNA |
CTD |
PMID:27346841 |
|
NCBI chr10:5,629,683...6,053,262
Ensembl chr10:5,631,369...6,044,637
|
|
G |
Gsdma |
gasdermin A |
increases expression decreases methylation |
EXP |
ochratoxin A results in increased expression of GSDMA mRNA ochratoxin A results in decreased methylation of GSDMA gene |
CTD |
PMID:37162024 |
|
NCBI chr10:83,614,336...83,639,543
Ensembl chr10:83,627,051...83,639,543
|
|
G |
Gsdmd |
gasdermin D |
increases expression |
ISO |
ochratoxin A results in increased expression of GSDMD mRNA; ochratoxin A results in increased expression of GSDMD protein |
CTD |
PMID:33543323 |
|
NCBI chr 7:107,542,489...107,547,051
Ensembl chr 7:107,542,083...107,547,055
|
|
G |
Gsk3b |
glycogen synthase kinase 3 beta |
increases phosphorylation |
ISO |
ochratoxin A results in increased phosphorylation of GSK3B protein |
CTD |
PMID:25002221 |
|
NCBI chr11:62,498,997...62,648,665
Ensembl chr11:62,504,316...62,648,646
|
|
G |
Gspt1 |
G1 to S phase transition 1 |
increases expression |
EXP |
ochratoxin A results in increased expression of GSPT1 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr10:4,362,528...4,397,215
Ensembl chr10:4,362,510...4,397,198
|
|
G |
Gsr |
glutathione-disulfide reductase |
multiple interactions |
ISO |
[NFE2L2 protein affects the susceptibility to ochratoxin A] which results in decreased expression of GSR mRNA |
CTD |
PMID:28710020 |
|
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
|
|
G |
Gss |
glutathione synthetase |
decreases expression |
EXP |
ochratoxin A results in decreased expression of GSS mRNA |
CTD |
PMID:12700408 PMID:16251485 PMID:18417182 PMID:23358140 |
|
NCBI chr 3:144,047,849...144,078,197
Ensembl chr 3:144,047,850...144,078,198
|
|
G |
Gsta1 |
glutathione S-transferase alpha 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of GSTA1 mRNA |
CTD |
PMID:12700408 |
|
NCBI chr 9:23,703,476...23,720,121
Ensembl chr 9:23,703,477...23,720,121
|
|
G |
Gsta2 |
glutathione S-transferase alpha 2 |
decreases expression increases expression |
EXP |
ochratoxin A results in decreased expression of GSTA2 mRNA ochratoxin A results in increased expression of GSTA2 mRNA |
CTD |
PMID:16251485 PMID:23358140 |
|
NCBI chr 8:79,184,535...79,196,827
Ensembl chr 8:79,184,322...79,196,798
|
|
G |
Gsta3 |
glutathione S-transferase alpha 3 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of GSTA3 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 9:23,658,574...23,684,240
Ensembl chr 9:23,658,574...23,684,240
|
|
G |
Gsta4 |
glutathione S-transferase alpha 4 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of GSTA4 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 8:79,066,967...79,084,193
Ensembl chr 8:79,066,934...79,084,182
|
|
G |
Gsta5 |
glutathione S-transferase alpha 5 |
multiple interactions decreases expression |
EXP |
[cafestol co-treated with kahweol] inhibits the reaction [ochratoxin A results in decreased expression of GSTA5 protein] |
CTD |
PMID:17110534 |
|
NCBI chr 8:79,105,561...79,117,472
Ensembl chr 8:79,105,661...79,117,472
|
|
G |
Gstcd |
glutathione S-transferase, C-terminal domain containing |
decreases expression |
ISO |
ochratoxin A results in decreased expression of GSTCD mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 2:221,499,732...221,591,888
Ensembl chr 2:221,499,083...221,591,857
|
|
G |
Gstk1 |
glutathione S-transferase kappa 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of GSTK1 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 4:71,118,979...71,123,298
Ensembl chr 4:71,118,896...71,123,292
|
|
G |
Gstm1 |
glutathione S-transferase mu 1 |
decreases expression affects expression |
EXP ISO |
ochratoxin A results in decreased expression of GSTM1 mRNA; ochratoxin A results in decreased expression of GSTM1 protein ochratoxin A affects the expression of GSTM1 mRNA |
CTD |
PMID:17110534 PMID:23358140 PMID:32905824 |
|
NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411
|
|
G |
Gstm2 |
glutathione S-transferase mu 2 |
increases expression affects expression |
EXP ISO |
ochratoxin A results in increased expression of GSTM2 mRNA ochratoxin A affects the expression of GSTM2 mRNA |
CTD |
PMID:24120684 PMID:32905824 |
|
NCBI chr 2:195,624,015...195,628,774
Ensembl chr 2:195,544,426...195,628,961
|
|
G |
Gstm4 |
glutathione S-transferase mu 4 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of GSTM4 mRNA |
CTD |
PMID:32905824 |
|
NCBI chr 2:195,667,940...195,685,315
Ensembl chr 2:195,680,004...195,685,323
|
|
G |
Gstm5 |
glutathione S-transferase, mu 5 |
increases acetylation increases expression multiple interactions decreases expression |
ISO |
ochratoxin A results in increased acetylation of GSTM3 promoter ochratoxin A results in increased expression of GSTM3 mRNA [ochratoxin A results in increased acetylation of GSTM3 promoter] which results in increased expression of GSTM3 mRNA ochratoxin A results in decreased expression of GSTM3 mRNA |
CTD |
PMID:29098329 PMID:32905824 |
|
NCBI chr 2:195,531,599...195,534,562
Ensembl chr 2:195,531,495...195,534,553
|
|
G |
Gsto1 |
glutathione S-transferase omega 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of GSTO1 mRNA; ochratoxin A results in decreased expression of GSTO1 protein |
CTD |
PMID:19287073 |
|
NCBI chr 1:246,721,089...246,731,228
Ensembl chr 1:246,721,221...246,731,468
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
decreases expression multiple interactions |
EXP ISO |
ochratoxin A results in decreased expression of GSTP1 mRNA; ochratoxin A results in decreased expression of GSTP1 protein [cafestol co-treated with kahweol] inhibits the reaction [ochratoxin A results in decreased expression of GSTP1 protein]; ochratoxin A inhibits the reaction [NFE2L2 protein binds to GSTP1 protein] |
CTD |
PMID:12700408 PMID:17110534 PMID:23358140 PMID:32905824 |
|
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
|
|
G |
Gstt1 |
glutathione S-transferase theta 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of GSTT1 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr20:12,856,613...12,873,586
Ensembl chr20:12,856,669...12,873,585
|
|
G |
Gstt2 |
glutathione S-transferase theta 2 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of GSTT2 mRNA |
CTD |
PMID:16251485 PMID:18417182 PMID:23358140 |
|
NCBI chr20:12,819,617...12,823,288
Ensembl chr20:12,819,170...12,823,288
|
|
G |
Gstz1 |
glutathione S-transferase zeta 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of GSTZ1 mRNA |
CTD |
PMID:32905824 |
|
NCBI chr 6:106,794,594...106,805,284
Ensembl chr 6:106,794,074...106,805,284
|
|
G |
Gtf2h5 |
general transcription factor IIH subunit 5 |
increases expression |
ISO |
ochratoxin A results in increased expression of GTF2H5 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 1:46,656,804...46,663,512
Ensembl chr 1:46,656,859...46,664,939
|
|
G |
Gtf3c5 |
general transcription factor IIIC subunit 5 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of GTF3C5 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 3:11,893,867...11,914,187
Ensembl chr 3:11,893,875...11,914,180
|
|
G |
Gtse1 |
G-2 and S-phase expressed 1 |
increases expression |
EXP |
ochratoxin A results in increased expression of GTSE1 mRNA |
CTD |
PMID:23208426 |
|
NCBI chr 7:116,949,997...116,966,826
Ensembl chr 7:116,950,053...116,966,806
|
|
G |
Gucy1b2 |
guanylate cyclase 1 soluble subunit beta 2 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of GUCY1B2 mRNA |
CTD |
PMID:30449730 |
|
NCBI chr15:36,589,501...36,669,441
Ensembl chr15:36,598,883...36,669,441
|
|
G |
H1f10 |
H1.10 linker histone |
decreases expression |
EXP |
ochratoxin A results in decreased expression of H1F10 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 4:120,440,515...120,441,578
Ensembl chr 4:120,440,870...120,441,448
|
|
G |
H1f6 |
H1.6 linker histone, cluster member |
increases expression |
ISO EXP |
ochratoxin A results in increased expression of H1-6 mRNA ochratoxin A results in increased expression of H1F6 mRNA |
CTD |
PMID:22124623 PMID:30449730 |
|
NCBI chr17:41,427,365...41,428,109
Ensembl chr17:41,427,323...41,428,119
|
|
G |
H2ax |
H2A.X variant histone |
decreases expression increases expression increases phosphorylation |
ISO EXP |
ochratoxin A results in decreased expression of H2AX mRNA ochratoxin A results in increased expression of H2AX protein ochratoxin A results in increased expression of H2AX mRNA; ochratoxin A results in increased expression of H2AX protein modified form ochratoxin A results in increased phosphorylation of H2AX protein |
CTD |
PMID:19287073 PMID:23358140 PMID:24243707 PMID:28286205 PMID:38301995 |
|
NCBI chr 8:44,671,907...44,673,262
Ensembl chr 8:44,671,786...44,673,239
|
|
G |
Hadhb |
hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta |
decreases expression |
ISO |
ochratoxin A results in decreased expression of HADHB protein |
CTD |
PMID:26861962 |
|
NCBI chr 6:26,153,572...26,187,668
Ensembl chr 6:26,153,578...26,184,869
|
|
G |
Hagh |
hydroxyacyl glutathione hydrolase |
decreases expression |
EXP |
ochratoxin A results in decreased expression of HAGH mRNA |
CTD |
PMID:23358140 |
|
NCBI chr10:13,874,883...13,889,527
Ensembl chr10:13,875,241...13,889,504
|
|
G |
Has1 |
hyaluronan synthase 1 |
increases expression decreases methylation |
EXP |
ochratoxin A results in increased expression of HAS1 mRNA ochratoxin A results in decreased methylation of HAS1 gene |
CTD |
PMID:37162024 |
|
NCBI chr 1:58,693,411...58,705,653
Ensembl chr 1:58,693,411...58,705,397
|
|
G |
Havcr1 |
hepatitis A virus cellular receptor 1 |
increases expression increases secretion multiple interactions |
EXP ISO |
ochratoxin A results in increased expression of HAVCR1; ochratoxin A results in increased expression of HAVCR1 mRNA; ochratoxin A results in increased expression of HAVCR1 protein ochratoxin A results in increased secretion of HAVCR1 mRNA AHR protein affects the reaction [ochratoxin A results in increased expression of HAVCR1 mRNA]; HSPA9 protein affects the reaction [ochratoxin A results in decreased expression of HAVCR1 protein]; NFE2L2 protein affects the reaction [ochratoxin A results in increased expression of HAVCR1 mRNA]; NR1I2 protein affects the reaction [ochratoxin A results in increased expression of HAVCR1 mRNA] HSPA9 protein affects the reaction [ochratoxin A results in increased expression of HAVCR1 protein] [1-aminobenzotriazole co-treated with ochratoxin A] results in increased expression of HAVCR1 protein |
CTD |
PMID:16251485 PMID:18308701 PMID:25218026 PMID:30291945 PMID:30449730 PMID:31369848 PMID:36227364 More...
|
|
NCBI chr10:31,118,667...31,151,730
Ensembl chr10:31,119,088...31,151,698
|
|
G |
Hbs1l |
HBS1-like translational GTPase |
increases expression |
ISO EXP |
ochratoxin A results in increased expression of HBS1L mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 1:16,092,529...16,170,082
Ensembl chr 1:16,092,547...16,170,074
|
|
G |
Hcfc1r1 |
host cell factor C1 regulator 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of HCFC1R1 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr10:12,705,139...12,706,852
Ensembl chr10:12,705,077...12,706,850
|
|
G |
Hdac3 |
histone deacetylase 3 |
increases expression |
EXP |
ochratoxin A results in increased expression of HDAC3 protein |
CTD |
PMID:17651772 |
|
NCBI chr18:29,770,637...29,789,850
Ensembl chr18:29,770,636...29,793,856
|
|
G |
Hdgfl3 |
HDGF like 3 |
increases expression |
EXP |
ochratoxin A results in increased expression of HDGFL3 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 1:135,822,600...135,876,719
Ensembl chr 1:135,827,549...135,876,719
|
|
G |
Hdlbp |
high density lipoprotein binding protein |
increases expression |
EXP |
ochratoxin A results in increased expression of HDLBP mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 9:93,948,099...94,018,040
Ensembl chr 9:93,949,913...94,018,048
|
|
G |
Hes1 |
hes family bHLH transcription factor 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of HES1 mRNA |
CTD |
PMID:21703336 |
|
NCBI chr11:70,705,763...70,708,176
Ensembl chr11:70,705,764...70,708,192
|
|
G |
Hes5 |
hes family bHLH transcription factor 5 |
decreases expression multiple interactions |
EXP |
ochratoxin A results in decreased expression of HES5 mRNA SHH protein modified form inhibits the reaction [ochratoxin A results in decreased expression of HES5 mRNA] |
CTD |
PMID:21703336 |
|
NCBI chr 5:165,522,138...165,523,684
Ensembl chr 5:165,522,234...165,523,001
|
|
G |
Hgf |
hepatocyte growth factor |
multiple interactions |
EXP |
ochratoxin A inhibits the reaction [HGF protein results in increased uptake of estradiol-17 beta-glucuronide] |
CTD |
PMID:18031729 |
|
NCBI chr 4:18,673,736...18,745,582
Ensembl chr 4:18,677,101...18,745,409
|
|
G |
Hif1a |
hypoxia inducible factor 1 subunit alpha |
increases expression decreases expression affects expression |
EXP ISO |
ochratoxin A results in increased expression of HIF1A mRNA ochratoxin A results in decreased expression of HIF1A mRNA ochratoxin A affects the expression of HIF1A protein |
CTD |
PMID:12700408 PMID:23358140 PMID:30876885 |
|
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
|
|
G |
Hif3a |
hypoxia inducible factor 3 subunit alpha |
decreases expression increases methylation |
EXP |
ochratoxin A results in decreased expression of HIF3A mRNA ochratoxin A results in increased methylation of HIF3A gene |
CTD |
PMID:37162024 |
|
NCBI chr 1:77,718,110...77,750,448
Ensembl chr 1:77,722,471...77,749,758
|
|
G |
Hist1h2bq |
histone cluster 1 H2B family member Q |
increases expression |
EXP |
ochratoxin A results in increased expression of HIST1H2BQ mRNA |
CTD |
PMID:22124623 |
|
NCBI chr17:41,432,100...41,441,487
Ensembl chr17:41,429,164...41,442,153
|
|
G |
Hist1h4b |
histone cluster 1 H4 family member B |
increases expression |
EXP |
ochratoxin A results in increased expression of HIST1H4B mRNA |
CTD |
PMID:18417182 |
|
NCBI chr17:42,480,467...42,484,912
Ensembl chr17:42,480,313...42,485,370
|
|
G |
Hk2 |
hexokinase 2 |
increases expression |
ISO |
ochratoxin A results in increased expression of HK2 protein |
CTD |
PMID:32835834 |
|
NCBI chr 4:115,234,509...115,283,530
Ensembl chr 4:115,234,509...115,283,530
|
|
G |
Hmcn1 |
hemicentin 1 |
increases expression |
ISO |
ochratoxin A results in increased expression of HMCN1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr13:62,615,461...63,084,524
Ensembl chr13:62,615,461...63,084,524
|
|
G |
Hmgb2 |
high mobility group box 2 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of HMGB2 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr16:32,710,651...32,713,230
Ensembl chr16:32,710,658...32,713,140
|
|
G |
Hmgn5 |
high mobility group nucleosome binding domain 5 |
increases expression |
ISO |
ochratoxin A results in increased expression of HMGN5 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr X:74,085,871...74,094,488
Ensembl chr X:74,085,875...74,094,441
|
|
G |
Hmmr |
hyaluronan-mediated motility receptor |
increases expression |
EXP |
ochratoxin A results in increased expression of HMMR mRNA |
CTD |
PMID:37162024 |
|
NCBI chr10:25,132,933...25,163,029
Ensembl chr10:25,132,977...25,163,060
|
|
G |
Hmox1 |
heme oxygenase 1 |
increases expression multiple interactions decreases expression affects expression |
EXP ISO |
ochratoxin A results in increased expression of HMOX1 mRNA; ochratoxin A results in increased expression of HMOX1 protein 8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [ochratoxin A results in increased expression of HMOX1 mRNA]; ochratoxin A inhibits the reaction [15-deoxy-delta(12,14)-prostaglandin J2 results in increased expression of HMOX1 mRNA] ochratoxin A results in decreased expression of HMOX1 mRNA; ochratoxin A results in decreased expression of HMOX1 protein ochratoxin A affects the reaction [NFE2L2 protein affects the expression of HMOX1 mRNA] AHR protein affects the reaction [ochratoxin A results in increased expression of HMOX1 mRNA]; NR1I2 protein affects the reaction [ochratoxin A results in increased expression of HMOX1 mRNA] ochratoxin A affects the expression of HMOX1 mRNA |
CTD |
PMID:15994020 PMID:16251485 PMID:17316727 PMID:19414514 PMID:23358140 PMID:26260164 PMID:28710020 PMID:30008028 PMID:30291945 PMID:30559759 PMID:32905824 More...
|
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hmox2 |
heme oxygenase 2 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of HMOX2 mRNA |
CTD |
PMID:16251485 |
|
NCBI chr10:10,797,076...10,831,178
Ensembl chr10:10,797,055...10,831,148
|
|
G |
Hnf1a |
HNF1 homeobox A |
decreases expression |
EXP |
ochratoxin A results in decreased expression of HNF1A mRNA |
CTD |
PMID:23358140 |
|
NCBI chr12:41,638,536...41,672,806
Ensembl chr12:41,645,587...41,672,104
|
|
G |
Hnf4a |
hepatocyte nuclear factor 4, alpha |
decreases expression |
EXP ISO |
ochratoxin A results in decreased expression of HNF4A mRNA; ochratoxin A results in decreased expression of HNF4A protein |
CTD |
PMID:16251485 PMID:23358140 PMID:30008028 |
|
NCBI chr 3:152,186,787...152,248,320
Ensembl chr 3:152,186,787...152,248,320
|
|
G |
Hnf4g |
hepatocyte nuclear factor 4, gamma |
decreases expression increases methylation |
EXP |
ochratoxin A results in decreased expression of HNF4G mRNA ochratoxin A results in increased methylation of HNF4G gene |
CTD |
PMID:37162024 |
|
NCBI chr 2:97,885,773...98,036,650
Ensembl chr 2:97,887,432...98,036,592
|
|
G |
Hnrnpf |
heterogeneous nuclear ribonucleoprotein F |
decreases expression |
ISO |
ochratoxin A results in decreased expression of HNRNPF protein |
CTD |
PMID:19445961 |
|
NCBI chr 4:151,083,262...151,104,464
Ensembl chr 4:151,083,062...151,109,038
|
|
G |
Hnrnpk |
heterogeneous nuclear ribonucleoprotein K |
decreases expression |
ISO |
ochratoxin A results in decreased expression of HNRNPK protein |
CTD |
PMID:19445961 |
|
NCBI chr17:6,262,936...6,275,001
Ensembl chr17:6,262,998...6,274,997
|
|
G |
Hras |
HRas proto-oncogene, GTPase |
increases expression |
EXP |
ochratoxin A results in increased expression of HRAS mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 1:196,290,127...196,299,823
Ensembl chr 1:196,296,263...196,300,615
|
|
G |
Hsd17b1 |
hydroxysteroid (17-beta) dehydrogenase 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of HSD17B1 mRNA |
CTD |
PMID:18417182 |
|
NCBI chr10:86,009,728...86,011,928
Ensembl chr10:86,009,728...86,011,927
|
|
G |
Hsd3b1 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 |
increases expression |
ISO |
ochratoxin A results in increased expression of HSD3B1 mRNA; ochratoxin A results in increased expression of HSD3B1 protein |
CTD |
PMID:23466516 |
|
NCBI chr 2:186,169,864...186,175,984
Ensembl chr 2:186,169,863...186,175,999
|
|
G |
Hsp90aa1 |
heat shock protein 90 alpha family class A member 1 |
increases expression |
ISO |
ochratoxin A results in increased expression of HSP90AA1 protein |
CTD |
PMID:26861962 |
|
NCBI chr 6:129,702,376...129,707,907
Ensembl chr 6:129,702,383...129,707,268
|
|
G |
Hsp90ab1 |
heat shock protein 90 alpha family class B member 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of HSP90AB1 protein |
CTD |
PMID:31369848 |
|
NCBI chr 9:15,432,986...15,438,358
Ensembl chr 9:15,433,691...15,438,488
|
|
G |
Hspa1a |
heat shock protein family A (Hsp70) member 1A |
decreases expression |
EXP ISO |
ochratoxin A results in decreased expression of HSPA1A mRNA ochratoxin A results in decreased expression of HSPA1A mRNA; ochratoxin A results in decreased expression of HSPA1A protein |
CTD |
PMID:16857307 PMID:17316727 PMID:19051279 PMID:19367635 |
|
NCBI chr20:3,870,765...3,873,221
Ensembl chr20:3,856,006...3,873,227
|
|
G |
Hspa2 |
heat shock protein family A (Hsp70) member 2 |
decreases expression decreases acetylation multiple interactions |
ISO |
ochratoxin A results in decreased expression of HSPA2 mRNA ochratoxin A results in decreased acetylation of HSPA2 promoter [ochratoxin A results in decreased acetylation of HSPA2 promoter] which results in decreased expression of HSPA2 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 6:95,128,504...95,131,281
Ensembl chr 6:95,128,350...95,131,287
|
|
G |
Hspa5 |
heat shock protein family A (Hsp70) member 5 |
decreases expression increases expression decreases methylation multiple interactions |
ISO |
ochratoxin A results in decreased expression of HSPA5 protein ochratoxin A results in decreased expression of HSPA5 mRNA ochratoxin A metabolite results in increased expression of HSPA5 mRNA; ochratoxin A results in increased expression of HSPA5 mRNA; ochratoxin A results in increased expression of HSPA5 protein ochratoxin A results in decreased methylation of HSPA5 promoter ochratoxin A promotes the reaction [bardoxolone methyl results in increased expression of HSPA5 protein]; Oleanolic Acid inhibits the reaction [ochratoxin A results in increased expression of HSPA5 protein]; TRAP1 protein affects the reaction [ochratoxin A results in increased expression of HSPA5 protein]; TRAP1 protein affects the reaction [Oleanolic Acid inhibits the reaction [ochratoxin A results in increased expression of HSPA5 protein]]; Ursolic Acid inhibits the reaction [ochratoxin A results in increased expression of HSPA5 protein] |
CTD |
PMID:19051279 PMID:19445961 PMID:24356939 PMID:30559759 PMID:33465424 PMID:36058351 PMID:36587836 More...
|
|
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
|
|
G |
Hspa6l-ps1 |
heat shock protein family A (Hsp70) member 6 like, pseudogene 1 |
increases expression increases acetylation multiple interactions |
ISO |
ochratoxin A results in increased expression of HSPA6 mRNA ochratoxin A results in increased acetylation of HSPA6 promoter [ochratoxin A results in increased acetylation of HSPA6 promoter] which results in increased expression of HSPA6 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr13:83,273,176...83,274,317
|
|
G |
Hspa8 |
heat shock protein family A (Hsp70) member 8 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of HSPA8 protein |
CTD |
PMID:31369848 |
|
NCBI chr 8:41,183,397...41,187,260
Ensembl chr 8:41,183,264...41,187,259
|
|
G |
Hspa9 |
heat shock protein family A (Hsp70) member 9 |
decreases expression increases expression multiple interactions |
ISO EXP |
ochratoxin A results in decreased expression of HSPA9 mRNA; ochratoxin A results in decreased expression of HSPA9 protein ochratoxin A results in increased expression of HSPA9 protein HSPA9 protein affects the reaction [ochratoxin A results in decreased expression of LONP1 protein]; HSPA9 protein affects the reaction [ochratoxin A results in increased expression of HAVCR1 protein] HSPA9 protein affects the reaction [ochratoxin A results in decreased expression of HAVCR1 protein]; HSPA9 protein affects the reaction [ochratoxin A results in decreased expression of LONP1 protein] |
CTD |
PMID:19051279 PMID:31369848 |
|
NCBI chr18:26,536,131...26,554,294
Ensembl chr18:26,535,798...26,554,292
|
|
G |
Hspb1 |
heat shock protein family B (small) member 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of HSPB1 mRNA; ochratoxin A results in decreased expression of HSPB1 protein |
CTD |
PMID:19051279 PMID:19367635 |
|
NCBI chr12:20,794,014...20,795,675
Ensembl chr12:20,794,028...20,795,743
|
|
G |
Hspd1 |
heat shock protein family D (Hsp60) member 1 |
increases expression |
EXP |
ochratoxin A results in increased expression of HSPD1 protein |
CTD |
PMID:31369848 |
|
NCBI chr 9:56,579,195...56,590,011
Ensembl chr 9:56,579,201...56,589,662
|
|
G |
Htr1a |
5-hydroxytryptamine receptor 1A |
increases expression |
EXP |
ochratoxin A results in increased expression of HTR1A mRNA |
CTD |
PMID:27346841 |
|
NCBI chr 2:36,693,462...36,698,026
Ensembl chr 2:36,694,174...36,695,442
|
|
G |
Htr4 |
5-hydroxytryptamine receptor 4 |
decreases methylation increases expression |
EXP |
ochratoxin A results in decreased methylation of HTR4 gene ochratoxin A results in increased expression of HTR4 mRNA |
CTD |
PMID:26431795 PMID:27346841 |
|
NCBI chr18:55,765,981...55,949,921
Ensembl chr18:55,766,725...55,949,321
|
|
G |
Hyls1 |
HYLS1, centriolar and ciliogenesis associated |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of HYLS1 mRNA; ochratoxin A results in decreased expression of HYLS1 mRNA |
CTD |
PMID:24356939 |
|
NCBI chr 8:33,912,692...33,921,760
Ensembl chr 8:33,912,692...33,921,760
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
multiple interactions increases expression |
ISO EXP |
[NFE2L2 protein affects the susceptibility to ochratoxin A] which results in increased expression of ICAM1 protein ochratoxin A results in increased expression of ICAM1 mRNA |
CTD |
PMID:28710020 PMID:37162024 |
|
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
|
|
G |
Id1 |
inhibitor of DNA binding 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of ID1 mRNA |
CTD |
PMID:12700408 PMID:17483316 |
|
NCBI chr 3:141,210,666...141,212,420
Ensembl chr 3:141,211,267...141,212,419
|
|
G |
Id2 |
inhibitor of DNA binding 2 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of ID2 mRNA |
CTD |
PMID:24356939 |
|
NCBI chr 6:41,740,556...41,742,393
Ensembl chr 6:41,728,946...41,744,400
|
|
G |
Id3 |
inhibitor of DNA binding 3 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of ID3 mRNA |
CTD |
PMID:21703336 |
|
NCBI chr 5:148,372,784...148,374,353
Ensembl chr 5:148,372,762...148,374,349
|
|
G |
Id4 |
inhibitor of DNA binding 4 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of ID4 mRNA |
CTD |
PMID:23358140 |
|
NCBI chr17:16,389,387...16,391,956
Ensembl chr17:16,389,387...16,392,470
|
|
G |
Idh1 |
isocitrate dehydrogenase (NADP(+)) 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of IDH1 mRNA; ochratoxin A results in decreased expression of IDH1 protein |
CTD |
PMID:32835834 PMID:32905824 |
|
NCBI chr 9:66,534,146...66,563,703
Ensembl chr 9:66,534,146...66,563,708
|
|
G |
Idh3b |
isocitrate dehydrogenase (NAD(+)) 3 non-catalytic subunit beta |
decreases expression |
ISO |
ochratoxin A results in decreased expression of IDH3B mRNA |
CTD |
PMID:19287073 |
|
NCBI chr 3:117,481,845...117,486,909
Ensembl chr 3:117,481,845...117,486,982
|
|
G |
Idh3g |
isocitrate dehydrogenase (NAD(+)) 3 non-catalytic subunit gamma |
decreases expression |
ISO |
ochratoxin A results in decreased expression of IDH3G mRNA |
CTD |
PMID:19287073 |
|
NCBI chr X:151,515,244...151,524,175
Ensembl chr X:151,515,247...151,524,171
|
|
G |
Idi2l3 |
isopentenyl-diphosphate delta isomerase 2 like 3 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of IDI2L3 mRNA |
CTD |
PMID:30449730 |
|
NCBI chr17:61,518,138...61,535,484
Ensembl chr17:61,519,390...61,531,603
|
|
G |
Ier3 |
immediate early response 3 |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of IER3 mRNA; ochratoxin A results in decreased expression of IER3 mRNA |
CTD |
PMID:24356939 |
|
NCBI chr20:2,928,378...2,929,582
Ensembl chr20:2,928,378...2,929,583
|
|
G |
Ifi35 |
interferon-induced protein 35 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of IFI35 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr10:86,381,023...86,389,279
Ensembl chr10:86,381,010...86,389,952
|
|
G |
Ifitm3 |
interferon induced transmembrane protein 3 |
increases expression multiple interactions increases acetylation |
ISO |
ochratoxin A results in increased expression of IFITM3 mRNA [ochratoxin A results in increased acetylation of IFITM3 promoter] which results in increased expression of IFITM3 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 1:196,111,026...196,112,135
Ensembl chr 1:196,111,043...196,112,203
|
|
G |
Ifng |
interferon gamma |
multiple interactions |
ISO |
[ochratoxin A results in increased susceptibility to Antigens] which results in increased expression of IFNG protein |
CTD |
PMID:28935500 |
|
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Ifrd1 |
interferon-related developmental regulator 1 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of IFRD1 mRNA |
CTD |
PMID:24356939 |
|
NCBI chr 6:57,269,395...57,317,833
Ensembl chr 6:57,269,384...57,288,990
|
|
G |
Igf1 |
insulin-like growth factor 1 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of IGF1 mRNA |
CTD |
PMID:16251485 |
|
NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
|
|
G |
Igf1r |
insulin-like growth factor 1 receptor |
increases expression |
EXP |
ochratoxin A results in increased expression of IGF1R protein |
CTD |
PMID:17651772 |
|
NCBI chr 1:121,549,831...121,838,548
Ensembl chr 1:121,550,743...121,831,777
|
|
G |
Igf2 |
insulin-like growth factor 2 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of IGF2 mRNA |
CTD |
PMID:19287073 |
|
NCBI chr 1:197,814,409...197,831,802
Ensembl chr 1:197,814,410...197,823,018
|
|
G |
Igfbp1 |
insulin-like growth factor binding protein 1 |
decreases expression increases expression |
ISO EXP |
ochratoxin A results in decreased expression of IGFBP1 mRNA; ochratoxin A results in decreased expression of IGFBP1 protein ochratoxin A results in increased expression of IGFBP1 mRNA |
CTD |
PMID:19287073 PMID:19717638 |
|
NCBI chr14:82,047,415...82,052,482
Ensembl chr14:82,047,415...82,052,482
|
|
G |
Igfbp4 |
insulin-like growth factor binding protein 4 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of IGFBP4 mRNA |
CTD |
PMID:18417182 |
|
NCBI chr10:83,995,253...84,007,272
Ensembl chr10:83,989,591...84,007,225
|
|
G |
Ihh |
Indian hedgehog signaling molecule |
decreases expression |
EXP |
ochratoxin A results in decreased expression of IHH mRNA |
CTD |
PMID:23358140 |
|
NCBI chr 9:76,504,315...76,510,532
Ensembl chr 9:76,504,315...76,510,532
|
|
G |
Il10 |
interleukin 10 |
increases expression |
EXP |
ochratoxin A results in increased expression of IL10 mRNA |
CTD |
PMID:19562491 |
|
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
|
|
G |
Il12a |
interleukin 12A |
decreases expression |
ISO |
ochratoxin A results in decreased expression of IL12A mRNA |
CTD |
PMID:30763683 |
|
NCBI chr 2:152,965,769...152,973,035
Ensembl chr 2:152,965,769...152,972,734
|
|
G |
Il12b |
interleukin 12B |
multiple interactions |
ISO |
[Lipopolysaccharides co-treated with ochratoxin A] results in increased expression of IL12B protein |
CTD |
PMID:28935500 |
|
NCBI chr10:28,888,832...28,903,802
Ensembl chr10:28,893,008...28,902,903
|
|
G |
Il13 |
interleukin 13 |
increases acetylation increases expression multiple interactions |
ISO |
ochratoxin A results in increased acetylation of IL13 promoter ochratoxin A results in increased expression of IL13 mRNA [ochratoxin A results in increased acetylation of IL13 promoter] which results in increased expression of IL13 mRNA |
CTD |
PMID:29098329 |
|
NCBI chr10:37,790,130...37,792,687
Ensembl chr10:37,790,130...37,792,737
|
|
G |
Il17a |
interleukin 17A |
multiple interactions |
ISO |
[ochratoxin A results in increased susceptibility to Antigens] which results in increased expression of IL17A protein |
CTD |
PMID:28935500 |
|
NCBI chr 9:23,144,402...23,147,889
Ensembl chr 9:23,144,402...23,147,889
|
|
G |
Il17rc |
interleukin 17 receptor C |
increases expression increases acetylation multiple interactions |
ISO |
ochratoxin A results in increased expression of IL17RC mRNA ochratoxin A results in increased acetylation of IL17RC promoter [ochratoxin A results in increased acetylation of IL17RC promoter] which results in increased expression of IL17RC mRNA |
CTD |
PMID:29098329 |
|
NCBI chr 4:146,618,321...146,631,444
Ensembl chr 4:146,619,004...146,631,442
|
|
G |
Il18 |
interleukin 18 |
increases expression increases secretion |
ISO |
ochratoxin A results in increased expression of IL18 mRNA ochratoxin A results in increased secretion of IL18 protein |
CTD |
PMID:33543323 PMID:38301823 |
|
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
|
|
G |
Il19 |
interleukin 19 |
increases expression |
EXP |
ochratoxin A results in increased expression of IL19 mRNA |
CTD |
PMID:35843423 |
|
NCBI chr13:42,397,715...42,411,637
Ensembl chr13:42,399,138...42,405,473
|
|
G |
Il1a |
interleukin 1 alpha |
increases expression |
ISO |
ochratoxin A results in increased expression of IL1A mRNA |
CTD |
PMID:28286205 |
|
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions increases expression increases secretion |
ISO EXP |
ochratoxin A inhibits the reaction [IL1B protein results in increased expression of CXCL8 protein]; ochratoxin A inhibits the reaction [IL1B protein results in increased expression of F3 protein] ochratoxin A results in increased expression of IL1B mRNA ochratoxin A results in increased expression of IL1B mRNA; ochratoxin A results in increased expression of IL1B protein [Lipopolysaccharides co-treated with ochratoxin A] results in increased expression of IL1B protein; [ochratoxin A results in increased susceptibility to Antigens] which results in increased expression of IL1B protein; NFE2L2 protein affects the reaction [ochratoxin A results in increased expression of IL1B mRNA]; sulforaphane inhibits the reaction [ochratoxin A results in increased expression of IL1B mRNA] ochratoxin A results in increased secretion of IL1B protein |
CTD |
PMID:18289624 PMID:18308354 PMID:24792326 PMID:28710020 PMID:28935500 PMID:33543323 PMID:38301823 More...
|
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il1r2 |
interleukin 1 receptor type 2 |
increases expression |
ISO |
ochratoxin A results in increased expression of IL1R2 mRNA |
CTD |
PMID:22124623 |
|
NCBI chr 9:42,384,280...42,424,726
Ensembl chr 9:42,384,433...42,424,725
|
|
G |
Il2 |
interleukin 2 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of IL2 mRNA |
CTD |
PMID:27193732 |
|
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
|
|
G |
Il20 |
interleukin 20 |
increases expression |
EXP |
ochratoxin A results in increased expression of IL20 mRNA |
CTD |
PMID:35843423 |
|
NCBI chr13:42,380,981...42,384,625
Ensembl chr13:42,380,981...42,384,625
|
|
G |
Il20ra |
interleukin 20 receptor subunit alpha |
increases expression |
EXP |
ochratoxin A results in increased expression of IL20RA mRNA |
CTD |
PMID:35843423 |
|
NCBI chr 1:14,424,215...14,494,226
Ensembl chr 1:14,451,228...14,493,602
|
|
G |
Il24 |
interleukin 24 |
increases expression |
EXP |
ochratoxin A results in increased expression of IL24 mRNA |
CTD |
PMID:23208426 PMID:23358140 |
|
NCBI chr13:42,353,089...42,358,487
Ensembl chr13:42,353,090...42,358,487
|
|
G |
Il4 |
interleukin 4 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of IL4 mRNA |
CTD |
PMID:24792326 |
|
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
|
|
G |
Il6 |
interleukin 6 |
increases expression multiple interactions |
EXP ISO |
ochratoxin A results in increased expression of IL6 mRNA ochratoxin A results in increased expression of IL6 mRNA; ochratoxin A results in increased expression of IL6 protein Quercetin inhibits the reaction [ochratoxin A results in increased expression of IL6 protein] [Lipopolysaccharides co-treated with ochratoxin A] results in increased expression of IL6 protein; [ochratoxin A results in increased susceptibility to Antigens] which results in increased expression of IL6 protein; sulforaphane inhibits the reaction [ochratoxin A results in increased expression of IL6 mRNA] |
CTD |
PMID:24792326 PMID:25532488 PMID:28286205 PMID:28710020 PMID:28935500 PMID:37162024 More...
|
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Inhba |
inhibin subunit beta A |
increases expression |
EXP |
ochratoxin A results in increased expression of INHBA mRNA |
CTD |
PMID:23358140 |
|
NCBI chr17:49,091,635...49,111,573
Ensembl chr17:49,095,920...49,108,982
|
|
G |
Ins2 |
insulin 2 |
multiple interactions |
ISO |
INS protein inhibits the reaction [ochratoxin A results in decreased phosphorylation of AKT1 protein]; INS protein inhibits the reaction [ochratoxin A results in decreased phosphorylation of MTOR protein] |
CTD |
PMID:30287338 |
|
NCBI chr 1:197,843,277...197,992,522
Ensembl chr 1:197,843,281...197,864,775
|
|
G |
Ipcef1 |
interaction protein for cytohesin exchange factors 1 |
increases expression decreases methylation |
ISO |
ochratoxin A results in increased expression of IPCEF1 mRNA ochratoxin A results in decreased methylation of IPCEF1 promoter |
CTD |
PMID:30559759 |
|
NCBI chr 1:43,237,903...43,451,735
Ensembl chr 1:43,269,202...43,427,969
|
|
G |
Iqgap1 |
IQ motif containing GTPase activating protein 1 |
increases expression |
EXP |
ochratoxin A results in increased expression of IQGAP1 mRNA |
CTD |
PMID:19717638 |
|
NCBI chr 1:134,679,581...134,769,776
Ensembl chr 1:134,679,586...134,769,755
|
|
G |
Isl2 |
ISL LIM homeobox 2 |
decreases expression |
ISO |
ochratoxin A results in decreased expression of ISL2 mRNA |
CTD |
PMID:24356939 |
|
NCBI chr 8:55,923,805...55,928,790
Ensembl chr 8:55,923,805...55,928,790
|
|
G |
Itch |
itchy E3 ubiquitin protein ligase |
decreases expression |
EXP |
ochratoxin A results in decreased expression of ITCH mRNA |
CTD |
PMID:18417182 |
|
NCBI chr 3:143,642,348...143,733,745
Ensembl chr 3:143,645,637...143,733,543
|
|
G |
Itga4 |
integrin subunit alpha 4 |
increases expression |
ISO |
ochratoxin A metabolite results in increased expression of ITGA4 mRNA; ochratoxin A results in increased expression of ITGA4 mRNA |
CTD |
PMID:26314263 |
|
NCBI chr 3:64,162,764...64,235,010
Ensembl chr 3:64,163,085...64,233,715
|
|
G |
Itga7 |
integrin subunit alpha 7 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of ITGA7 mRNA |
CTD |
PMID:18417182 |
|
NCBI chr 7:1,360,125...1,388,886
Ensembl chr 7:1,359,940...1,388,450
|
|
G |
Itgal |
integrin subunit alpha L |
increases expression |
ISO |
ochratoxin A metabolite results in increased expression of ITGAL mRNA; ochratoxin A results in increased expression of ITGAL mRNA |
CTD |
PMID:26314263 |
|
NCBI chr 1:181,918,183...181,955,735
Ensembl chr 1:181,918,183...181,955,732
|
|
G |
Itgam |
integrin subunit alpha M |
increases expression |
EXP |
ochratoxin A results in increased expression of ITGAM mRNA |
CTD |
PMID:24792326 |
|
NCBI chr 1:182,659,047...182,709,501
Ensembl chr 1:182,659,000...182,709,503
|
|
G |
Itgb2 |
integrin subunit beta 2 |
increases expression |
ISO |
ochratoxin A metabolite results in increased expression of ITGB2 mRNA; ochratoxin A results in increased expression of ITGB2 mRNA |
CTD |
PMID:26314263 |
|
NCBI chr20:11,061,394...11,097,656
Ensembl chr20:11,061,430...11,097,600
|
|
G |
Itgb4 |
integrin subunit beta 4 |
increases expression |
EXP |
ochratoxin A results in increased expression of ITGB4 mRNA |
CTD |
PMID:19717638 |
|
NCBI chr10:101,206,657...101,243,012
Ensembl chr10:101,206,665...101,243,012
|
|
G |
Itk |
IL2-inducible T-cell kinase |
decreases expression |
ISO |
ochratoxin A metabolite results in decreased expression of ITK mRNA; ochratoxin A results in decreased expression of ITK mRNA |
CTD |
PMID:26314263 |
|
NCBI chr10:30,753,344...30,814,685
Ensembl chr10:30,753,344...30,814,685
|
|
G |
Itpkb |
inositol-trisphosphate 3-kinase B |
increases expression |
ISO |
ochratoxin A results in increased expression of ITPKB mRNA |
CTD |
PMID:30559759 |
|
NCBI chr13:92,069,160...92,164,281
Ensembl chr13:92,069,216...92,162,004
|
|
G |
Jakmip2 |
janus kinase and microtubule interacting protein 2 |
decreases expression |
EXP |
ochratoxin A results in decreased expression of JAKMIP2 mRNA |
CTD |
PMID:18417182 |
|
NCBI chr18:35,532,552...35,747,938
Ensembl chr18:35,532,552...35,747,775
|
|
|